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ABSTRACT
The Immunophilin family. The immunophilin family of proteins consists of two
members, Cyclophilins and FK-506 binding proteins (FKBP's). Immunophilins are
ubiquitous and highly evolutionarily conserved. Initially characterised by their high
affinity binding to immunosuppressant drugs Cyclosporin A (CsA) and FK-506
respectively, these proteins were shown to have intrinsic enzymatic activity,
exhibiting catalysis of peptidyl prolyl cis-trans isomerisation (PPIase activity) around
an Xaa-Pro bond. Subsequent studies have shown the involvement of immunophilins
in many cellular processes, for example as components of the multi-protein complex
responsible for the assembly and maturation of steroid hormone receptors.
The work described in this thesis focused on the over-expression, purification,
biochemical characterisation, crystallisation and 3-D structure determination of three
members of the immunophilin family. The overall goal of the project was to use
biochemical and structural information derived from these studies to assist in the
elucidation of the various roles played by these proteins in diverse systems.
Cyclophilin 3. Cloning and expression of eleven cyclophilin homologues from the
free-living nematode Caenorhabditis elegans (C. elegans) has recently been
reported. Cyclophilin 3 (Cyp-3), one of the most abundantly expressed isoforms, was
chosen as the initial target for further study. The structure of the protein was solved
to high resolution, allowing identification of a number of key structural features that
differ from those of the archetypal cyclophilin, Cyclophilin A. These newly
determined features, which may prove to be functionally significant, were used to
define a new cyclophilin subfamily. The PPIase activity and degree of inhibition of
the protein by CsA were also characterised. A series of experiments involving metal
binding to Cyp-3 were also carried out. Results presented include binding of an anti-
arthritic gold complex to Cyp-3. Attempts to induce metal catalysed oxidation of
cysteines present in the reduced form in the structure of Cyp-3 are described. The
first reported direct determination of a ligand binding constant in protein crystals is
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reported, following correlation of data obtained from both solution and X-ray
crystallographic studies of the binding of a di-peptide ligand (Ala-Pro) to Cyp-3.
Cyclophilin 40. Cyclophilin 40 (Cyp 40) is a two domain immunophilin containing a
conserved cyclophilin domain linked via a charged linker region to the C-terminal
domain comprised largely of three copies of the tetratricopeptide repeat (TPR) motif.
Cyp 40 constitutes part of the "mature" steroid hormone receptor complex,
interactions with Hsp90 have been described, although the exact nature of the
interaction has not been well defined. Using cloned bovine Cyp 40, two very
different crystal forms were grown. The resultant structures, monoclinic and
tetragonal Cyp 40, are illustrated and described. The structure of monoclinic Cyp 40
obtained was used as the basis for comparative protein modelling studies on a
number of cyclophilin 40 type proteins from different species, the results of which
are included. The second major objective was to use the experimentally determined
protein structure to derive new insights into the interactions seen with an important
partner protein, Hsp90. A model of the terminal five residues of Hsp90 (MEEVD)
binding to Cyp 40 is reported. A modelled interaction between 95 C-terminal
residues of hsp90 and the groove formed by the folding of the TPR domain of Cyp
40 is also described. The over-expression, purification and crystallisation trials of
two Hsp90 C-terminal fragments are also reported.
FKBP 22. Isolation of FKBP 22 from the endoplasmic reticulum of Neurospora
crassa (N. crassa) has recently been reported. The C-terminal sequence appears to be
unique among other FKBP sequences, being rather highly charged and is consistent
with an amphipathic helical conformation. Crystallisation and preliminary partial X-
ray structure determination of FKBP22 from N. crassa are reported.
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This chapter will introduce the Immunophilin family of proteins to be discussed in
this thesis. Background information on the isolation, characterisation and activities of
this family of proteins will be described.
1.1.1
The immunophilin super-family comprises two members, Cyclophilins
and FK-506 Binding Proteins (FKBPs).
Immunophilins are ubiquitous and highly conserved proteins originally identified by
their high affinity binding to immunosuppressant drugs. They can be divided into
two classes, Cyclophilins bind Cyclosporin A, the FKBP's are binding proteins for
the compounds FK-506 and rapamycin. The isolation, characterisation and structure
determination of the archetypal members of these protein families will be described
in greater detail later in this chapter.
Previous work demonstrating the immunophilin family served as ligands for
immunosuppressant drugs greatly advanced studies of the mechanism of
immunosuppression, but gave few clues as to the normal function of these proteins.
Their degree of ubiquity however suggests additional roles in normal cellular
processes, in the absence of exogenous drug.
The mechanism of immunosuppression involving a complex of the drugs (CsA and
FK-506/Rapamycin) with their cognate immunophilins interacting with target
proteins will be briefly described later in this chapter.
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Immunophilins are also classified as Peptidyl Prolyl Isomerases, due to their intrinsic
enzymatic activity. All members of the immunophilin family show peptidyl-prolyl
isomerase (PPIase) activity. A third type of PPIase was discovered in 1990 and was
assigned to a new protein family, the Parvulins. Parvulins however, do not appear to
be associated with any known immunosuppressant drugs and therefore fall out-with
the remit of this thesis.
1.1.2
Peptidyl-prolyl cis-trans isomerase activity (PPIase activity)
As previously described, three unrelated protein families Cyclophilins, FKBP's and
Parvulins possess PPIase activity. In this section PPIase activity will be considered in
more detail, and will include
■ A brief discussion of the nature and occurrence of X-Pro peptide bonds
■ The catalysis of protein folding brought about by prolyl isomerases
■ Proposed PPIase reaction mechanisms
■ Development of an assay for PPIase activity
■ Examples of the efficiency of these enzymes
1.1.2.1
X-Pro peptide bonds
Planar peptide bonds in proteins have been shown to occur predominantly in the
trans conformation. In 1990, Stewart et al investigated the occurrence of the cis
isomer in protein structures. To do this they examined high resolution X-ray
structures deposited with the Protein Data Bank. This study revealed there were very
few cis peptide bonds present in native folded proteins. The exception was proline as
approximately 10% of peptidyl-prolyl imide (X-Pro) bonds occur as cis isomers in
native, folded proteins (Stewart et al., 1990). The importance of proline residues in
defining and maintaining the structural integrity of proteins was described in a
publication by Macarthur and Thornton (Macarthur and Thornton, 1991).
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1.1.2.2




Cis-trans equilibrium and PPIase activity.
The conversion of trans proline to cisproline involves a rotation about the
bond. PPIase activity reduces the energy barrier for the above reaction. Note the
direction of the main chain shown by the arrows is opposite in the two conformers.
Cyclophilins were initially characterised by their enzymatic activity. These proteins
exhibited the ability to catalyse the slow cis-trans isomerisation step of proline-
peptide (Xaa-Pro) bonds in the folding of oligopeptides and also accelerated the
slow, rate limiting steps in the folding of several proteins (Fischer et al., 1984;
Bachinger, 1987; Lang et ah, 1987a).
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1.1.2.3
Proposed PPIase reaction mechanism
A number of different reaction mechanisms have been proposed to explain the
catalysis of cis-trans isomerisation induced by immunophilins. These have included:
1. The formation of a tetrahedral intermediate formed by the nucleophilic addition
of a cysteine or nucleophilic residue to the carbonyl carbon of the Xaa-Pro bond
(Fischer et al., 1989a).
2. Catalysis by protonation, involving side chain residues protonating the C-N
peptide bond (Fischer et al., 1989a; Kofron el al., 1991).
3. Catalysis by desolvation which suggested desolvation of the substrate is the first
step of the reaction, evidenced by the rate of cis-trans isomerisation being
accelerated in nonpolar solvents (Radzicka et al., 1992; Eberhardt et al., 1992)
4. Catalysis by distortion/twisted amide model. It was proposed that the C-N bond
was rotated allowing stabilisation of this distorted intermediate in the binding site of
the molecule (Harrison and Stein, 1990; Rosen et al., 1990). These models arose
from the suggestion that drugs inhibit the PPIase activity of the molecule by
mimicking an intermediate state in the cis-trans interconversion of peptide and
protein substrates. This appears to be currently the most favoured mechanism.
5. Solvent assisted mechanism. Similar to catalysis by distortion, except water
molecues not binding site residues in the protein important in the mechanism,
causing distortion of the amide bond (Ke et al., 1993; Zhao and Ke, 1996).
A summary of the various theories of the PPIase mechanism was provided in two
review articles (Galat and Metcalfe, 1995; Ivery, 2000). The more recent review
additionally discusses information on the potential PPIase mechanism provided from
recent structural studies of a number of members of the immunophilin family solved
with ligands bound in the active site.
The tight binding of CsA, FK-506 and rapamycin to their respective partners may be
as a consequence of their ability to mimic the conformation of the transition state of
the cis-trans reaction seen with peptide and protein substrates. Closer examination of
protein structures with drugs bound has help shed more light onto this topic. A recent
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paper (Ivery, 2000) provides a brief but reasonably comprehensive review of papers
reporting both theoretical and mechanistic studies of PPIase activity.
1.1.2.4
Assays ofPPIase activity
An assay for PPIase activity was developed by Fischer et al (Fischer et al., 1984).
This spectrophotometric assay utilised the high degree of conformational selectivity
of chymotrypsin towards peptide substrates of the type X-Pro-Phe-pNA.
Chymotrypsin hydrolysis of the p-nitroanilide bond was shown to only occur if the
prolyl amide bond was in the trans conformation, resulting in the release of
chromogenic dye (pNA), accumulation of which could be measured
spectrophotometrically. The ability of immunophilins to catalyse this cis-trans
isomerisation therefore manifests itself in this particular assay by making more
substrate available for hydrolysis with the consequent increase in measurable release
of pNA.
Figure 2
Schematic illustration of the PPIase assay (adapted from Goethel and Marahiel,
1999).
28
A number of competing processes exist within this assay, including the underlying,
parallel, reversible cis-trans isomerisation and the irreversible chymotrypsin
catalysed hydrolysis of the trans isomer conformation. In aqueous solutions, the
peptide substrate is present largely in the trans confomer, resulting in hydrolysis with
a very rapid burst phase with a small contribution from substrate isomerised during
the experiment. This resulted in a consequently poor signal to noise ratio and was a
limiting factor in the degree of usefulness of the assay as originally described. A
modified version of the assay with a rigorous mathematical treatment of the resultant
spectrophotometric progress curves was reported in 1991 (Kofron et ah, 1991). The
principal modifications to the experimental set-up were twofold.
(1) Use of a novel solvent system for the substrates (lithium chloride and
trichloroethanol), to push the equilibrium towards the cis X-Pro isomer, resulting in
an increase in available substrate from approximately 10% to 50 - 70%.
(2) Carrying out the assay at low temperature and also at a variety of wavelengths.
The improved assay allowed the study of the kinetics of the reaction under saturating
conditions, allowing determination of both steady state parameters for PPIase
substrates and inhibition patterns for a number of ligands.
1.1.2.5
Efficiency ofPPIase activity
Modification to the PPIase activity assay as suggested by Kofron et al allowed
determination of kinetic parameters of the catalytic efficiency of immunophilins. Cyp
A and FKBP12 were shown to be efficient catalysts of isomerisation, (Kofron et al.,
1991). Many other members of the family have been characterised, a number of





Cyp A 14.6 x 106M"V (Kofron etal., 1991)
BmCyp-1 7.9 x 106M"'s"' (Page et al., 1995a)
Cyp 3 2.4 x lO^ 's"1 (Dornan et al., 1999a)
Cyp 40 1.9 x 106M"1s"1 (Kiefferet al., 1992)
FKBP 12 0.66 x 106M"'s"' (Kofron et al., 1991)
FKBP 22 6.94 x 105M"1s"1 (Solscheid and Tropschug, 2000)
FKBP 52 2.6 x ioVtV (Peattie et al., 1992)
Table 1




Mechanism resulting in immunosuppression
Elucidation of the cellular mechanisms underlying the immunosuppressive effects of
CsA and FK-506 were the focus of a huge research effort for a number of years. The
PPIase activity of these two proteins was shown to be non-essential for the resulting
immunosuppressive activity, active site mutants of Cyp A were still able to bind CsA




















thereby blocking nuclear transport of cytoplasmic transcription factors, primarily NF-


















Roles of immunophilins in the absence ofexogenous drugs
Despite having similar roles in immunosuppression and sharing PPIase activity, these
two protein families are unrelated both in primary sequence and structure.
Immunophilins have a broad phylogenetic distribution, (for reviews see (Galat and
Metcalfe, 1995; Kay, 1996; Hamilton and Steiner, 1998), many species possessing
numerous immunophilin isoforms. The roles played by immunophilins within the cell
remains largely to be elucidated, however their degree of evolutionary conservation
and ubiquity suggests an important role for these proteins. Evidence in support of a
role for immunophilins acting in many pathways i.e. protein folding, regulation of
cellular processes and molecular chaperoning of partner proteins has grown over
recent years. A number of these potential roles will be discussed in later chapters. The
focus will be in particular on the larger two domain immunophilin Cyclophilin 40.
The broad goal of the project to be discussed in this thesis was to use protein
structures, in an attempt to shed light on the natural roles of selected members of the
immunophilin family. The study of this intriguing family of proteins may provide
insights into possible applications in a number of fields including development of





Cyclosporin A, a potent and specific inhibitor of HLA mismatched
allograft rejection
Cyclosporin A (CsA) was originally identified in the early seventies by Sandoz (now
Novartis) during screening trials for natural microbial products which showed anti¬
bacterial and anti-fungal properties. It was discovered that a compound produced by
the fungus Tolypocladium inflatum Gams (Borel et ah, 1989) acted as an anti-fungal
antibiotic. This compound was subsequently shown to possess not only antibiotic
properties but also potent immunosuppressive activity, demonstrated by results of
screening studies earned out in animals treated with purified fungal extracts. Extracts
producing effects in animal models were further characterised and shown to consist
mainly of CsA. CsA is a cyclic undecapeptide, its structure is shown in Figure 4.
Chemical structure of Cyclosporin A, a natural cyclic undecapeptide from
Tolypocladium inflatum Gams.
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Following extensive trials, CsA received approval for clinical use in 1983, its
principal application being to help prevent organ rejection following transplant
surgery. CsA therapy has been credited with revolutionising the field of organ
transplantation, increasing life expectancy and quality of life for many patients
following such surgery. A number of additional uses for this drug have been found,
however it was in the field of immunosuppression upon which most research interest
focused.
The mechanism of action of this drug resulting in the immunosuppression seen in
patients was largely unknown, therefore many groups were interested in isolating
proteins interacting physiologically with CsA, in an attempt to determine its mode of
action.
1.2.2
The isolation and characterisation ofCyclophilin A (Cyp A)
The first immunophilin to be discovered was the abundant cytosolic protein
cyclophilin A (Cyp A), isolated by its high affinity binding to CsA. Cyp A was
initially identified from a preparation of bovine thymocytes applied to a CsA affinity
column, proteins which bound tightly were selected as targets for further study
(Handschumacher et al., 1984). This group went on to purify to homogeneity a
protein of approximately 17kDa, which showed the required high affinity binding to
CsA. Material was isolated from two primary sources, bovine thymus cytosol and
human spleen (Flarding et ah, 1986). Using this purified material Harding et al were
able to elucidate the sequence of these two proteins, and show that they were
essentially identical. The protein was called Cyclophilin A due to its association with
Cyclosporin A.
1.2.3
Cyclophilin A and Peptidyl- prolyl cis-trans isomerase activity
In the early eighties a significant amount of research focused on a number of
problems associated with the fast and slow phases of protein folding/refolding. A
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particular area of interest was in the rate of cis-trans interconversion of proline
containing peptides, with an emphasis on isolating and characterising proteins that
were catalytically active. Numerous tissue extracts were investigated, amongst those
showing demonstrable catalytic activity of the cis-trans interconversion was an
extract prepared from porcine kidney cortex. The protein fraction responsible for the
activity was purified and characterised, and classified enzymatically as a peptidyl-
prolyl cis-trans isomerase (PPIase). N-terminal sequencing of the purified protein
indicated that it was identical in sequence to the first 38 amino acids of Cyclophilin




FK-506 and Rapamycin: immunosuppressive agents structurally
unrelated to CsA
As a result of the success of CsA the search was on for new compounds with both
more potent immunosuppressive activity and fewer side effects than CsA. This led to
the discovery of two compounds, FK-506 isolated from the actinomycete
Streptomyces tsukubaensis, (shown to be 50 times more potent an
immunosuppressive agent than CsA) (Tanaka et al., 1987; Kino et al., 1987a; Kino et
al., 1987b) and Rapamycin, another macrolide also first isolated as an anti-fungal
agent from cultures of Streptomyces hygroscopius (Sehgal, 1995).
35
Figure 5
Chemical structures of (A) FK-506 from Streptomyces tsukubaensis and (B)
Rapamycin from Streptomyces hygroscopius
The mechanisms of immunosuppression by these structurally unrelated compounds
(CsA and FK-506) was shown to be remarkably similar, acting upon the common
target molecule calcineurin as described earlier in this chapter. Rapamycin has an
alternative, calcium independent, mode of action resulting in immunosuppression
(Bierer et al., 1990; Morris, 1995).
36
1.3.2
The isolation and characterisation ofFKBPs
Using an FK-506 affinity matrix, two groups independently isolated proteins from a
number of sources, the JURKAT T cell line (Siekierka et al., 1989) and bovine
thymus and human spleen (Harding et al., 1989). Due to the high degree of
functional similarity with cyclophilins, these proteins were tested for PPIase activity.
The authors proved the proteins did indeed possess PPIase activity and therefore
belonged to the immunophilin family.
Cloning and expression of FKBP 12
This small, abundant cytosolic protein was cloned from JURKAT cells and over-
expressed in E. coli allowing further characterisation to be carried out (Standaert et
al., 1990). These authors showed that FKBP was approximately 12kDa, hence this
founder member of the FKBP protein family became known as FKBP 12. Isolation,
sequencing and PPIase activity of a Neurospora crassa homologue of FKBP 12 was
reported at the same time (Tropschug et al., 1990).
37
1.4
STRUCTURAL STUDIES OF CYCLOPHILINA AND FKBP12
Structures of native Cyclophilin A and FKBP12 have been reported, as have many
structures of complexes of these proteins with small molecule and protein ligands.
The structures of firstly human cyclophilin A followed by FKBP12 will now be
considered in greater detail.
1.4.1
Structure ofhuman Cyclophilin A
The structure of native human Cyp A was first determined in 1991 to a resolution of
o
2.5A (Kallen et ah, 1991; Ke et ah, 1991). Subsequently, a number of higher
resolution Cyp A type structures from not only human but also other species
including Saccharomyces cerevisiae, Escherichia coli, and the respectively free-
living and parasitic nematodes Caenorhabditis elegans and Brugia malayi have been
reported.
All cyclophilin structures available to date share a very highly conserved fold; an
anti-parallel 8-stranded (3-barrel capped at either end by two a-helices. Figure 6
illustrates the structure of human Cyp A, residues subsequently shown to be
important in the interaction with CsA (Pflugl et ah, 1993) are highlighted. A
comparison of both native and liganded cyclophilins from various species showed
the main structural differences between the proteins were to be found in external loop
regions (Taylor et ah, 1997).
The structure was compared with that of other (3-barrel proteins, for example, retinol-
binding protein, [3-lactoglobulin and superoxide dismutase (Ke, 1992). Unlike other
members of this fold family, the centre of the cyclophilin barrel is filled with
hydrophobic residues, precluding ligand binding within the barrel core.
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Figure 6
The structure of human cyclophilin A
Helices, loops and P-strands (drawn as arrows) are shown. The residues marking the
beginnings and ends of secondary structure elements are labelled. Side chains of
some of the residues defining the active site (R55, F60, M61, Q63, G72, A101,
N102, Qlll, F113, W121, L122, H126) are shown as balls and sticks. The figure
was prepared by Molscript (Kraulis, 1991).
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A number of publications reporting structures with CsA or small peptide ligands
bound to Cyp A suggested the overall integrity of the native structure is maintained
following ligand binding. Analysis of structures of Cyp A bound to either CsA or one
of eleven CsA analogues revealed a maximum inter structure root mean square
deviation (r.m.s.d) of only 0.2A for the Ca backbone residues 4-67 and 76-160 of the
protein (Taylor et al., 1997).
1.4.2
Structure ofFKBP 12
The first reported structures of human FKBP 12 were in complex with FK-506 and
rapamycin, to resolutions of 1.7 and 2.4A respectively (Vanduyne et al., 1991a;
Vanduyne et al., 1991b). An NMR solution structure of native FKBP was also
published in 1991 (Michnick et al., 1991). Once again, numerous structures of bound
and free FKBP 12 have been published since the first structures were reported. At the
time of writing a search of the PDB structure database found 37 structures of proteins
with an FKBP domain alone or ligand bound, however these are mainly FKBP 12.
It is therefore unsurprising that all FKBP structures available to date share a very
highly conserved fold, a five stranded anti-parallel [3-sheet wrapped with a right
handed twist around a short stretch of a-helix, linked together by flexible loops. The
structure of human FKBP 12 is shown in Figure 7. Free FKBP 12 has a greater
degree of flexibility than bound, particularly within two loop regions, known as the
40's and 80 s loops. FK-506 binds in a cavity formed between the [31-sheet and the a-
helix, being flanked on either side by the 40's and 80 s loops. The structures of bound
and free protein, like Cyp A, are also essentially identical as reported in a recent
paper (Burkhard et al., 2000).
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Figure 7
The structure of native human FKBP12. PDB ID no. 1D60 (native FKBP solved to a
resolution of 1.85A) was used as the template molecule. Helices, loops and P-strands
(drawn as arrows) are shown. The figure was prepared using Molscript (Kraulis,
1991)
These two defining features of the immunophilin family, high affinity binding to
immunosuppressant drugs and possession of PPIase activity were derived from
research focussed on two very different areas of biochemistry, illustrating an
interesting convergence from diverse fields on this enigmatic family of proteins.
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1.5
THE GROWING IMMUNOPHILIN FAMILY
Numerous cyclophilins and FKBP's have been identified since the first reports
appeared in the literature. They now constitute an expanding family of proteins, with
a very diverse phylogenetic distribution including vertebrates, invertebrates, insects,
plants, fungi, bacteria and archebacteria. (for reviews see (Galat and Metcalfe, 1995;
Kay, 1996; Gothel and Marahiel, 1999; Ivery, 2000). Immunophilins are also very
widely expressed in many different tissues and sub-cellular compartments.
Genome sequencing projects have greatly facilitated the isolation and
characterisation of both cyclophilins and FKBP's. Many species contain numerous
immunophilin homologues, indeed within a given organism, multiple copies of
particular immunophilin types (especially cyclophilins) are often found. Cyclophilin
A type proteins remain amongst the most abundant, however both cyclophilin and


















■ | j§|. Cyclophilin Domain
TPR domain
RNA binding
3 TPR Repeats CaM
Arg/Lys/Ser Bipartite NLS X9
rich




Leu rich RBH1 Zinc finger RBH2 RBH3 RBH4
Figure 8
Modular architecture of human cyclophilin proteins.
A search of the SWISS PROT, TREMBL and TREMBL-NEW databases, using
"cyclophilin" and " Homosapiens'" identified 30 entries, of which 29 were
cyclophilins or "cyclophilin like" proteins or fragments. Closer inspection of the
sequence, molecular weight and sub-cellular localisation of these proteins allowed
broad grouping into the eleven cyclophilin types illustrated above. Green box
represents a cyclophilin domain, a blue box indicates a TPR domain. Approximate



























Modular architecture of human FKBP proteins.
A search of the databases with "FKBP" and "Homo sapiens" identified 44 entries, of
which 30 were FKBPs or "FKBP like" proteins or fragments. Using the same criteria
as the previous figure, these proteins could be grouped into the thirteen types
illustrated above. Pale green box represents an FKBP domain, a blue box indicates a
TPR domain. Approximate relative amino acid lengths of each protein are indicated,
however the figures are not drawn to scale.
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Isolation of larger FKBP's
A number of reports of larger proteins with affinity for FK-506 appeared in the
literature from 1990 onwards, variously called "Hsp56", (Yem et al., 1992),
"p59/p60/FKBP59" (Callebaut et al., 1992; Massol et al., 1992; Renoir et al., 1992;
Lebeau et al., 1992). These proteins were frequently isolated as components of
steroid receptor complexes, often associated with heat shock protein 90, hence they
were described as Heat shock protein (Hsp) binding immunophilins. This interaction
with Hsp 90 was further studied and was shown to evolutionarily highly conserved,
as evidenced by data from experiments using both yeast and mammalian systems
(Tai et al., 1992; Tai et al., 1993). Further characterisation of purified FKBP 59
resulted in it being renamed FKBP 52, due to its determined molecular weight
(Peattie et al., 1992). The N-terminus of FKBP 52 is comprised largely of three
repeats of the FKBP 12 domain. Domain one shares highest amino acid homology
with FKBP 12 (55%), domains two and three are increasingly divergent.
The trigger factor of E. coli contains an FKBP like domain, both PPIase and
chaperone activities have been reported for this protein. The PPIase active site and
the high affinity binding site for unfolded protein substrates were shown to be
located within different domains of the intact protein, co-operation between the two
domains was required for full activity (Scholz et al., 1997).
1.5.1
Immunophilin functions
The functions of these abundant and highly conserved proteins have proved very
difficult to determine. In a few cases, however, roles for members of this family have
been characterised. A comprehensive although now somewhat out of date review
was published in 1995 (Galat and Metcalfe, 1995) which included data on
immunophilin function where known.




Cyclophilins in the pathogenesis ofHIV infection
Cyclophilin A and B were isolated in a two-hybrid screen for proteins interacting
with the HIV-1 Gag protein (Luban et al., 1993). Cyclophilin A in particular was
seen to be a constituent of the HIV-1 virion and was shown to be required for the
infectious activity of HIV-1 virions (Franke et al., 1994; Thali et al., 1994; Braaten
and Luban, 2001). Numerous studies addressed the possible role of Cyp A in the
pathogenesis of HIV-1 infection, however results remained largely difficult to
interpret. HIV-1 replication was shown to be inhibited by CsA and its non-
immunosuppressive analogues by binding to Cyp A and interfering with its
association with the virion (Franke and Luban, 1996; Papageorgiou et al., 1996). A
crystal structure of the N-terminal domain of HIV-1 capsid (residues 1-151) in
complex with Cyp A was published (Gamble et al., 1996) and revealed a loop on the
HIV-1 capsid (formed by residues 85 - 93 in the HIV viral sequence) bound in the
Cyp A active site. The trans conformation of Pro90 within this loop was unexpected,
and was taken to be indicative of the role potentially played by Cyp A in HIV
infection. The exact role played by Cyp A in HIV-1 infection is however as yet
unclear.
1.5.1.2
Calcium regulated cell signalling
FKBP 12 was first found associated with the calcium release channel/Ryanodine
receptor (RyR) of the sarcoplasmic reticulum (Jayaraman et al., 1992) and also with
the predominantly endoplasmic reticulum receptor IP3 which mediates calcium
release from the ER (Cameron et al., 1995). FKBP was soon implicated in the
regulation of these large calcium release channels, each of which are comprised of 4
identical subunits, one molecule of FKBP binding to each of the four subunits of the
tetramer (Timerman et al., 1993). Recent reports have characterised and mapped the
FKBP 12 binding site on different isoforms of the RyR and IP3 receptors (Bultynck
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et al., 2001) and also investigated the mode of action of FKBP 12 with this receptor
(Gaburjakova et ah, 2001)
1.5.1.3
Plant growth and differentiation
The isolation of pasticcino mutants of PAS1 (pasl, pas2 and pas3) identified these
genes as being involved in control of cell division and differentiation, stages critical
to plant development. The gene products were characterised in greater detail
(Vittorioso et al., 1998). The product of the PAS1 gene from Arabidopsis thaliana is
an FKBP 52 type protein, PAS1 (Faure et al., 1998). The protein was approximately
50% similar to mammalian FKBP 52, shared 4 of the 14 residues involved in the
binding to FK-506, with 6 binding residues being those commonly found in other
FKBP proteins. The C-terminal region of PAS 1 contains 3 copies of the TPR motif.
Mutation in the PAS1 gene produces plants with a very disordered phenotype and a
greatly reduced flowering ability. This study provides an excellent example of a role
for FKBP 52 like proteins in plant development, characterisation of partner proteins
for PAS1 may provide further insight into their roles.
A role for Cyclophilin 40 in the vegetative but not reproductive maturation of the
shoot in A. thaliana has been shown (Berardini et al., 2001). An A. thaliana Cyp 40
homologue is encoded by the SQUINT gene (SQN). Loss of function mutations in
this gene produced plants with a reduced number of juvenile leaves and also subtle
changes in inflorescence morphology. The authors suggest these results indicate Cyp
40 plays a specific role in Arabidopsis development, regulating the activity of
specific signalling pathways.
1.5.1.4
Immunophilins as stress reactive proteins
Recently, a number of papers have been published providing evidence that
cyclophilins are involved in responses to and also regulated by, a variety of
environmental stress factors, for a short review see (Andreeva et al., 1999).
These factors have included heat, oxidative and heavy metal stress.
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Heat shock
A report in which the level of Cyp 40 mRNA was increased 75 fold following
exposure of a breast cancer cell line to heat stress was recently published. There was
however no corresponding increase in the level of Cyp 40 protein expression, even
after prolonged exposure to the elevated temperature, due to an increased rate of
turnover of the protein (Mark et ah, 2001).
Evidence for FKBP proteins acting in the stress response is more limited, however,
the level of wheat FKBP77 mRNA was 14 fold higher under conditions of heat stress
(Kurek et ah, 1999).
Oxidative stress
Up-regulation of cyclophilin protein production increased by greater than 10%
following exposure to oxidative stress. Other "molecular chaperones" were also up-
regulated in human umbilical vein endothelial cells (Dreher et ah, 1995). In a similar
vein, results were presented by another group, investigating the effect of reactive
oxygen species (ROS) on vascular smooth muscle cells (Fiao et ah, 2000). Heat
shock protein 90 and cyclophilin B were amongst those secreted in response to
oxidative stress. Oxidative stress was reported to regulate cyclophilin function in
vitro and in vivo (Jin et ah, 2000). The exact nature of the role of these proteins in
ischaemic events remains unclear, however a great deal of research is focussed in
this area.
In 1998, Jaschke et al published a paper reporting a novel interaction between Cyp A
and Aopl (a member of the family of proteins thought to be involved in defence
against the effects of oxidative stress). A yeast two hybrid screen revealed a specific
interaction (not substitutable by another cyclophilin). Further experiments suggested
Cyp A also stimulated the enzymatic activity of Aopl. This group hypothesised Cyp
A acted as a helper protein for Aopl, working together against the damaging effects
of oxidative stress (Jaschke et ah, 1998). This suggestion is further supported by
additional data showing Cyp A is involved in protecting cells against oxidative
stress. In this study necrotic cell death was induced by "chemical ischaemia", Cyp A
was shown to have a protective role whilst, in this test system Cyp D had a
deleterious effect (Doyle et ah, 1999).
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Up-regulation of cyclophilin mRNA was seen in Solatium commersonii (potato) in
response to a number of stress events including cold, drought, chemicals and
wounding, suggestive of a general role in protecting the plant against various stress
factors (MezaZepeda et al., 1998).
Heavy metals
Two cyclophilin genes were isolated from the common earthworm, Cyp A and Cyp
B type isoforms. Following exposure to heavy metals, Cyp A mRNA was
upregulated 38 fold whilst Cyp B expression remained stable (Sturzenbaum et al.,
1999).
1.5.2
Immunophilins as protein folding catalysts and molecular chaperones
Two main classes of "molecular chaperone" activity have been identified.
1. Proteins with enzymatic properties accounting for acceleration of the rate
limiting steps in protein folding (protein folding catalysts).
2. That which is functionally responsible for the correct, folding, assembly and
transport of newly synthesised proteins in the cell, which also fulfil the accepted
definition of a molecular chaperone.
These are frequently overlapping activities and therefore cannot be considered as
necessarily mutually exclusive.
1.5.2.1
PPlases as folding catalysts, contributing steric information to the folding process
PPIase activity
The PPIase activity of Cyp A has been shown to be necessary for functional
maturation and expression of the al homo-oligomeric neuronal nicotinic and type 3
serotonin receptors in Xenopus oocytes (Helekar and Patrick, 1997). This was
demonstrated by a CsA induced reduction in functional receptor expression and also
by mutation of an active site residue (R55A) that also resulted in reduced functional
receptor expression. PPIase activity of the cyclophilin from B. subtilis has also been
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shown to be necessary to allow growth of the organism under starvation conditions
(Gothel et al., 1998).
In co-operation with Hsp 70 and Hsp 60, cyclophilins are a component of the
mitochondrial protein folding machinery in Neurospora crassa, (Rassow et al.,
1995). There is evidence that the larger cyclophilin 40 proteins induce
conformational changes in the transcriptional factor c-Myb which allows the C-
terminal negative regulatory domain of c-Myb to interact with and inhibit its N-
terminal DNA binding domain (Leverson and Ness, 1998). Duina et al, (Duina et al.,
1998a) also suggest a requirement for a Cyp 40 type cyclophilin (Cpr 7) in the
negative regulation of the heat shock response in Saccharomyces cerevisiae, under
both stress and non-stress conditions. A role for the PPIase domain of FKBP 52 in
movement of the glucocorticoid receptor (GR) to the nucleus and in an interaction
with cytoplasmic dynein (a retrograde motor protein) was proposed in a recent paper
(Galigniana et al., 2001).
A number of authors have demonstrated that in vitro, cyclophilins accelerate the rate
limiting cis/trans PPIase steps in the folding pathway of peptide and protein
substrates, especially in proline-rich proteins (Lang et al., 1987b; Bachinger, 1987).
The importance of such a mechanism to speed up a rate limiting step in protein
folding may be particularly important in collagens, due to the abundance of the
repeating Gly-X-Pro tripeptide motif (where X can be any amino acid) in these
proteins (Schonbrunner et al., 1991; Lang et al., 1987b; Bang and Fischer, 1991;
Schonbrunner and Schmid, 1992; Freskgard et al., 1992; Lang et al., 1987a).
FKBP 12 has also been shown to catalyse the folding of protein substrates including
RNAaseTl (Tropschug et al., 1990), carbonic anhydrase (Kern et al., 1994) and
FKBP 12 itself (Scholz et al., 1996).
1.5.2.2
Molecular chaperones
Ellis first proposed the concept of molecular chaperones in a landmark paper
published in Nature in 1987 (Ellis, 1987). The earliest precise definition of a
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"molecular chaperone" was published in 1989 (Ellis and Hemmingsen, 1989). This
read as follows "Molecular chaperones are proteins whose role is to mediate the
folding of certain other polypeptides and, in some instances, their assembly into
oligomeric structures, but which are not components of these final structures".
Proteins belonging to the molecular chaperone family have therefore, amongst other
functions, adapted to promote efficient protein folding, interacting with newly
synthesised polypeptide chains to minimise inappropriate interactions and maximise
the yield of native folded protein. The requirement for assisted folding is thought to
arise from the greater incidence of co-translational protein folding found in
eukaryotes when compared with post-translational folding that tends to be the norm
in prokaryotes. This is thought to be due to the higher incidence of multi-domain
proteins in eukaryotes.
Diseases involving protein misfolding/aggregation have also focused considerable
research effort upon mechanisms within the cell which operate to minimise or
prevent "off-pathway" reactions leading to the adverse effects seen with these
diseases.
The initial definition of a molecular chaperone has subsequently been expanded to
cover numerous accessory functions associated with assembly of large multiprotein
complexes and it is in these roles that larger immunophilins appear largely to
function.
"Chaperone activity of immunophilins"
It has been suggested that cyclophilins affect the dynamics of protein-protein
interactions in vitro by preventing aggregation of early folding intermediates of
protein substrates (Freskgard et ah, 1992). In vivo, several lines of evidence point to
a role for cyclophilins in protein folding, transport and assembly. Cyclophilins have
also been implicated in protein processing. Substrates of cyclophilin A include
collagen (Bachinger, 1987; Steinmann et ah, 1991), carbonic anhydrase (Fransson et
ah, 1992; Kern et ah, 1994), calcitonin (Kern et ah, 1993), creatine kinase (Ow et ah,
2001) and homo-oligomeric alpha 7 neuronal nicotinic and type 3 serotonin receptors




been shown to be involved in processing a number of proteins including transferrin
(Lodish and Kong, 1991) and are also important in both prolactin signal transduction
and nuclear retrotranslocation (Rycyzyn et ah, 2000). The cyclophilin domain from
larger proteins has also been implicated in protein processing with various substrates.
Two examples include the 150kDa tumour recognition complex in which the N-
terminal cyclophilin domain exhibits both PPIase and chaperone activities (Rinfret et
al., 1994) and RanBP2 in the visual system, where the cyclophilin domain acts to
chaperone red/green opsin. Evidence in support of a role for immunophilins in
chaperone functions is mounting, two examples are discussed in greater detail below.
The best characterised example of cyclophilin function in vivo, is the 26kDa
photoreceptor cyclophilin ninaA from Drosophila melanogaster. The ninaA gene
product has been shown to be essential for the proper folding and intra-cellular
transport of isoforms of the photopigment rhodopsin, RH1 and RH2, from the rough
endoplasmic reticulum through the cytoplasm to the cell surface (Stamnes et al.,
1991; Baker et al., 1994; Ondek et al., 1992).
The identification of two new retinal cyclophilin isoforms, types I and II, (Ferreira et
al., 1995) provided another example of the role of cyclophilins in the visual system,
in this case vertebrate retina cone receptors. The cyclophilin domains were present as
part of a larger multi-domain protein, RanBP2. These authors showed that two
contiguous domains of this large protein, Ran-binding domain 4 and cyclophilin,
acted both in vitro and in vivo as a specific chaperone for bovine red/green opsin
(R/G opsin). The interaction was unlike that seen with NinaA however, the
cyclophilin domain did not bind opsin directly but stabilised the interaction between
R/G opsin and the RBD4 domain (Ferreira et al., 1996). A follow up paper by the
same group (Ferreira et al., 1997) suggested the cyclophilin domain was mediating a
modification of the R/G opsins, probably via a prolyl isomerisation step. Proline
isomerisation was also suggested as a potential molecular switch, regulated by
cyclophilin for the loading of opsin onto RanBP2 during visual pigment processing
in cones.
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A chaperone function was also suggested for Cyp 40 (Freeman et al., 1996). In this
series of experiments Cyp 40 was capable of interacting with an unfolded substrate to
maintain it in a intermediate folding competent state, without being able to
completely refold the substrate.
1.5.2.3
Immunophilins as highly specific chaperone proteins
Evidence against immunophilins as essential folding catalysts/chaperones was
provided in a paper describing the dodecuplet mutant in yeast. This paper reported
that deletion of 12 immunophilins (8 cyclophilins and 4 FKBPs) from the budding
yeast S. cerevisiae (Dolinski et al., 1997) produced very minor phenotypic changes,
essentially the sum of the individual mutational effects. This group went on to
propose each immunophilin therefore regulates and enhances the functions of a
specific number of unique binding partner proteins, as yet largely undetermined,
rather than carrying out non-specific chaperone activities.
1.5.2.4
Immunophilins and steroid hormone receptors
A number of studies have implicated members of the larger two domain
immunophilin family (Cyp 40, FKBP 52 AND FKBP 51) in the maturation of steroid
hormone receptors. These proteins function to maintain the receptor in an activation
competent state. They may also be acting as scaffold proteins, bringing together the
many components of these multi-protein complexes. Within mature steroid receptor
heterocomplexes the large immunophilins compete directly for a common TPR
acceptor site in Hsp90 (Owensgrillo et al., 1995; Ratajczak and Carrello, 1996; Nair
et al., 1997). A recent report (Reynolds et al., 1999) has linked the incorporation of
FKBP 51 into glucocorticoid receptor complexes, at the expense of FKBP 52, to
reduced receptor hormone binding affinity, thus providing the first definitive
evidence that the TPR-containing immunophilins can alter hormone recognition by
steroid receptors. In Saccharomyces cerevisiae, Cpr 7 is implicated in the negative
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regulation of the heat shock response under both stress and non-stress conditions
(Duina et ah, 1998a). Cpr6 binds Hsp 90 and shares a 49% sequence similarity with
Cpr7 in the C-terminal domain, (Duina et ah, 1996a; Warth et ah, 1997), however,
only Cpr7 is able to functionally support steroid receptor activity in yeast (Duina et
ah, 1996b; Duina et ah, 1998b).
1.5.3
Multi-domain immunophilins
Immunophilins are frequently found as domains of larger proteins. A number of
examples have been mentioned earlier in this chapter including Cyp 40, RanBP,
FKBP 52 and FKBP 77. Other examples of large proteins containing an
immunophilin domain include Cyps 4, 8 and 9 from C. elegans (Page et ah, 1996)
and the 150kDa natural killer cell tumour recognition protein. This protein was
isolated as part of a putative tumour recognition complex and contains an N-terminal
cyclophilin domain (Anderson et ah, 1993). The largest proteins isolated to date
(358kDa), which contain cyclophilin domains are members of the Ran binding
nuclear pore complex forming proteins, with a C-terminal cyclophilin domain
(Yokoyama et ah, 1995; Vetter et ah, 1999).
Large FKBP containing proteins include type 9 adenylate cyclase that contains one
FKBP type domain (Nagase et ah, 2000) and numerous trigger factor proteins
containing an FKBP type domain.
1.5.3.1
Hsp 90 binding immunophilins
Members of the immunophilin family are frequently found associated with the late
phase of steroid hormone receptor maturation (discussed in greater detail in Chapter
5, section 5.3.5). A clear preference for particular immunophilins can be determined
for individual steroid receptors, by an as yet undetermined mechanism. The precise
nature of the interactions between members of these multiprotein complexes is
slowly being dissected out by a variety of approaches. One of the most useful has
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been exploitation of bioaffinity interactions between proteins, using deletion/point
mutants to determine residues critical for the interactions seen. Structural data on a
complex between any of the components of these receptor complexes would provide
valuable insight into the precise nature of the interactions.
The immunophilins associated with these receptors share a common domain,
containing three copies of the tetratricopeptide repeat motif.
1.5.3.2
The Tetratricopeptide Repeat Motif
The tetratricopeptide repeat is a highly degenerate motif of thirty-four amino acids
within which no residue is completely conserved. It was first identified and
characterised from the CDC23 gene product of S. cerevisiae and from the product of
the nuc2+ gene from S. pombe, as a novel repeating 34 amino acid motif (Sikorski et
ah, 1990; Hirano et al., 1990). These proteins are both involved in chromosome
segregation, controlling regulation of the cell cycle. Around the same time, TPR
containing proteins, SSN6 and SKI3, (Smith et al., 1995) were also shown to be
involved in RNA synthesis.
The TPR motif is often found in tandem arrays of 3 to 16 units, and has been
identified in a wide variety of proteins with disparate functions. This includes
mediation of protein-protein interactions, particularly in the assembly of multi-
protein complexes. TPR containing proteins include subunits of the anaphase
promoting complex, the NADPH oxidase subunit p67phox, transcription factors, the
PKR protein kinase and peroxisomal and mitochondrial import proteins (Zachariae
and Nasmyth, 1996; Leto, 1996; Ma and Whitlock, 1997; Moir et al., 1997; Tang et
al., 1996; Chambraud et al., 1999).
A search of the Pfam Protein Families Database (a large collection of protein
multiple sequence alignments), (Bateman et al., 2000) revealed some 605 TPR
containing proteins have been isolated and characterised to date. This number can be




SELECTION OF PROTEIN TARGETS FORMING THE MAIN
FOCUS OF THIS THESIS
Requirement for protein structures: Of growing importance is a need to define the
structural basis of the interaction between immunophilins and their target proteins,
leading to greater understanding of their biological functions. Towards this aim, a
number of immunophilin targets have been selected as outlined below, and will be
discussed in greater detail in subsequent chapters.
Cyclophilin 3 from Caenorhabditis elegans: In 1996, the cloning and
characterisation of eleven cyclophilin genes from the free-living nematode worm
Caenorhabditis elegans (Page et al., 1996) provided an opportunity to study the
various biological roles played by these proteins in this genetically tractable and well
characterised organism. Studies on Cyclophilin 3 will be described in Chapter 3 of
this thesis.
Cyclophilin 40 and its interaction with Hsp90: Cyclophilin 40 was independently
isolated by two groups (Kieffer et al., 1992; Ratajczak et al., 1993). Studies on
Cyclophilin 40 will be described in Chapter 4. Preliminary purification and
characterisation of regions from the C-terminal domain of Hsp90 will be described in
Chapter 5. Chapter 6 will cover modelling studies involving a number of Cyp 40 type
proteins and also attempts to model the interaction between the C-terminal domain of
Hsp90 with Cyp 40.
FKBP 22: FKBP 22 from Neurospora crassa was first isolated from a preparation of
N. crassa hyphae (Solscheid and Tropschug, 2000). Structural studies on FKBP22








Cell culture media, predominantly Luria-Bertani Medium, (LB) and LB agar were
obtained from the in-house media facility (ICMB, University of Edinburgh),
ampicillin was also obtained from this facility. Kanamycin and carbenicillin were
purchased from Melford Laboratories. Stock solutions of each antibiotic at
appropriate concentrations (lOOmg/ml for ampicillin and carbenecillin, lOmg/ml for
kanamycin) were made up in water, filter sterilised, aliquoted and stored frozen at -
20°C.
Small scale preps (10ml-250ml) involved growing cells in an appropriately sized
container. Large-scale cell culture involved growing cells in two litre flasks, in a
shaking incubator. Experimental conditions i.e. temperature and rate of stirring were
controlled by setting the shaking incubator (New Brunswick), conditions normally
employed were 37°C with agitation at 200rpm.
Occasionally the in-house fermenter facility, run as a service, was utilised in an
attempt to produce large amounts of protein from one large (12 litre) prep.
The Gradifrac system from Amersham Pharmacia Biotech (APB) was used for all
protein purification protocols described in this thesis. Unless otherwise stated, all
chromatography resins and columns used were also sourced from APB.
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Electrophoretic analysis was carried out using the MiniProtean II system from
Biorad, gels were dried for further analysis and storage using the gel drying system
of Promega.
2.2
PREPARATIONAND HANDLING OF CLONES
2.2.1
General cloning and expression strategy
The approach taken required firstly; isolation of target gene(s) followed by insertion
of the gene into a suitable plasmid vector. Transformation of the plasmid into a
suitable E. coli strain (chosen for its regulated ability to over-express the target
protein at high levels) was the final step.
Cloning of all the proteins used throughout the duration of the work described in this
thesis was carried out by collaborating groups, as set out in the text of chapters 3, 4,
5 and 6. Thanks to those groups for the clones.
Many of the standard laboratory techniques used in connection with the handling and
preparation of cells for use and storage are described in a very useful and
comprehensive text (Sambrook and Russell, 2000).
2.2.1.1
Miniprep method to recover plasmid DNA
The method as outlined in the QIAprep Miniprep Handbook was followed. Briefly, a
single colony was picked into 5 mis of LB, supplemented with antibiotic and grown
overnight. The cell suspension was centrifuged for 5 minutes to pellet cells, followed
by
1. Resuspension of cells in 250pl of resuspension buffer PI (50mM Tris-HCl,
lOmM EDTA, 100pg/ml Rnase, pH 8.0) and transfer to an eppendorf tube.
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2. Addition of 250pl of lysis buffer P2 (200mM NaOH, 1% SDS), followed by
gentle inversion to mix.
3. Addition of 350pl of neutralising buffer N3 (3.0M potassium acetate, pH 5.5),
followed by immediate inversion.
4. Centrifuge for 10 minutes at top speed in a microfuge.
5. Place QIAprep spin column into a 2ml collection tube. Apply supernatant from
step 4 to the QIAprep spin column.
6. Centrifuge for 30 - 60 seconds.
7. Wash spin column by adding 0.5ml of buffer PB and repeat centrifugation.
8. Repeat wash as above, using 0.75ml PE buffer.
9. Discard flow through and centrifuge for an additional minute to remove residual
wash buffer.
10. Place QIAprep column in a clean 1.5ml centrifuge tube. To elute DNA, add 50pl
of EB buffer (lOmM Tris-HCl pH 8.5) to the centre of each QIAprep column, let
stand for 1 minute and centrifuge for 1 minute.
2.2.1.2
Storage ofplasmid
Plasmids recovered by the above protocol were stored frozen (-20°C) in 20pl
aliquots.
2.2.1.3
Preparation ofcalcium competent cells
The following method was used to prepare calcium competent cells for
transformation
1. Pick single colonies of the given E.coli strain, into 5-10ml of media without
antibiotic, grow overnight.
2. Inoculate lOOmls of media with 1ml overnight culture.
3. Grow at 37°C until the OD60o was 0.6 - 0.9.
4. Aseptically transfer cells to two sterile centrifuge tubes, leave on ice for 10 mins.
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5. Pellet cells, 3000g, 4°C, 5 minutes.
6. Remove the supernatant, add 10ml ice cold sterilised lOOmM CaCh to each tube,
resuspend pellet.
7. Repeat centrifugation step, as above.
8. Remove supernatant and gently resuspend cells in a final volume of 2ml lOOmM
CaCb. Pooled cells may be stored for a week at 4°C.
2.2.1.4
Transformation ofplasmid of interest into competent cells.
1. Transfer 1 OOpl of calcium competent cells to a sterile eppendorf, leave on ice.
2. Add 2 - 5pi DNA/Plasmid, mix very gently and leave on ice for 60 minutes.
3. Heat shock at 42°C for 2 minutes.
4. Remove tube from water bath and place on ice for 5 minutes.
5. Add 1ml Luria Bertani broth and incubate with shaking at 37°C for 20 minutes.
6. Transfer between 50 and lOOpl of recovered cell suspension to LB Agar plates,
supplemented with an appropriate antibiotic. Spread with a glass spreader.
7. Leave plate with agar on the bottom to allow the liquid to soak into the media.
8. Incubate overnight at 37°C in an inverted position.
2.2.1.5
Storage of transformed cells
Small overnight cultures were grown; 800pl was aliquoted into a cryogenic vial and
200pl sterile glycerol added. The vial was vortexed to mix cells and cryoprotectant,
followed by freezing at -80°C.
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2.3




The availability of milligram quantities of pure, soluble protein is one of the critical
factors that must be addressed when embarking upon biochemical and structural
characterisation of proteins.
Throughout the course of the work described in this thesis, many different proteins
were produced using a standard methodology developed. This method was used to
try to ensure that starter cultures for large-scale preps (4-15 litres) were over-
expressing the protein of interest. The method developed involved firstly testing
small scale cultures for over-expression of the protein of interest, followed by
selection of the "best expresser" to be used in setting up a fresh overnight culture
(100ml to 1 litre) to use as the inoculum for the large scale prep (4 -15 litres).
The method is described below and was followed with only minor modifications for
all the proteins discussed in this thesis.
2.3.1.1
Small scale test expression ofcultures
Clones were supplied by collaborating groups either on LB Agar plates or in semi¬
solid maintenance media. To try and ensure uniformity of protein produced (very
important when considering crystallisation trials), it was considered preferable to
start with a single bacterial colony expressing the protein of interest. The first step
therefore was to plate out the bacteria onto LB agar supplemented with appropriate
antibiotic, grow overnight at 37°C followed by isolation of single colonies for further
experimentation. Plates were stored at 4°C, sealed with parafilm.
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Protocol to test for over-expression of proteins of interest.
1. Streak bacteria onto an LB agar plate supplemented with appropriate antibiotic.
2. Incubate plate overnight at 37°C.
3. Identify single colonies, pick a number of these single colonies individually into
lOmls of media (LB, 2XYT, Terrific broth), supplemented with antibiotic as
appropriate, using a sterile platinum loop.
4. Incubate the 10ml culture overnight at 37°C in a shaking incubator.
5. Inoculate 10ml fresh media (with antibiotic) with overnight culture. Dilution
varied from 1:20 to 1:100.
6. Place the overnight culture on ice/leave at room temperature.
7. Grow cells until the OD6oo between 0.4 and 0.6.
8. Remove 200pl of culture prior to induction, freeze at -20°C.
9. Induce with IPTG to 0.4mM; incubate for a further 3-4 hours.
10. Remove a 200pl post induction sample; defrost pre-induced sample, spin top
speed in microfuge for 5 minutes.
11. Remove supernatant, take a 20pl aliquot to test on an SDS PAGE gel, add 5pl of
5X reducing sample buffer.
12. Resuspend pellets in 80pl deionised water plus 20pl 5X reducing sample buffer.
13. Heat at 100°C for 5 minutes, briefly microfuge, load 20pl onto SDS PAGE gel.
14. Run gels, stain/de-stain and check for over-expression of protein of interest.
15. Determine which colony appears to be producing the most protein, with
minimum contaminants.
16. Set up large scale second overnight culture using a 1:100 ratio of the original
overnight culture with fresh media and antibiotics.
17. Inoculate large volume (4-15 litres) using the second overnight culture, derived
from a culture proven to over-express the required protein.
2.3.1.2
Large scale expression ofproteins of interest
Cultures obtained by following the above protocol were used as the starter culture for
large scale preps, as mentioned in the previous section. Two culture conditions were
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used for the work described in this thesis, a shaking incubator system using 2 litre
flasks and utilisation of the 15 litre fermenter facility available within the Institute.
2.3.1.3
SDS-PAGE polyaerylamide gel electrophoresis
The method followed was the SDS-PAGE system developed by Laemmli (1970),
using the MiniProtean II system from Biorad. To detect protein, gels were routinely
stained with Coomassie Brilliant Blue R-250. This is the staining method most
frequently employed, capable of detecting of the order of 0.1 - lpg of protein per
band. Molecular weight determination was assisted by the addition to each gel of a
lane containing marker proteins of known molecular weight and composition,
allowing an estimate to be made of the amount of recombinant protein produced.
2.3.1.4
Purification ofprotein of interest
The starting point for all experiments was to ensure the availability of pure, soluble
protein. Purification protocols were developed de novo for each protein discussed in
this thesis, the goal, as always, being to produce the maximum amount of purified
protein, using the minimum number of steps. A number of standard approaches were
routinely taken and are listed below
The first step in extracting intracellular proteins produced in E. coli involves
disruption of the cell wall, thus releasing proteins into solution. One of the gentlest
methods available to produce this effect involves the addition of hen egg white
lysozyme to the solubilised cell pellet, followed by a centrifugation step to pellet
unwanted cell debris. Additionally, metal chelators such as EDTA are required to
further disrupt the structural integrity of the outer lipopolysaccharides. Disruption of
the cell wall does however lead to the protein coming into contact with proteases,
resulting in the potential for proteolytic attack on the recombinant protein, with
consequent degradation of protein during the purification process. Addition of a
number of proteolytic inhibitors to buffers used in the early stages of purification,
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coupled with a fast (minimum number of steps) protocol, conducted at 4°C with pre¬
cluded solutions minimises the risk to protein.
As with previous steps, a standard protocol to obtain clarified cell lysate was
developed, and is outlined below.
2.3.1.5
Preparation ofclarified cell lysates
1. Cell pellets produced from large scale preps were defrosted and weighed.
2. Pellets were solubilised in lysis buffer, the composition of which was protein
specific, however the pH was usually around 7.5 - 8.0 to facilitate the action of
lysozyme (see individual chapters for detailed protocols including buffers used).
Pellets were solubilised to 10% (w/v) unless otherwise stated in later chapters.
3. Lysozyme was added dry to 0.01% (final concentration) and the mixture shaken
and incubated on ice for an hour.
4. An equal volume of water at 4°C was added and the solution shaken hard.
5. Magnesium chloride was added to 5mM, followed by DNase and RNase to a
final maximum concentration of 0.01% (w/v).
6. The protein solution was incubated for an hour, followed by the addition of
EDTA to a final concentration of lOmM.
7. The cell supernatant was centrifuged for an hour at 20,000rpm, the supernatant
frozen at -20°C and the pellets discarded after SDS PAGE analysis had
established the protein was predominantly present in the supernatant.
(Steps 5 and 6 were optional)
2.3.1.6
Designing an effective purification strategy
A purification protocol for each protein was developed by firstly collating all
available information on the protein of interest. Factors which were considered
important at this stage included the pi of the protein (calculated from sequence or
measured), the amino acid sequence, degree of solubility, protein stability and
whether the protein had a bioaffinity tag. This information was used in an attempt to
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develop a suitable purification method for each protein. The methods were subject to
frequent revision until an apparently optimum protocol was developed.
The two techniques most frequently employed throughout this project were ion
exchange and affinity chromatography.
Ion exchange chromatography
Ion exchange chromatography is dependent on a number of parameters including the
pH of the buffer system used and the isoelectric point of the proteins to be separated.
Selection of suitable conditions for each protein (resin, pH, ionic strength), made ion-
exchange a very useful technique throughout the duration of this project.
Affinity chromatography
The principle of affinity chromatography, as the name suggests, exploits an affinity
interaction between two molecules (GST/Glutathione) or metal chelates with specific
residues (nickel/histidine residues). Clones of a number of proteins of interest were
engineered to contain tags of either GST or six histidine residues, facilitating the
purification of the proteins bearing the tags. The tagged protein may carry a cleavage
site, allowing removal of the affinity tag subsequent to purification of the protein of
interest.
2.3.1.7
Concentration of target proteins
Ultrafiltration was used to concentrate protein samples. Dependent upon sample
volume, one of two methods was used. Large volumes (>50ml) used the Amicon
stirred cell system, applying pressure through a membrane of a defined molecular
weight cut-off. This allowed smaller molecules to pass through whilst retaining the
protein of interest.
Smaller volumes were concentrated using centrifugation, with devices varying in size





The Coomassie Plus Protein Assay Reagent Kit (Pierce) was used for protein
quantitation. The reagent is a ready to use modification of the Bradford (Bradford,
1976) coomassie dye binding colorimetric method for total protein quantitation.
A standard curve was constructed using bovine serum albumin. A number of
dilutions of the protein samples were made to ensure it could be measured within the
limits of the assay. Protein concentrations were determined from the standard curve






Dynamic light scattering was used to assist in the characterisation of purified
proteins in solution. A number of studies have shown a strong correlation between
monodisperse solutions and success in crystallisation trials. The correlation between
the aggregation state of protein samples and the outcome of crystallisation trials was
investigated for fifteen proteins (Zulauf and Darcy, 1992).
In an attempt to utilise this potentially useful technique, each "new" protein target
was routinely analysed by light scattering. The information obtained from these
experiments included some estimate of the purity of the protein sample, its state of
aggregation and thermal stability. Consequently some insight into the suitability of
the protein for crystallisation trials was obtained from these studies.
2.4.1.1
Theoretical background to selected results from dynamic light scattering
The following results were considered to be of most interest for the proteins analysed
and are briefly described below.
■ Polydispersity
The polydispersity value of a given sample indicates the standard deviation of the
spread of particle sizes about the reported average radius. A high polydispersity
value therefore indicates a greater spread in size distribution, hence a less uniform
population of protein molecules.
An estimate of the degree of sample polydispersity is very useful as a number of
reports in the literature had suggested protein solutions with low polydispersity
(monodisperse solutions) are more likely to crystallise than those with high
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polydispersity (McPherson et al., 1995). A polydispersity value of less than 1 is a
good indicator that the protein is essentially monodisperse in solution.
■ Estimated molecular weight
The molecular weight of the protein is approximated from the hydrodynamic radius
calculated from the measured translational diffusion coefficient, using the Stokes
Einstein equation. This calculation involves many assumptions and is based upon an
empirically derived relationship between the Radius (RH) and molecular weight of a
number of well characterised globular proteins. It is also assumed the protein is
present in an aqueous buffer system, however parameters can be altered to
accommodate samples of different viscosities.
■ Baseline
The baseline represents an estimation of the degree of compliance of data with its
theoretical size distribution. A baseline of 1.000 is indicative of the actual
distribution being fully resolved, using the assumptions inherent in theoretical size
distribution.
■ Sum of Squares
This is a measurement of the closeness of fit between the experimental data and an
autocorrelation function generated from the analysis results.
2.4.2
Mass spectrometric analysis ofprotein targets
Mass spectrometry was used to further characterise protein samples prior to
crystallisation trials. Two mass spectrometry methods were used; Electrospray
Ionisation (ES) and matrix assisted laser desorption ionisation (MALDI). These two
methods differ somewhat in detail, however both result in the gentle ionisation of
large bio-molecules including intact proteins and peptides.
In electrospray ionisation mass spectrometry, the sample is introduced into a
continuous liquid stream (typically a mixture of organic and aqueous liquids such as
50:50 methanol:water), the mixture is pumped slowly at high voltage through a
hypodermic needle, to electrostatically disperse (electrospray) small droplets which
rapidly evaporate and impart their charge onto the protein sample. Large ions are
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typically multiply charged, resulting in data being presented as a mass-to-charge
(m/z) spectrum which can be deconvoluted. Deconvolution sums up the signal
intensity into a single peak at the molecular weight of the sample.
In matrix assisted laser desorption ionisation spectroscopy, a large excess of matrix
material is co-precipitated with the protein sample by pipetting a very small volume
of the mixture onto a metal substrate and allowing it to dry. The resulting solid is
then irradiated by very short laser pulses, producing gas phase, protonated molecules.
The resultant m/z spectrum can once again be deconvoluted to assign peaks.
2.5
CRYSTALLISATION TRIALS OF TARGETPROTEINS
Crystallisation Of Nucleic Acids And Proteins, A Practical Approach (Ducruix and
Giege, 1999) was frequently consulted during experimental work described herein
and also in the preparation of this section of the thesis.
The goal of any crystallographic project is the repeatable production of single, high
quality protein crystals that diffract to high resolution. Achievement of this goal
requires consideration of a number of important components of the process.
2.5.1
Getting started
The ideal starting goal for an X-ray crystallographic project is the availability of a
large amount (typically 10-100mg) of soluble, purified target protein. The need to
have a constantly available supply of protein of reproducible characteristics and
quality has frequently been re-stated in a number of comprehensive yet accessible
texts available on the crystallisation of biological macromolecules, (Ducruix and
Giege, 1999; McPherson, 1999). The concept of "crystallographic grade" purity and
quantity of protein must be addressed prior to beginning crystallisation trials. The
proteins crystallised during the work described in this thesis did not necessarily
conform to these ideal conditions. Their expression and purification has been
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outlined earlier in this chapter in section 2.3 and will be more fully described,
including deviations from the ideal, in Chapters 3 (Cyclophilin 3) and 4 (Cyclophilin
40). However, the various criteria for the availability of highly purified protein were
largely met, therefore crystallisation trials were set up.
2.5.1.1
Designing an effective crystallisation strategy.
Prediction of conditions which will de novo crystallise a protein is very difficult, if
not impossible as the process is a multi-parametric one, due to the complex nature of
biological macromolecules and their associations with crystallisation agents. All
available information on the target protein should be collated ie pi, solubility,
number of free cysteine residues, nature (hydrophobic/philic), any known
ligands/partner proteins, monomer/dimer/oligomer, stability vs time, temperature/pH
and integrated into preliminary attempts to crystallise the protein.
2.5.1.2
The theory of crystallisation
The exact mechanisms underlying the process of crystallisation of proteins is still not
well defined. As mentioned above, the process is a multi-parametric one, involving
the three classical steps of nucleation, growth and cessation of growth. A number of
the parameters important in crystallisation of proteins are highlighted in Table 2.
To grow protein crystals, molecules have to be brought into a supersaturated,
thermodynamically unstable state. Upon return to equilibrium, the molecules may
develop into an amorphous or hopefully crystalline phase. Once supersaturation has
been reached, formation of the first ordered aggregates can lead to an initial
nucleation phase. This is followed by a crystal growth phase producing crystals with
varying degrees of usefulness and finally the cessation of growth phase, which may
result from a number of processes including simply depletion of the target protein
from the system.
70
PARAMETERS AFFECTING THE CRYSTALLISATION OF PROTEINS
Intrinsic physico-chemical parameters
Supersaturation (concentration of protein and precipitant)
Temperature and pH
Time (rates of equilibration and growth)
Ionic strength and purity of chemicals used in crystallisation
Biochemical and biophysical parameters
Sensitivity of the molecule to physical parameters listed above ie pH, temperature
Binding of ligands e.g. inhibitors, substrates, peptides
Additives e.g. reducing/oxidising agents
Sample ageing
Purity of macromolecule
Macromolecular contaminants in the sample
Sequence micro heterogeneities e.g. fragments, post-translational modifications
Conformational heterogeneity e.g. flexible domains, oligomers and aggregates
Batch effects
Table 2
Table 2 highlights a number of parameters considered during crystallisation trials of
the proteins discussed in this thesis. Table adapted from (Ducruix and Giege, 1999)
2.5.1.3
Methods of crystallisation
A number of techniques are commonly employed to produce protein crystals.
Throughout the work described within this thesis, the Vapour Diffusion method was
followed.
Crystallisation by vapour diffusion
A droplet of target protein was mixed with crystallisation solution, ("mother liquor"),
at a ratio of 1:1 (commonly 2pl protein solution + 2pl mother liquor) and equilibrated
against a reservoir solution containing mother liquor. As a result of this dilution of
the protein with mother liquor, the reservoir has a higher concentration of
crystallising solution than that in the droplet/mother liquor mix. Equilibration
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proceeds by diffusion of volatile species (water/organic solvents), until the vapour
pressure of the droplet is equal to that of the reservoir. This results in the
concentration of all droplet components, including the protein, resulting in the
droplet being brought into a state of super-saturation.
Experimental set up for crystallisation
Experiments described in this thesis predominantly used "hanging drop" vapour
diffusion, occasionally "sitting drop" vapour diffusion was used in attempts to
improve crystal size and morphology.
The following protocol was used for all crystallisation experiments described in this
thesis, with minor modification as appropriate for either hanging or sitting drops. The
later steps in the process were carried out as quickly as possible, to minimise possible
denaturation of the protein.
1. Establish composition of crystallisation solutions to be used, calculate quantities
required to make 1ml of desired mother liquors, take note of location and nature
of each individual crystallisation solution on an alpha numeric grid.
2. Label a 24 well Linbro plate with the date, protein and plate number, ensuring
correct orientation of the plate with respect to its alpha numeric labelling, to
ensure agreement with the planned conditions.
3. Place small pieces of plasticine into the top comers of the plate.
4. Apply grease around the wells on the plate using soft white paraffin.
5. Place appropriate components of each mother liquor into appropriate wells, as
calculated and outlined in step 1.
6. Mix well components either by trituration or shaking.
7. Equilibrate to required temperature (if appropriate).
8. Apply a very small volume of protein solution (typically 1.5-2pl) to a siliconised
22mm round glass coverslip.
9. Apply an equal volume of appropriate mother liquor to each drop.
10. Carefully lift and invert the coverslip and drop onto the well.
11. Seal by pressing gently on the coverslip.
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12. Examine drops immediately post set up, and at regular intervals thereafter, note
any changes in appearance ie denaturation, precipitation and crystallisation.
Initial crystallisation trial conditions for "new" proteins routinely included an
ammonium sulphate (AS) screen, a polyethyleneglycol 4000 (PEG 4000) screen and
"Crystal Screen 1", a commercially available kit containing solutions consisting of
the 50 most successful crystallisation conditions, as established from searching
published literature. The AS and PEG screens involved screening protein at a defined
concentration (a minimum of lOmg/ml was routinely used) against grids varying
precipitant concentration (AS or PEG) and pH.
2.5.1.4
Co-crystallisation experiments
The method as outlined above was also used in attempts to co-crystallise proteins
with a number of peptide and non-peptide ligands. The molecule to be co-crystallised
was introduced into the well as a component of the mother liquor.
2.5.2
Crystal soaking
Soaking is a technique commonly employed to introduce a target molecule (ligand)
into a pre-formed crystal lattice. The following criterion should be met if the soaked
crystal is to prove useful for subsequent X-ray diffraction studies.
1. The ligand must be soluble to an acceptable concentration (10 - 500mM) in a
solution that closely mirrors mother liquor.
2. The ligand must be small enough to reach its target site by passing through
solvent channels within the crystal lattice; therefore for larger ligands co-
crystallisation is more appropriate.
3. The proposed binding site in the protein of the target molecule must be
unoccupied; compounds with high affinity binding to the active site were also
more likely to be visible in the calculated electron density.
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4. The crystal must be able to withstand both transfer into and prolonged incubation
in, a solution containing the ligand. Crystal cracking, loss of edge definition
followed by the crystal dissolving all resulted in no/poor diffraction.
A number of experiments were conducted to establish soaking conditions for each
crystal/ligand pair, and involved trial and error, combined with close and frequent
observation by binocular microscope, of the gross morphology of the crystal
undergoing soaking.
2.5.3
Preliminary characterisation ofprotein crystals
An important aspect of the experiment is to select individual crystals most likely to
produce data of the required quality. This selection process begins with careful
microscopic inspection of crystals in the drop, followed by crystallographic
screening, in which individual crystals are exposed to X-rays and the resultant
diffraction pattern assessed for usefulness.
To be useful in the X-ray diffraction studies, crystals should ideally fulfil a number
of requirements, as set out below.
■ They must be protein crystals, ideally single, free from micro-satellites and of a
reasonable size (ideally no smaller than O.lx 0.1 x 0.1mm).
■ Have symmetrical, sharply defined faces and edges.
■ Be capable of diffracting to the degree of resolution required to answer questions
posed by the experiment.
■ The degree of mosaic spread in the crystal should ideally not exceed 1°.
■ Tolerate exposure to X-rays, allowing collection of a dataset. The advent of cryo-
crystallography (mounting crystals in a protective solution followed by flash
freezing in liquid nitrogen) has greatly facilitated collection of datasets from
single crystals, due to enhanced survival time in the beam.
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2.5.3.1
Crystal handling prior to data collection
Data collection and preliminary processing were carried out under the supervision of
members of the Structural Biology Group, ICMB.
Crystals were removed from the drop by "fishing" with an appropriately sized
cryoloop, transferred into freezing solution (if required) and flash frozen in liquid
nitrogen.
Under a stream of liquid nitrogen, the loop assembly was mounted onto a
goniometerhead (a device that has two perpendicular arcs that allow rotation,
alignment and centring of the crystal). Maintenance of the crystal in the liquid
nitrogen stream was essential to avoid icing and/or thawing of the drop
The crystal was centred in the X-ray beam, and a "test" image shot. Routinely, two
frames (with the crystal rotated through 90° between frames) were used to initially
estimate crystal quality.
The quality of diffraction data produced was assessed, followed by either discarding
the crystal or setting up for a data collection. Dependent upon the diffraction pattern
produced from the test frames, several parameters can be optimised at this stage.
These include changing the distance from crystal to detector, exposure time and
oscillation range per frame, all with the aim of extracting the maximum amount of




Determination of the unit cell and space group of a protein crystal (protein crystal
characteristics)
Protein crystals are ordered 3-dimensional arrays of molecules held together by non-
covalent interactions. The repeating unit forming the crystal is known as the unit cell,
the overall array is referred to as the crystal lattice. Irradiation of a crystal produces a
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phenomenon referred to as scattering. Scattering of X-rays by the ordered molecules
within the crystal results in the emission of X-rays from the crystal, each having a
different direction and intensity. Collection and processing of these diffracted X-rays
produces a diffraction pattern. The diffraction pattern can reveal a large amount of
information about likely crystal quality, including the degree of uniformity of the
crystal lattice, completeness and resolution of data available. Initial assessment of the
data was necessary to determine the space group of a crystal to allow determination
of a suitable data collection strategy.
2.5.4.2
Handling ofcrystals prior to X ray diffraction studies
Protein crystals are fairly fragile and at all stages were treated gently and
manipulated as little as possible in an attempt to minimise damage. All data
collections were carried out on frozen crystals, to prolong crystal life in the X-ray
beam. Freezing solutions suitable for each crystals were therefore necessary. An
ideal freezing solution will maintain crystal integrity while also minimising the
production of ice in the droplet (ice is troublesome as it produces rings which can
obscure data). A standard approach taken with reasonable success throughout this
project was to supplement mother liquor with 20% glycerol. Crystals were
transferred from mother liquor into freezing solution using an appropriately sized
cryoloop, incubated in freezing solution for approximately 5 seconds and flash
frozen in liquid nitrogen.
Professor Malcolm D. Walkinshaw or Dr. Paul Taylor carried out all data processing.
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2.6
PEPTIDYL PROLYL CIS-TRANS ISOMERASE (PPIASE) ASSAY
This assay determines the rate of conversion of cis to trans of a proline containing
peptide, working on the principle that chymotrypsin will cleave the peptide only
when it is in the trans conformation, resulting in the release of chromogenic dye.
PPIase activity was assayed essentially as described by Fischer et al (Fischer et ah,
1989b), with the suggested substrate solvent application as described by Kofron et al.
The peptide substrate Suc-Ala-Ala-Pro-Phe-P-Nitroanalide (Bachem) was dissolved
in trifluroethanol (TFE) with 470mM LiCl to give a lOOmM stock solution that was
diluted to 4mM immediately prior to use.
The experimental setup was as follows; proteins were diluted into 50mM
FLEPES/86mM NaCl pH 8.0 (PPIase Buffer) to give a 2000nM stock. In a 1ml
cuvette, 10jul of protein (20nM final concentration) was added to 860/x 1 PPIase buffer
and incubated on ice for an hour. Chymotrypsin (100/rl of a 6mg/ml solution) was
added to the cuvette followed by transfer of the cuvette to a thermostatted Peltier cell
holder by which the reaction temperature was maintained at 5°C. The sample was
allowed to equilibrate until a steady baseline was established. The reaction was
started by the addition of 30/x 1 (120nM) of peptide substrate followed by rapid
mixing. The absorbance change at 400nm due to the release of p-nitroaniline was
recorded using a Perkin Elmer Lambda 20 spectrophotometer, with data collected
every 0.1 second over a two minute time period. A number of protein concentrations
were tested using the above method. Analysis of the data was carried out using a
double reciprocal Lineweaver-Burke plot which gives an intercept at 1/Vmax on the y-
axis, and 1/[S]=-1/Km on the x-axis. The slope of the line is KM/ Vmax.
Cyclosporin A inhibition and ligand binding assays were earned out essentially as
described above except that the samples were preincubated for a minimum of 60




SEQUENCE ANALYSIS, ALIGNMENT AND MODELLING
STUDIES
The ExPASy Molecular Biology server (http://www.expasv.ch/) was used as a
gateway to a number of useful "proteomics" tools. These included access to the
SWISS-PROT AND TrEMBL protein databases and also many useful tools and
software packages including sequence similarity programmes (BLAST, Fasta3) and
multiple sequence alignment packages (CLUSTALW, Multalin). A number of tools
were also available to assist in the primary and secondary structure analysis of target
proteins including Compute pI/Mw, PredictProtein and PSIpred.




CRYSTALLISATION OF CYCLOPHILIN 3 FROM THE




In 1996, the cloning and characterisation of eleven cyclophilin genes from the free-
living nematode worm Caenorhabditis elegans provided an opportunity to study the
various biological roles played by these proteins in this well characterised and
genetically tractable organism (Page et ah, 1996). Data on both temporal and spatial
expression patterns for several cyclophilin isoforms was subsequently obtained by
the same group, shedding more light onto the roles played by individual cyclophilins
throughout the lifecycle of C. elegans, (Page and Winter, 1998; Dornan et ah,
1999a).
Previous studies had identified cyclophilins from diverse parasitic species including
the closely related nematode Brugia malayi (Page et ah, 1995a, Page et ah, 1995b),
Plasmodium falciparum, (Hirtzlin et ah, 1995; Reddy and Ingallinera, 1995; Reddy,
1995), Leishmania major (Hoerauf et ah, 1997), Trypanosoma brucei brucei (Daothi
et ah, 1998). The potent anti-parasitic effects of sub-immunosuppressive levels of
CsA on these parasites had been clearly demonstrated, (Chappell and Wastling,
1992) resulting in a great deal of interest in identifying the mechanisms and
pathways responsible for these effects.
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Cyclophilin homologues from the free-living nematode C. elegans
Sequence alignments of the proteins encoded by cyps 1-18 showed the C. elegans
proteins to be highly variable, falling broadly into four categories.
■ Category 1 included CYPS-2, -3, and -7, most closely resembling Cyp A.
■ Category 2 comprised CYP-6 as a Cyp B type secreted isoform.
■ Category 3 comprised CYP-1 and -5 Cyp C type proteins with characteristic
mitochondrial localisation sequences.
■ Category 4 included CYPS -4, -8, -9, -10, -11, -12, -13, -14, -15, -16, -17 and
-18 representing the most divergent Cyp D type, possessing one or more residue





CsA Binding Domain changes Signal
peptide
Insert pi
CYP-1 (C) 18 Conserved Yes Yes 6.24
CYP-2 (D) 18 A103C No Yes 8.23
CYP-3 (A) 18 Conserved No Yes 8.88
CYP-4 (D) 58 A103K, W121Y No No 9.4
CYP-5 (C) 19 Conserved Yes No 8.75
CYP-6 (B) 19 Conserved Yes No 5.25
CYP-7 (A) 18 Conserved No Yes 8.68
CYP-8 (D) 54 A103R, W121H No Yes 9.89
CYP-9 (D) 36 A103K, W121H, L122C No Yes 8.6
CYP-10 (D) 16 A103N, W121H, H126Y No No 5.27
CYP-11 (D) 20 W121F No Yes 6.07
CYP-12 (D) 18 W121H No No 7.9
CYP-13 (D) 36 A103C No No 5.67
CYP-14 (D) 44 R55S, F60Y, M61V, A101V,
A103N, W121Y
No No 5.45
CYP-15 (D) 71 H126N No No 6.44
CYP-16 (D) 25 M61I, W121E, No No 6.86
CYP-17 (D) 62 R55Q, F60K, Q63M, A101S,
N102D, A103T, Q111L, F113Y,
W121P, L122S, H126G
No Yes 8.35
CYP-18 (D) 24 R55K, F60K, Q63L, A101I,




Characterisation of the eighteen cyclophilin homologues isolated from C. elegans.
After Table 2 from (Page et al., 1996). CsA binding domain residue numbering
scheme is based upon that of human Cyp A.
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A study to biochemically and structurally characterise a number of cyclophilin
isoforms from the eleven available was proposed. Detailed information obtained
from such a study may have had implications in the design of targeted antiparasitic
drugs. Cyclophilin 3 was chosen as the initial target for further study.
The goal of this part of the project was to fully characterise the protein





All cloning was carried out by Dr. Antony P. Page, Wellcome Centre For Molecular
Parasitology, The Anderson College, The University of Glasgow, 56 Dumbarton
Road, Glasgow, Gil 6NU.
The following is provided for completeness, cyp-3 was cloned from cDNA using a
reverse transcriptase polymerase chain reaction (RT-PCR) method as described
previously (Page et ah, 1996). Briefly, poly-A+ mRNA was obtained using the
Micro-Fast Track Kit (InVitrogen), and cDNA was synthesized using a cDNA
synthesis kit (Amersham, Little Chalfont, UK). RT-PCR conditions were as follows;
lOpmol of each primer (cyp3F/Nde and cyp3R/EcoRI) 5mM MgCL; 6.7mM 2-ME;
4.4jiiM EDTA (pH8); ImM of each dNTP; 113/u.g/ml non-acetylated BSA), 2/rl of
mixed stage cDNA and lpil Taq polymerase (Advanced Biotechnologies), cycled
20X at 94°C for 30 sees, 60°C for 1 min and 72°C for 1 min in 100/rl. The primers
included engineered restriction sites (Ndel and EcoRY) which after restriction
digestion, allowed directional sub-cloning into similarly digested pET-5a expression
vector (Promega). Ligation and transformation protocols of the Promega pET-5
technical manual were followed. Plasmid DNA was isolated (Plasmid Kit, Qiagen)
and the insert was sequenced in both directions by thermal cycle sequencing on an
Applied Biosystems Automated Sequencer to validate that no mutations had been
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generated by the RT-PCR procedure. The plasmid DNA was then transformed into
competent BL21 (DE3 pLysS) cells (Promega) for subsequent recombinant protein
expression.
3.2.2
pET expression ofCYP-3 in E.coli
The standard protocol adopted throughout the duration of this work was followed
(see chapter 2, Section 2.3). A number of experiments were conducted to optimise
the yield of protein produced. These included varying the following factors during
the cell culture phase of the process:
(1) Temperature, (2) ODooo at which the cells were induced, (3) Amount of IPTG
used for induction, (4) Time post induction before cells harvested, (5) Rate of
shaking/degree of aeration (as estimated from volume/flask).
Little difference could be seen when comparing the yields of protein produced,
therefore the standard approach of inducing cells at an ODooo of 0.6 with 0.4mM
IPTG and harvesting 4 hours post induction was followed.
The cell cultures were centrifuged, supernatant discarded and pellets frozen at -20°C.
3.2.3
Purification of recombinant Cyclophilin 3
The cell pellets were defrosted on ice and solubilised in lysis buffer (10% w/v)
containing 50mM HEPES, 5mM benzamidine, 5mM EDTA, 5mM (3
mercaptoethanol, pH 7.5. Lysozyme (ICN/FLOW) was added to 0.1% w/v and
incubated on ice for 1 hour. An equal volume of deionised water at 4°C was added
and the cell suspension mixed. Magnesium chloride to a final concentration of 5mM
was added, followed by the addition of RNase and DNase to a final maximum
concentration of 0.01% (w/v). EDTA was added to a final concentration of lOmM.
The lysed cells were centrifuged, the resulting supernatant was usually frozen and
stored at -20°C. To begin the process of purification, the supernatant was defrosted
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slowly on ice and the pH adjusted to 6.8, using 2M HEPES, pH6.5. The cell extract
was filtered (glass micro-filter through to 0.45pm filter). Protein extract was purified
to homogeneity using two purification steps. SP Sepharose cation exchange
chromatography with the following buffers - Buffer A: 50mM HEPES, 5mM EDTA,
5mM (3-Me pH 6.8 and Buffer B; Buffer A + 0.5M NaCl (pH 6.8). The protein was
bound in batch mode to pre-equilibrated resin, incubated for an hour with frequent
mixing and poured into an XK 26/20 column. Column fractions were tested on 15%
SDS-PAGE gels and fractions containing the protein of interest were pooled and
dialysed, using dialysis tubing with a 3kDa cut-off, overnight against buffer A.
Protein solution was filtered through a 0.2pm filter and applied to Resource S resin.
CYP-3 was eluted from this resin with the following buffers, Buffer A 20mM
HEPES pH 6.8, Buffer B, A+ 0.5M NaCl.
Fractions containing CYP-3 were pooled and concentrated to 20mg/ml as estimated




Dynamic light scattering analysis of the purifiedprotein
Dynamic light scattering experiments on the purified Cyp 3 were carried out using
the DynaPro 801 with microsampler attatchment. A number of protein concentrations
were tested, the protein was monitored for stability and tendency to aggregate.
3.3.2
Electrospray ionisation mass spectrometry
Purified protein was further characterised by electrospray ionisation mass
spectrometry on a Micromass Platform II spectrometer. The sample was first
subjected to a reverse-phase chromatography step, retained protein eluted with a
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solution of water/acetonitrile/TFA (0.05% v/v) and introduced online into the
instrument stream.
3.3.3
Peptidyl Prolyl Isomerase (PPIase) assay
The experimental setup was as described in Chapter 2, Section 2.6. Cyclosporin A
inhibition assays were carried out essentially as described above except that the
samples were pre-incubated for a minimum of 60 minutes with varying amounts of
CsA (kindly provided by Novartis AG).
Ala-Pro ligand binding studies were carried out in the same manner.
3.3.4
Crystallisation of Cyclophilin 3
The hanging drop vapour diffusion method as described in chapter 2, section 2.5.1.3
was used throughout this series of experiments.
3.3.5
Data collection
Crystals were transferred from the hanging drop using an appropriately sized cryo-
loop into cryo-protectant solution containing mother liquor plus 20% glycerol.
Crystals were removed from the cryo-protectant solution after 5 seconds and
mounted in a cryo-loop and flash frozen in liquid nitrogen. To establish if the crystal
was of sufficient quality to merit a data collection, 2 frames were shot, with 90°
between images. X-ray data from suitable crystals were collected at 100K using a
MAR image plate and processed using DENZO (Otwinowski and Minor, 1993).
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3.4
STRUCTURE DETERMINATION OF THE TETRAGONAL FORM
OF CYCLOPHILIN 3
3.4.1
The structure was solved and refined by members of the Structural Biochemistry
Group, ICMB, University of Edinburgh. Dr. Paul Taylor first solved the structure.
Refinement and later ligand binding studies were carried out by Dr. Su-ying Wu as
part of her PhD programme.
Structure solution and refinement
The structure was solved by molecular replacement using the program AMoRe
(Navaza, 1994) with the human cyclophilin A structure as the model. Positional and
B-factor refinement were performed using SHELX-97 (Sheldrick, 1997), water





Purification ofrecombinant Cyclophilin 3
Figure 10 shows SDS PAGE gels illustrating a representative purification run.
Conditions were subject to frequent revision, resulting in an optimised purification
protocol, utilising 2 cation exchange steps.
(A)
A representative gel illustrating
successful induction of over-
expression of CYP-3 by IPTG. Lane
1 uninduced cell culture, lanes 2, 3
and 4, 2, 3 and 4 hours post induction
respectively. Lane 5 molecular weight
markers.
1 2 3 4 5
Figure 10 A - D





Representative gel illustrating a
typical elution profile from SP
Sepharose. Lanes 1 and 15, molecular
weight markers. Lanes 2—11, elution
of CYP-3 by an NaCl gradient, lane
11 unbound material, lanes 13 and 14
"start material" (clarified cell extract),
filtered and unfiltered respectively






Representative gel illustrating a
typical elution profile from Mono S
resin. Lanes 1 and 13, molecular
weight markers, lanes 2 and 3
material post SP Sepharose and
dialysis, unfiltered and filtered
respectively. Lanes 4—12 elution of





purified and concentrated CYP-3.
Lanes 1 and 9, molecular weight
markers. Lanes 3, 5 and 7 0.5pl, 2pl
and 5pi of CYP-3 loaded (lane 7




Dynamic light scattering analysis
Table 4 illustrates a typical data-set obtained from a dynamic light scattering
experiment carried out using purified CYP-3. As outlined in Chapter 2,









1 0.5 19kDa 1.003 1.532
2 0.1 18 kDa 1.000 1.223
3 0.1 18 kDa 1.001 1.216
4 0.3 17 kDa 1.001 1.064
5 0.7 17 kDa 1.001 1.354
6 0.5 20 kDa 1.006 1.174
7 0.4 18 kDa 1.000 0.750
8 0.4 18 kDa 1.000 0.753
9 0.5 17 kDa 1.000 1.447
10 0.2 19 kDa 1.004 1.476
11 0.5 17 kDa 1.000 0.897
12 0.1 17 kDa 0.999 0.763
Mean values 0.4 18 kDa 1.001 1.135
Table 4
Purified CYP-3 at 2 - 10 mg/ml was analysed as described in Chapter 2, using the
room temperature micro-sampler attachment of the DynaPro 801.
The four results parameters highlighted above were considered to be most important
in the initial analysis of an "unknown" protein sample. As can clearly be seen from
the results, the closeness of fit between the experimental and theoretical data was
very high. These results therefore suggested the protein was essentially of a uniform
composition (mono-disperse) and present in solution as a monomer and was
therefore an excellent candidate for crystallisation trials.
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3.5.3











The protein was further characterised by
electrospray ionisation mass spectrometry on a
Micromass Platform II spectrometer. Mass
spectrometric analysis was carried out by Dr. Juan
Zou as part of a collaborative project investigating
the binding of metals to CYP-3. The sample, native
protein at 5pmol/pl in a solution of 50% acetonitrile
in water with 0.2% formic acid added was
introduced into the instrument stream via an infusion
pump, the m/z spectrum deconvolved using MaxEnt
software.
Figure 11
Mass spectrometry gives a molecular mass of 18,420 Da. The calculated molecular
mass of the sequence is 18,550 Da and suggests that the N-terminal methionine
residue is removed post-translationally. The calculated molecular mass of the
sequence omitting the N-terminal methionine is 18,419 Da. Additional peaks seen




Two crystal forms were grown from the protein isolated using the purification
protocol outlined in section 3.2.3. The standard hanging drop vapour diffusion
method as described in Chapter 2 Section 2.5.1.3 was followed. Following the
establishment of crystallisation conditions, in attempts to increase crystal size, sitting
drop vapour diffusion was tried on a number of occasions.
Initial hints as to the "crystallisability" of the protein were obtained from promising,
shaped precipitates. Further refinement of these initial conditions, resulted in two
very different crystal forms, thin plates and tetragonal bipyramids. The process of
refinement of crystallisation conditions involved incremental changes to pH and
precipitant concentration, followed by close analysis of the drops for any changes. A
number of additives were also tested. The first crystals produced at 4°C were thin
plates, conditions were refined at 18°C to produce crystals of greater size and better
morphology.
Photographs illustrating sequential changes in crystal morphology are reproduced in
Figure 12.
Details of the refinement of crystallisation conditions that produced large single
crystals suitable for X-ray diffraction analysis are shown in Table 5.
3.5.5
Preliminary characterisation and data collection
Crystal quality is most important in determining the quality of data collected,
however other factors such as exposure time, required oscillation range and crystal to
detector distance can also influence the success of a data collection. Parameters such
as those above were optimised to produce usable data to the highest resolution
possible for a given crystal.
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Figure 12
Photographs showing changes obtained in CYP-3 crystal morphology during the
process of refinement of crystallisation conditions
Figure 12A
Thin plate form: 4|ll hanging drops consisted of 50mM citric acid/sodium citrate
pH 6.0, 13% methoxypolyethylene glycol 5000 (MPEG 5000). Protein concentration
was 14 mg/ml. The drop was suspended over a well containing lOOmM citric
acid/sodium citrate pH 6.0 and 26% MPEG 5000, an incubated at 4°C. Thin plate
crystals with dimensions 0.5 X 0.2 X 0.005mm grew within a few days. X-ray data
were collected from one such thin plate crystal. These crystals were orthorhombic
and diffracted to 1.9A in one direction, with unit cell dimensions of a=58.9 A,
b=67.5A, c=76.4A. No further studies were carried out using crystals of this form as
they were severely anisotropic.
Figure 12B
Small tetragonal bipyramid form: 4pl hanging drops consisted of 50mM sodium
citrate pH 5.6, 15% MPEG 5000 7.5% DMSO. Protein concentration was 7mg/ml.
The drop was suspended over the well containing lOOmM citric acid/sodium citrate
pH 5.6, 15% DMSO and 30% MPEG 5000, at 18°C. Small tetragonal bipyramid
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crystals with dimensions 0.1 X 0.05 X 0.05mm grew overnight. X-ray data were
also collected from these small crystals. Crystals typically diffracted to 2.5A, with the
same unit cell dimensions as the larger crystals.
Figure 12C
This photograph illustrates two small tetragonal crystals that had formed as a twin.
Twinning of crystals presented little problem, as they predominately grew as single
crystals. The crystals seen in this photograph are also of intermediate size (0.15 X 0.1
X 0.1mm), useful for data collection at medium to high resolution (maximum
resolution on the home source was 2.2k). Crystal size was a limiting factor in
obtaining higher resolution data, therefore sitting drop vapour diffusion was tried in
an attempt to obtain larger crystals.
Figure 12D
Large tetragonal bipyramid form: 4pl sitting drops consisted of 50mM sodium
citrate pH 5.6, 15.5% w/v (MPEG 5000). Protein concentration was 7mg/ml. The
drop was placed onto a micro-bridge into a well containing lOOmM sodium citrate
and 31% MPEG 5000 and incubated at 18°C. Large tetragonal bypyramid crystals





































































Structure solution and refinement
Crystals belong to space group P4i2]2 with unit cell dimensions a=b=60.60 A
c=123.12 A. The merging R-Factor is 8.3 % and the data is 97% complete to a
resolution of 1.8A. Results of the final refinement are summarised in Table 6.
Summary of refinement statistics Native
o
Resolution range (A) 10-1.8
Rfinal (all data) ( F>4c) 20.81% (19.69%)
Rfree ( F>4c>) 28.47% (26.61%)
Root mean square deviations from ideal geometry
Bond lengths (A) 0.031
Angle distance (A) 0.026
Mean B-factor (A2) 30.37
Table 6
Summary of the final refinement statistics used in the structure determination of
CYP-3
The structure was solved by using the molecular replacement programme AMoRe
(Navaza, 1994), with Cyclophilin A as the search model. This model gave a single 10
sigma peak in the rotation function and this rotated model gave a 9 sigma peak in the
translation function. The structure was refined using SHELX-97 (Sheldrick, 1997) by
Su-ying Wu.
All residues are well defined in the electron density map, the exceptions being 2
residues in the N-terminal region (Metl and Ser2), 2 residues in the loop region (Gly
87 and Glu 88) and Lys 172 in the C-terminal region. Data analysis indicated the
structure to be of acceptable quality.
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3.6.2
The Overall Architecture ofCYP-3
The overall architecture of CYP-3 is similar to that of known X-ray and NMR
cyclophilin structures (Braun et al., 1995), (Taylor et al., 1997) with an anti-parallel
8-stranded (3-barrel capped at either end by two a-helices. The centre of the barrel is
filled with hydrophobic residues from the side chains of Val 6, Phe 8, lie 20, Met 22,
lie 63, He 69, Leu 105, Phe 119, Leu 121 and He 165. These hydrophobic residues
pack tightly within the core, excluding the possibility of a ligand-binding site within
the (3-barrel core. Ligand binding has been shown to occur in the active site groove
on the surface of the protein see (Taylor et al., 1997) for review. The CYP-3
structure is very highly conserved when compared with the structure of human
cyclophilin A, the best characterised member of the family (Kallen et al., 1991; Ke et
al., 1991), (Figure 13). The root mean square deviation is 0.55A for the 620
corresponding C, N, Ca and O atoms from amino acid residues 2 to 44 and 55 to 171
in CYP-3 and residues 2 to 44 and 48 to 164 in Cyp A.
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Figure 13
Overlay of the structures of C. elegans CYP-3 and human cyclophilin A. The eight
labelled strands are shown in blue, the two helices are shown in green, and the
additional CYP-3 loop structure is shown in orange. The human Cyp A loop (in blue)
contrasts with the shape adopted by the divergent loop, which is formed mainly by 7
additional residues (48KSGKPLH54) in the CYP-3 sequence. The figure was
prepared using Molscript (Kraulis, 1991).
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3.6.3
Key Structural Features ofCyclophilin 3
Figure 14 shows an alignment of the cyclophilin domains from a number of proteins
against human Cyp A. CYP-3 and Cyp A are 67% identical (77% similar) at the
amino acid level (Page et al., 1996). The presence of an additional seven amino acid
insert in cyclophilin 3 when compared to cyclophilin A, provides the most striking
distinguishing feature between these two family members, as can clearly be seen in
Figure 13. A number of interesting features have been identified from the structural
studies of CYP-3 and these will be discussed in the following section, and are also
highlighted in Figure 14, see legend for details
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3.6.3.1
The active site ofCYP-3
The active site of CYP-3 is also very similar to that found in human Cyp A, all 13
residues important in binding to Cyclosporin A being conserved (Pflugl et al., 1994;
Page et al., 1996), (Figure 14). The only significant structural difference seen is in
the conformation adopted by Arg 62 that places the corresponding side chain atoms
0.7A apart. The side chains of Met 68 and Lys 125 are also very slightly shifted
(Figure 15). This fits with the similar enzymatic activity and inhibition by CsA as is
found for human Cyp A. The very close structural similarity of the active site region
also suggests that the possible natural cellular substrates are also similar between C.
elegans and mammals.
Figure 15
Stereo diagram showing the active sites of CYP-3 (red) and human Cyclophilin A
(green). This clearly shows the complete conservation of all 13 residues important in
the binding of CsA. The only significant structural difference between these two





The most distinctive structural feature distinguishing CypA from CYP-3 is an
additional insert of seven residues 48KSGKPLH54, which forms a protruding loop
located above the active site of CYP-3 (Fig 13). This feature has also been observed
in the Bm-CYP-1 cyclophilin structure from the filarial nematode Brugia malayi,
(Taylor et al., 1998; Mikol et al., 1998).
The loop is held in place by a very specific network of hydrogen bonds from the side
chain of Glu-83. The carboxylic group of Glu 83 forms two strong hydrogen bonds
with amide main chain nitrogen atoms of Lys 48 and Ser 49 (Fig 16), resulting in an




The divergent loop of C. elegans CYP-3
The two strong hydrogen bonds from the carboxylic group of Glu 83 to the amide
main chain nitrogen atoms of Lys 48 and Ser 49 are shown in violet. The "divergent"
loop structure provides a distinctive recognition feature of this subfamily of
cyclophilins.
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Many cyclophilin homologues with additional loops (including human/bovine
cyclophilin 40 and some parasite and plant cyclophilins) have a conserved glutamate
in a homologous position. Thus the role of Glu 83 in these "divergent loop"
structures is therefore to both lock and tether the loop into a particular conformation.
The loop provides a distinctive recognition feature of this sub-family of cyclophilins
and may prove to have functional significance in a number of important interactions
including protein-protein recognition mechanisms.
Loop structures do however show some divergence as can be seen on comparing the
structures from CYP-3 and B. malayi (Taylor et al., 1998). The presence of inserts of
6-8 residues has been described previously in a number of members of this protein
family, including many plant species (Chou and Gasser, 1997). It is a particularly
common feature of the nematode cyclophilins, being found in 7 of the 11 initially
characterised from C. elegans (Page et al., 1996). A consensus sequence for this
additional loop based on multiple sequence alignments is (**GK*LH).
It is interesting to note that this loop also contains part of a conserved ATP/GTP-
binding site motif A (A/G-X4-G-K-S/T) (Walker et al., 1982). The high degree of
conservation of this inserted sequence over diverse species suggests the loop
structure and its locking mechanism are an important functional part of the protein
whose role remains to be elucidated, rather than a neutral addition.
3.6.3.3
Conserved cysteines
Conserved cysteines: CYP-3 shares with many other cyclophilins including most
divergent loop cyclophilins, such as Bm-CYP-1, two highly conserved cysteines
(Figure 14). The sulphur atoms of Cys40 and Cysl68 are well defined in the electron
density and are separated by 5.38 A, and are present in the structure as reduced





The sulphur atoms of Cys40 and Cysl68 are present in the structure as reduced
cysteine residues. Torsion angles of the 2 residues are N-Ca- C(3-S = 53° for Cysl68
and -72° for Cys40. The sulphur atom of Cysl68 is 3.74A away from nitrogen Ne2
of His 54, 3.2A from the carbonyl oxygen of Cys40 and 3.5A away from the
backbone NH of Lys 56. Molecular modelling has shown that a simple rotation about
the Ca-C(3 cysteine side chain bonds enables a disulphide bond to form (N-Ca- C(3-S
= -167° for Cysl68 and N-Ca- CJ3-S = -134° for Cys40).
These changes from the original staggered conformation to an alternatively favoured
staggered conformation results in an S-S distance of 2.1A, with no other short non-
bonded inter-atomic contacts. The role of these conserved residues is unknown. The
unexpected presence of the reduced form of these cysteine residues suggests the
intriguing possibility that this feature may provide a signalling mechanism in
response to oxidative stress. The formation of an S-S bond in an oxidising
environment may provide a dynamic signal inducing conformational change(s).
Alternatively, the sulfhydryl group of the reduced Cysl68 and Cys40 along with the
imidazole side chains of His 54 may provide a metal ion co-ordination site.
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Interestingly, His-54 (or equivalent) is conserved in many of these divergent loop
cyclophilins (Figure 14) and may also be an important part of this putative redox
signalling mechanism.
There may be a general link between cyclophilins and a cellular stress response as
suggested by the association of human Cyp A with the thiol-specific antioxidant
protein Aopl (Jaschke et al., 1998). This activity is stimulated by the interaction
between Aopl with Cyp A and is not inhibited by CsA. One mechanism for the
control of oxidative stress in bacteria is by the protein OxyR which is activated by
the formation of an intra-molecular disulphide bond (Zheng et al., 1998). A similar
mechanism was proposed for the activation of the Hsp33 chaperone protein which is
also redox regulated (Jakob et al., 1999). Oxidation of Hsp33 by hydrogen peroxide
causes disulphide bond formation, release of bound zinc and activation of the
chaperone activity of Hsp33.
The X-ray structures of CYP-3 and CYP-1 from Brugia malayi, (Taylor et al., 1998;
Mikol et al., 1998) another member of the divergent-loop subclass of cyclophilins,
both show the conserved cysteine residues in the reduced form. Furthermore, His54
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which is incorporated in the divergent loop is located 3.6 A from the sulphydryl
group of Cysl68. The arrangement of two cysteines and a histidine provides a
suitable co-ordination site for zinc. A very similar co-ordination geometry involving
two cysteines and a histidine is present in the X-ray structure of a zinc complex of
alcohol dehydrogenase (Cho et al., 1997). The arrangement of cysteines and
histidines, often present in this newly defined divergent-loop subclass, are therefore
potentially involved in either metal co-ordination or in a redox signalling process
triggered by the formation of a Cys40 to Cysl68 disulphide bond.
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3.6.3.4
Temporal and spatial expression pattern ofCYP-3
CYP-3 represents one of the most abundantly expressed cyclophilins in the nematode
Caenorhabditis elegans. This observation is based both on the analysis of relative
transcript abundance and due to the fact that it has been isolated 18 independent
times during the C. elegans expression sequence tag (EST) project ([Anon], 1998).
The semi-quantitative RT-PCR analysis of the post-embryonic temporal expression
pattern of cyp-3 indicates that this transcript is most abundant during early larval




Graphical representation of the
semi-quantitative RT-PCR result,
illustrating the peak seen for the cyp-3
transcript in the second larval stage.
The temporal abundance of cyp-3 is
expressed as a ration to the
constitutively expressed gene ama-1.
Thanks to Tony Page for the figure.
The expression pattern seen for the cyp-3 transcript may correlate with a peak in the
amount of newly synthesised structural proteins produced by the developing larvae.
Spatial expression pattern
The spatial expression pattern of CYP-3 was examined by constructing a
translational fusion of the promoter region with a reporter gene and staining the
transgenic nematodes for (3-galactosidase activity. This analysis revealed a very
specific tissue localisation for this highly conserved cyclophilin, being expressed
exclusively in larval stages in the single celled anterior excretory system. This
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reporter construct is tagged to a nuclear localisation signal, hence the specific signal
is observed in largest mononucleate cell of C. elegans, the excretory cell (White,
1988).
Figure 19 A and B
Micrograph showing the
exclusive cyp-3 reporter gene
expression in C. elegans.
Nuclear localised /?-
galactosidase activity is
restricted to the single anterior
mononuclear cell. A and B
represent individual larval
nematodes.
Bar represents 1 Opm.
Thanks to Tony Page for the
figure.
The exclusive excretory cell expression pattern is also intriguing. The excretory
system in C.elegans is involved in osmoregulation and secretion (White, 1988). The
role in osmoregulation is supported by gland cell laser ablation experiments, which
resulted in worms becoming bloated and dying in hypotonic medium (Nelson and
Riddle, 1984). The importance of the excretory system in secretion is well
established for parasitic nematodes, where it is the source of surface coat antigens for
parasites such as Toxocara canis (Page et al., 1992a; Page et al., 1992b). A role for
CYP-3 in either osmoregulation or secretion however, remains to be established.
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CHAPTER 3B.
FURTHER STRUCTURAL AND ENZYMATIC STUDIES
OF CYCLOPHILIN 3
3.7
EXPERIMENTS FOCUSSING ON CONSERVED CYSTEINE
RESIDUES
3.7.1
Metal catalysed oxidation of cysteine residues present in the structure
ofCYP-3 in the reduced form.
In an attempt to induce disulphide bond formation between Cys40 and Cysl68, a
number of attempts were made to utilise the ability of metals to catalyse an oxidation
reaction. Crystals were soaked overnight in solutions of mother liquor containing a
number of different concentrations of either silver nitrate (lOmM) or iron III chloride
hexahydrate (107mM). The soaked crystals were then flash frozen and exposed to X-
rays. Following oxidisation trials, difference electron density maps were calculated,
using the native structure as the reference. The difference maps were examined to
establish if there had been any changes in the density around residues Cys 40 and
Cys 168. No changes could be seen in electron density, therefore no further
experiments were carried out.
Attempts using mercury derivatives were carried out as part of a Summer
Studentship, held by James Brown. This series of experiments resulted in the crystals
either diffracting very poorly or not at all, suggestive of metal perturbing the crystal
lattice. Crystallographic aspects of the work described above were carried out by
Professor Malcolm D. Walkinshaw, Drs Su-ying Wu and Paul Taylor.
Interest in CYP-3 metal interactions, focusing particularly on the four free Cys thiols,
continued within the laboratory.
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3.7.2
Anti-arthritic gold complex binding to CYP-3
A number of anti-arthritic gold (I) drugs are in clinical use, their critical target sites
are thought to be thiolate sulphurs (cysteine residues), there is however little
structural data on adducts of anti-arthritic Au (I) complexes with proteins.
Cyclophilin 3 was identified as an excellent template for these studies for two main
reasons; the availability of crystals amenable to soaking experiments that
subsequently still diffracted well and also the presence of four free Cys thiols
identified as likely target sites for metal and in particular Au binding.
Studies using this system with an Au (I) phosphine complex (AuPEtjCl) were carried
out in collaboration with Dr. Juan Zou and others from the group of Professor Sadler,
Department of Chemistry, University of Edinburgh. Crystals were soaked with gold
complex for time periods that varied between approximately 30 minutes and two
weeks. Crystals were significantly altered following soaking with gold complex
solutions; cracks appeared and the crystals lost edge definition. Crystals soaked for
approximately 30 minutes showed no additional electron density upon calculation of
difference maps, whilst those soaked for more than 6 hours failed to diffract at all.
Data was obtained from crystals soaked for 2 and 4 hours.
Protein in solution was also reacted with varying amounts of complex, to provide
samples for mass spectrometric analysis. Experiments to confirm the accessibility of
the four free Cys thiols were carried out. Protein was reacted with the disulphide 5,5'-
dithio-bis 2-nitrobenzoic acid (DTNB), changes in the absorption at 412nm were
monitored. Native and reacted proteins were also analysed by LC-ESI-MS.
The structure was solved using molecular replacement, with the native CYP-3
structure as the template. Difference electron density maps of crystals soaked for 2 or
4 hours in a 3.5mM solution of gold complex clearly showed a large peak
corresponding to a single gold site in the region of an active site residue, His 133.
Further rounds of refinement revealed the gold had indeed bound to the Ne2 nitrogen
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of His 133 and to PEt3. Complexation of Au to the active site histidine was also
shown to be inhibitory to PPIase activity, as assayed by the PPIase activity assay
described earlier in Chapter 2, Section 2.6.
Figure 20 A and B
(A) Refined structure of the gold binding site in CYP-3, showing His 133 bound to
AuPEt3. Lack of definition of the PEt3 ligand is probably due to rotational disorder.
(B) Stereoview of CYP-3 after reaction with AuPEt3Cl showing the S atoms of the 4
Cys residues (light spheres) and [AuPEt3]+ bound to the Ne2 nitrogen centre of
Hisl33. The figures were prepared using Bobscript (Esnouf, 1997), Molscript
(Kraulis, 1991) and Raster3D (Merritt and Bacon, 1997).
These results presented above are more fully described and discussed in a publication
by Zou et al., 2000.
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3.7.3
Peptidyl-prolyl cis-trans isomerase activity and its inhibition by
Cyclosporin A
Representative spectral progress curves showing the formation of the isomer of the
model substrate tetrapeptide can be seen in Fig 21.
0 nM protein (A)
20 nM protein (B)
10 nM CsA (C)
20 nM CsA (D)
40 nM CsA (E)
60 nM CsA (F)
100 nm CsA (G)
60 80
Time in seconds
Inhibition of CYP-3 PPIase activity by Cyclosporin A
Figure 21
Representative spectral progress curves showing CYP-3 catalysed acceleration of the rate
of isomerisation of the tetrapeptide substrate. The uncatalysed rate (no CYP-3) is labelled
A. The curve labelled B shows the catalytic effect of 20nM CYP-3. Inhibition of the
isomerisation reaction by increasing concentrations of the cyclophilin binding drug
cyclosporin A is illustrated by curves C through G. The spectral curves obtained
following pre-incubation with 10, 20, 40, 60 and lOOnM CsA are shown.
CYP-3 clearly accelerates the rate of isomerisation of the tetrapetide substrate relative to
the uncatalysed thermal isomerisation rate and the catalysis is inhibited by addition of the
cyclophilin binding drug cyclosporin A. The enzyme reaction was found to follow
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Michaelis Menten kinetics with the velocity of the reaction (v) increasing with substrate
concentration [S] as shown in Figure 22.
Effect of increasing substrate concentration [S] on the










0 200 400 600 800 1000 1200
Substrate concentration [S] in jiM
Figure 22
First order rate kinetics were observed and a double reciprocal Lineweaver-Burke plot of
1/v against 1/[S] gave values of kcat= 860 s"1, Km = 350 pM which corresponds to a
value of kcat/Km of 2.4 x 106 M"1 s"1. These values are similar to the published values for
human CypA using the same substrate which has kcat= 12700s"1, Km 870 pM and
kcat/Km = 14.6 x 106M"' s"1 (Kofron et ah, 1991).
A concentration of 16nM CsA was required to inhibit 50% of the CYP-3 PPIase activity
(IC50). This value is comparable to the IC50 value of 19nM, obtained for the inhibition of
human CypA by CsA (Liu and Walsh, 1990).
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3.8
EXPERIMENTS FOCUSSING ON PEPTIDE LIGANDS BINDING
TO CYP-3
3.8.1
Soaking and/or co-crystallisation experiments with CYP-3
A number of studies have shown cyclophilins to be capable of binding to a variety of
peptide and non-peptidic ligands (Taylor et al., 1997) for review. CYP-3 proved to be a
robust model system amenable to both co-crystallisation with and soaking in of, of a
number of ligands. This was a particularly attractive model system for a number of
additional reasons outlined below:
■ Availability of a significant number of good quality crystals of dimensions suitable
for X-ray structure analysis.
■ The ability of these crystals to withstand repeated cycles of soaking followed by
freezing and exposure to X-rays, allowing data for a number of points to be obtained
from the same crystal.
■ Short data collection times as a consequence of both the space group and point group
of these protein crystals. Sufficient data can be collected overnight on the home
source and within an hour at a synchrotron radiation source equipped with CCD
detectors (approximately 30° of data was collected for the native structure, this data
was 97% complete).
■ Availability of a high resolution native structure, allowing relatively straightforward
analysis of any changes induced by ligand binding.
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3.8.2
The First Direct Determination of a Ligand Binding Constant in
Protein Crystals
Collaborative experiments with Dr. Su-ying Wu investigating ligand binding to CYP-3
were carried out.
3.8.2.1
Ala-Pro binding to CYP-3
Soaking experiments were carried out with a number of small molecules and peptides, in
an attempt to better understand the specificity of binding in this system. The di-peptide
Ala-Pro provided a good model system with which to investigate the dynamics of
soaking small peptide ligands into CYP-3 protein crystals.
The structures of Ala-Pro bound to CYP-3 were solved and refined and the occupancy of
Ala-Pro in the crystal calculated by Dr. Su-ying Wu as part of her PhD studies. This data
was correlated with that obtained from studies of the protein in solution, using the PPIase
activity assay. The validity of using data from protein crystal structures with ligands
bound as the basis of evaluating the system in solution has long been questioned. Results
presented in this study suggest that, certainly for this model system, it is both a valid and
useful approach to take.
The starting point for this series of experiments were CYP-3 crystals grown as described
previously, soaked overnight (between 17 and 27 hours) with Ala-Pro at a final
concentration of 120mM in well solution. The crystals were harvested into freezing
solution, followed by flash freezing in liquid nitrogen and exposure to X-rays. Due to
their robustness, the same crystal could be used more than once, allowing collection of
data for two ligand concentrations from the same crystal. Intermediate concentrations of
ligand were soaked into crystals in a similar manner, downstream processing was as for
the 120mM soaked crystal. All diffraction data were collected on the home source.
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A series of CYP-3 crystals were soaked against different concentrations of Ala-Pro (1.2 -
120mM), and their individual X-ray structures refined. The high resolution structure of
native CYP-3 was used as a template. The concentrations of ligand were as follows,
1.2mM, 6mM, 18mM, 36mM, 60mM and 120mM. This series of structures with different
concentrations of ligand bound were used to determine the degree of ligand occupancy in
the crystal, at the same time the binding constant was investigated in solution using the
PPIase activity assay.
The assay was carried out as described in Chapter 2, Section 2.6. Protein was pre-
incubated with ligand at appropriate concentrations, substrate added and the absorbance
change at 400nm due to the release of p-nitroaniline was recorded, with data collected
every 0.1 second over a two minute time period. Analysis of the data produced allowed
calculation of a concentration of Ala-Pro (23.3mM), producing 50% inhibition of PPIase
activity. This IC50 value was taken as an estimate of Kd in solution.
Figure 23 illustrates data obtained from both crystallographic and solution studies
carried out using different concentrations of Ala-Pro. Figure 23 A-G illustrates
difference electron density maps of crystals soaked with increasing ligand
concentration. Figure 23 H and I illustrate representative spectral progress curves
showing inhibition of CYP-3 PPIase activity with increasing concentrations of Ala-
Pro and the plot of K0bS against inhibitor concentration respectively.
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Figures 23 A - G
Difference Electron Density Maps of Crystals Soaked with Increasing Ligand
Concentration
(2Fo-Fc) maps highlighting the ligand, Arg62 and active site water molecules were
contoured at 1.5 sigma using the program O (Jones et ah, 1991). (A) The native Cyp 3
structure shows density for the water molecules. (B and C) The crystals were soaked
in 1.2 mM and 6mM Ala-Pro respectively. The electron density contoured at 1.5
sigma looks almost identical to the native structure. (D and E) The crystals were
soaked in 18 mM and 36 mM Ala-Pro respectively and can be clearly interpreted as
having features ofboth the native (green) and liganded (colour-type) forms. (F and G)
The crystals were soaked in 60 and 120 mM Ala-Pro respectively. The electron
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(H) Inhibition of PPIase activity of CYP-3 with increasing concentrations of Ala-Pro.
Absorbance values were collected every 0.1s over 2 minutes. The protein
concentration was 20 nM. Concentrations of Ala-Pro range between 0 to 60 mM were
added. (I) Determination of the Kd for PPIase inhibition of CYP-3 by Ala-Pro. Initial
velocities from Figure 23H were used to determine k0bS (k0bs=v/[S]) where v is the
velocity and [S] is the substrate concentration (Liu and Walsh, 1990). A plot of k0bS
against inhibitor concentration gives an Ala-Pro concentration of 23.3 mM for 50 %
inhibition. This IC50 value can be taken as an estimate for Kd using the following
assumptions: Kd=[E][L]/[EL] and at 50% inhibition: [E] = [EL] = 1/2 [E]T(where [ET]
= total protein concentration, [E]= free protein concentration, [L]= free ligand
concentration and [EL]=protein concentration bound to ligand). With a large excess
of ligand, the assumption [L]so%=[L] ~ [L]t can be made. At the point at which half
maximal inhibition occurs [EL]= [E] and Kd=[L]T .
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Figure 24A
Refined occupancy of the seven different crystal structures
Refined occupancy of the seven different crystal structures. Each point on the curve
represents the occupancy of Ala-Pro, as determined from the refined X-ray structures of
crystals soaked in a given concentration of Ala-Pro. The ligand concentrations used in
the soaking experiments were 0, 1.2, 6, 18, 36, 60 and 120 mM.
Figure 24B
Plot of Ligand concentration against Qi/Qn
Qi: occupancy of ligand (fraction of the protein sites in the crystal occupied by ligand)
Qn: fraction of the protein sites in the unliganded state (= (1-QO)
The ligand occupancies of the different crystals were measured by
crystallographic refinement described in the text. The experimental data fit
the theoretical line with high R2 of 0.990 and a slope 1/Kcd = 0.0373. This gives a
value for Kcd (the crystal dissociation constant) of 26.8 mM.
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CYP-3 was a very useful template molecule for this particular series of experiments
due to the relatively small change seen in the conformation of the molecule upon
ligand binding. The side chain of Arg62 moves slightly to accommodate the ligand,
no other significant changes are seen with this small di-peptide ligand.
To correlate solution study data with that obtained from X-ray analysis of the crystals, it
was necessary to determine the degree of occupancy of ligand at each concentration used
in the crystal soaking experiments.
Figure 23 illustrates electron density around the ligand and Arg62. The two
conformations, free and bound, can be clearly distinguished in the density. The
occupancy of each state was determined by the refinement program SHELX-97
(Sheldrick, 1997)
This series of experiments revealed a very close correlation between the results obtained
from solution studies and X-ray crystallographic analysis. A plot of CYP-3 PPIase
activity with increasing concentrations of Ala-Pro clearly showed the peptide having an
inhibitory effect. Initial velocities were calculated from this series of peptide
concentrations, and were used to determine &0bsd (&obsd =v/[S]), where v is the velocity and
[S] is the substrate concentration (Liu and Walsh, 1990).





The structure of Cyp 3 has a number of features that distinguish it from the
"classical" cyclophilin, Cyp A. In the work presented in this Chapter, Cyclophilin 3
has been characterised, as a member of the "divergent loop" subfamily of
cyclophilins. The determining features of the sub-family include an insert of 7 or 8
residues forming a short loop, a highly conserved glutamate pinning down this loop
in a specific fashion and two highly conserved cysteines in close proximity that
remain in the reduced form. These features seen in the CYP-3 structure, when
considered together may provide further sub-specialisation within the "divergent
loop" sub-family of cyclophilin proteins.
The enzymatic activity of the protein was also established, and was shown to be
broadly in line with that of human Cyp A, as may have been expected from complete
conservation between the two proteins of residues critical in binding CsA. The
binding affinity of Cyp 3 to CsA was somewhat altered, perhaps suggestive of
different natural substrates for the two proteins. This also might be expected, due to
the presence of 3 Cyp A type cyclophilins from C. elegans, suggesting a number of
possible sub-specialisation's within the family.
The presence of so many cyclophilin isoforms in C. elegans is intriguing but also
problematic, due to the increased likelihood of functional redundancy between
similar isoforms of the protein. Characterisation of both temporal and spatial
expression patterns may help shed more light upon when these proteins are active. A
role for the PPIase activity of cyclophilins in the folding of newly synthesised
collagen molecules had been suggested. The expression pattern seen for Cyp 3 peaks
at the second larval stage. This expression pattern may correlate with an increase in
the amount of newly synthesised structural proteins produced by the developing
larvae. Defining a role for Cyp 3 in the processing of these proteins was however
hard, particularly due to the highly specific expression pattern seen. The protein is
exclusively expressed in the anterior excretory cell. As yet there is no evidence to
support a role for Cyp 3 in any of the functions associated with the excretory cell.
The role(s) played by Cyp 3 remain to be determined. A possible role in signalling a
response to oxidative stress has been suggested, due to the presence of two cysteines
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in close proximity, both of which are present in the reduced form. Modelling studies
suggest that a disulphide bond could form between these residues, following a simple
rotation around the Ca-Cp cysteine side chain bonds. Experiments attempting to
induce such disulphide bond formation by exposing native crystals to a number of
metals (attempting to simulate an oxidising environment) were largely inconclusive
as the soaked crystals diffracted poorly or not at all. This was however indicative of
movement within the crystal lattice, suggesting the metal soaks did have some effect
upon the crystals. Experiments using various concentrations of hydrogen peroxide
were also carried out, on both protein in solution and native crystals (Carnegie
Summer Studentship, held by Simon Wilkinson). Solution data suggested one
disulphide bond was formed, however once again soaked crystals failed to diffract,
suggestive of a disruption in the crystal lattice.
The activation of proteins by disulphide bond formation has been shown previously
for a number of proteins and is reviewed in (Aslund and Beckwith, 1999). Two
examples will be considered in more detail. The E. coli transcription factor OxyR is
activated by reversible disulphide bond formation and is deactivated by enzymatic
reduction (Zheng et ah, 1998). The small molecular chaperone Hsp 33 has also been
shown to be activated by this mechanism. Under reducing conditions all six cysteine
residues of Elsp 33 are present as thiols, and the protein exhibits no chaperone
activity. Exposure to an oxidising environment however resulted in the formation of
two intra-molecular disulphide bonds followed by activation of chaperone activity.
Recent publications have reported the two stage activation and crystal structure of
this small chaperone protein (Graumann et ah, 2001; Vijayalakshmi et ah, 2001)
respectively. A second structure of Hsp 33 waas published shortly after (Kim et ah,
2001). In both structures, the "chaperone active" oxidised protein is present as a
domain swapped dimer, the formation of the disulphide bond bring crucial in both
activation and dimerisation of the protein. These results showing induction of
conformational change following activation and disulphide bond formation in Hsp 33
are broadly in agreement with a possible explanation for results from soaking
experiments carried out on Cyp 3. Induction of disulphide bond formation by either
metal or hydrogen peroxide catalysed oxidation may have induced significant
conformational change within regions of the molecule, leading to perturbation of the
crystal lattice, with consequent loss of diffraction from the crystals.
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Cyp 3 proved to be a very useful and robust model system to study protein-ligand
interactions. The crystals were amenable to soaking, froze well and were capable of
withstanding freeze thawing allowing collection of more than one data point from a
concentration series from a single crystal. Studies using the dipeptide Ala-Pro both in
solution and "in crystallo" allowed direct comparison between the two states and
showed good correlation between data obtained by these two methods. This series of
experiments provided good evidence that data obtained from X-ray crystallographic





CRYSTALLISATION OF BOVINE CYCLOPHILIN 40
4.1
INTRODUCTION
This chapter will focus on bovine Cyclophilin 40 (Cyp 40), presenting results of
characterisation studies and two crystal structures of the protein, derived from very
different crystal forms.
The protein to be discussed in this thesis is derived from a clone supplied by the
Ratajczak laboratory, Nedlands, Western Australia.
Cyclophilin 40 was first identified by this group whilst investigating the oestrogen
receptor from bovine uterus. The receptor was isolated from tissue samples using a
single, highly selective affinity chromatography step. In the absence of sodium
molybdate, the receptor was isolated in association with three main partner proteins;
a 90kDa protein subsequently identified as Hsp 90, and two smaller components, at
40kDa and 22kDa (Ratajczak et al., 1990). The 40kDa receptor-associated protein
was purified to homogeneity using preparative SDS PAGE followed by
electroelution. A later paper by the same group describes the cDNA cloning and
complete sequencing of the 40kDa binding protein, allowing its identification as a





Coning ofbovine cyclophilin 40 (Cyp 40)
All cloning of Cyp 40 was carried out by members of the Ratajczak group, Nedlands,
Australia
GST-Cyp 40
Bovine cyclophilin 40 was initially cloned as a fusion protein with glutathione-S-
transferase. The following information is provided for completeness. Briefly, the
approach taken was to express bovine oestrogen receptor binding cyclophilin
(ERBC), referred to as Cyclophilin 40 (Cyp 40) throughout this thesis, as a GST
fusion protein using the prokaryotic pGEX-2T vector (Smith and Johnson, 1988).
The entire open reading frame of wild type bovine Cyp 40 cDNA was amplified
using specific PCR primers with built in restriction sites to facilitate cloning into
pGEX-2T. A thrombin cleavage site at the GST/Cyp 40 junction allowed the
isolation of recombinant Cyp 40 after thrombin digestion and subsequent GST
removal, (Ratajczak et al., 1995).
Cyp 40
To produce untagged wild type bovine cyclophilin 40, a Cyp 40 cDNA template was
amplified by PCR using sequence specific oligonucleotide 5' and 3' primers
containing Ndel and BamHl restriction enzyme sites, respectively. A TGA stop
codon was placed immediately before the BamHl site. The PCR fragment was
ligated into pGEM-T (Promega) and the sequence integrity of both ends of the insert
in an isolated clone was confirmed by automated sequence analysis (Applied
Biosystems). An Xhol to Bell fragment excised from wild type Cyp 40 cDNA was
replaced to eliminate PCR generated errors within this region. A full-length Cyp 40
fragment produced by Ndel and BamHl digestion was then cloned into the pET -11
plasmid vector. The pET-ll-Cyp 40 WT expression plasmid was transformed into
the E.coli expression host BL-21(DE3),(Carrello et al., 1999).
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4.2.2
pET expression ofrecombinant Cyp 40 in E.coli.
The standard protocol developed throughout the course of this project, for large-scale
over-expression of proteins under control of the T7 promoter was used (see Chapter
2, Section 2.3) for both GST-Cyp 40 and Cyp 40. All work was carried out either on




GST-fused recombinant cyclophilin 40 (GST-CyP40 WT) (Ratajczak and Carrello,
1996) was expressed following a 4 hour induction with 0.4 mM IPTG (ICN/Flow).
Cell pellets were frozen at -20°C, thawed slowly on ice and solubilised in lysis buffer
(20mM Tris pH 7.8 buffer containing 150 mM NaCl, 2 mM EDTA, 5 mM DTT, 1%
v/v Triton X-100 and 5 mM benzamidine). Lysozyme was added to 0.1% w/v and
the cell suspension incubated on ice for 1 hour. An equal volume of distilled water at
4°C was added, the cell suspension mixed and centrifuged at 48400g for 60 minutes.
The resulting supernatant was frozen at -20°C. To begin purification the supernatant
was thawed slowly to keep the protein cold, followed by filtration through a series of
membranes, the final step being 0.45 fim, prior to the purification steps to be outlined
later in this chapter.
4.2.2.2
Cyp 40
Induction and harvesting of the non-fusion version of the protein was essentially as
described above for the GST-bCyp40 WT protein. Clarified lysate from a 6 litre
culture of E.coli expressing Cyp 40, grown in LB supplemented with ampicillin at
lOOpg/ml, after cell lysis and centrifugation was bound in batch mode to Q
Sepharose Fast Flow. The protein and resin were incubated for 1 hour on ice with
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frequent mixing, packed into a column and attached to the Gradifrac system as in
Chapter 2 Section 2.3.
4.2.3
Purification of recombinant Cyp 40
4.2.3.1
GST-Cyp 40
The protein extract was purified to near homogeneity using 4 purification steps.
Unless otherwise stated all chromatographic resins were obtained from Amersham
Pharmacia Biotech (APB).
1. Glutathione-sepharose affinity chromatography. Protein was applied in Buffer A
(50 mM Tris pH 7.5 buffer), GST-tagged protein was eluted with Buffer A
containing 25mM reduced glutathione.
2. Anion exchange chromatography. Protein from glutathione-sepharose
chromatography was applied to Resource Q resin in Buffer A. Elution with a linear
gradient from Buffer A to Buffer A plus 1 M NaCl gave peak fractions which were
pooled, concentrated, quantitated for protein concentration by the Bradford method
and dialysed overnight against Buffer A.
3. Thrombin cleavage, GST fusion protein was cleaved with purified thrombin at a
ratio of 1:100 for 90 minutes at room temperature. Cleaved protein was subjected to
a second round of chromatography on glutathione sepharose as already described.
4. Final ion exchange chromatography step removing thrombin and trace
contaminants.
Clarified supernatant obtained from a 4 litre culture of E. coli expressing GST-Cyp
40 grown in LB supplemented with ampicillin at lOOpg/ml after cell lysis and
centrifugation was bound in batch mode to 9ml glutathione sepharose 4B. This
mixture was incubated on ice for 1 hour and poured into a disposable column
fashioned from a 10ml syringe. The fusion protein was eluted competitively with
reduced glutathione. Fractions were tested on SDS PAGE gels, those enriched for the
fusion protein (66kDa) were pooled and dialysed against Buffer A to remove
glutathione, the partially purified protein was then applied to anion exchange resin,
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followed by elution of bound proteins by a gradient of NaCl. At this stage, the fusion
protein was sufficiently pure to attempt thrombin cleavage, followed by another
round of ion-exchange chromatography.
4.2.4
Removal of the GST affinity tag
GST is a large molecule of approximately 26kDa, therefore prior to crystallisation
trials its removal was essential. The expression plasmid contained a thrombin
cleavage site at the GST/Cyp40 junction. Thrombin is a serine protease that cleaves
only certain Arg - X and less frequently Lys -X bonds with a clear preference for Pro
proceeding the Arg or Lys. Two methods were employed to remove the GST tag and
are outlined below.
4.2.4.1
Thrombin immobilised on Affigel 10
Human thrombin purified in house and supplied by Dr Holger Husi was coupled to
Affigel 10 (Biorad) following manufacturers instructions, and packed into a
disposable column, fashioned from a syringe. Clarified lysate enriched for the fusion
protein following affinity chromatography was cycled repeatedly over the Affigel
resin, with samples for SDS PAGE analysis taken at regular intervals. The
application of protein to the resin was repeated until no intact fusion protein could be
visualised on gels. The resulting material was re-applied to glutathione sepharose,
removing any remaining traces of un-cleaved material and also the cleaved GST tag.
To remove contaminating thrombin the protein solution was applied to Resource S
resin. SDS PAGE analysis showed the resulting protein after Resource S ion
exchange chromatography was largely free of contaminants, therefore the protein




Direct addition of thrombin to the protein solution
Prior to attempting a large-scale thrombin digestion of fusion protein, it was
necessary to determine the optimum enzyme to substrate ratio required for the
reaction. This was achieved by incubating 4-5 pg aliquots of fusion protein with
increasing amounts of thrombin (stock concentration 2.3mg/ml), followed by
analysis on SDS PAGE gels. The enzyme to substrate weight ratio required for
efficient cleavage of pGEX-2T recombinant proteins generally ranged between 1:500
and 1:100.
Conditions for optimal cleavage of the fusion protein were determined following a
number of small scale trials varying the following factors (1) ratio of purified
thrombin to fusion protein, (2) time and (3) temperature. A number of other
parameters had also to be considered, including minimising unwanted proteolytic
activity, denaturation of the purified protein and also efficient usage of the limited
amount of thrombin available.
4.2.5
Untagged Cyp 40
Purification to near homogeneity was achieved in two ion exchange steps.
1. Anion exchange chromatography. Protein was applied to a column of Q
Sepharose. In Buffer A, 50mM Tris pH 7.5, the column was washed to baseline and
then developed with a gradient of Buffer A plus 1 M NaCl. Protein was eluted by
150 mM NaCl and fractions were analysed on 12% SDS-PAGE gels followed by
staining with Coomassie Blue. Fractions containing Cyp 40 were pooled and
dialysed overnight at 4°C against 20 mM Tris pH 8.0 buffer (Buffer C).
2. The protein sample was applied to Mono Q resin in Buffer C, retained protein
was eluted with a gradient of Buffer C plus 0.5 M NaCl. Positive fractions were




Biochemicalpull-down assay to isolate proteins specifically retained by
Cyp 40
In an attempt to isolate partner proteins for Cyp 40, GST-Cyp 40 was used in a
preliminary "fishing" experiment. GST-Cyp 40 was incubated with S. pombe whole
cell extract, followed by incubation with glutathione sepharose resin. Unbound
proteins were removed by repeat washes with buffer. Proteins retained on the resin
were subjected to SDS PAGE analysis.
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4.3
CHARACTERISATION OF CYP 40
4.3.1
Dynamic light scattering analysis of the purifiedprotein
Dynamic light scattering studies of the purified protein were carried out as described
in Chapter 2, Section 2.4.1, a number of factors were varied, including protein
concentration and temperature.
4.3.2
Electrospray ionisation mass spectrometry
The protein was further characterised by electrospray ionisation mass spectrometry
on a Micromass Platform II spectrometer. The sample was introduced into the
instrument stream via an infusion pump, the m/z spectrum deconvoluted using
MaxEnt software. Thanks to Miss Violet Anderson for the mass spectrometry results.
4.3.3
Crystallisation ofCyclophilin 40
The hanging drop vapour diffusion method as described in Chapter 2, Section 2.5.1.3
was used throughout this series of experiments.
4.3.4
Data collection
Crystals were transferred from the hanging drop using an appropriately sized cryo-
loop into a cryo-protectant solution containing mother liquor plus 20% glycerol.
Crystals were removed from the cryoprotectant solution after 5 seconds and mounted
in a cryo-loop and flash frozen in liquid nitrogen. X-ray data were collected at 100K




STRUCTURE DETERMINATION OF TWO CRYSTAL FORMS OF
CYCLOPHILIN 40
4.4.1
Structure solution and refinement
Structures resulting from two different crystal forms, monoclinic and tetragonal Cyp
40, were solved and refined by Dr. Paul Taylor of the Structural Biochemistry
Group, ICMB, University of Edinburgh.
The structures were solved by molecular replacement. A single domain cyclophilin
was used as a model in both cases.
4.4.2
Monoclinic Cyp 40
The structure was refined using data to 1.8 A resolution and gave a final R= 17.83%.
All residues were well defined in the final electron density with the exception of the
five C-terminal residues. The architecture of the complete molecule shows two
distinct domains (Figure 32); an N-terminal cyclophilin domain from residues 1 to
183, a linker region of 30 amino acids from residues 184 to 213 and a C-terminal




The structure was refined using data to 2.2A resolution and gave a final R=24.32%.
Residues 2 - 298 of the structure are well defined in the final electron density,





Purification ofGST-Cyp 40 and Cyp 40













(A) Results of thrombin cleavage
trials ofGST-Cyp 40. Gel illustrates
experiments on the effect of
temperature and time on protein
cleavage. Lanes 1-6, protein
incubated with thrombin at room
temperature for 60, 50, 40, 30, 20,
and 10 minutes respectively. Lanes
7-12, protein incubated on ice, for
the same time intervals. Lane 13,
GST-Cyp 40 pooled and
concentrated following elution from
glutathione sepharose. Lane 14,
molecular weight markers.
123456 789 10 11
.Cyp
40
(B) Gel illustrating application of
cleaved GST-Cyp 40 to glutathione
sepharose, to separate uncut protein
and tag from cleaved material. Lane
1, uncut, lane 2, cleaved material,
lanes 3-11, unbound Cyp 40, lanes
12 and 13, GST protein eluted with
reduced glutathione. Lane 14, molecular
weight markers.
(C) Illustration of "negative" purification
of cleaved Cyp 40. Protein applied to
Mono S resin, removing contaminants and
thrombin. Lane 1, cleaved start material,
lanes 2-11, wash fractions from two
applications to the Mono S column.
(D) Purified Cyp 40, Lane 1, pooled
protein prior to concentration. Lanes 2, 3
and 5, 16pl, 4pl and 2pl of Cyp 40 loaded
(lane 5 equivalent to approximately 16pgs
of protein. Lane 6, molecular weight
markers.
Figure 25
SDS page gels illustrating a representative purification run ofGST-Cyp 40.
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(A)
A representative gel illustrating
successful induction of over-
expression of Cyp 40 by IPTG.
Lanes 1 - 3 lysed cell pellets,
lanes 4-6, cell supernatant.
Lane 9, "start material",
(clarified cell extract), lanes 10
- 14, wash fractions. Lane 15,
molecular weight markers.
(B)
Representative gel illustrating a
typical elution profile from Q
Sepharose. Lanes 1 - 4, wash
43kDa fractions. Lanes 5-14, elution
of Cyp 40 by an NaCl gradient.
The peak of protein can be
clearly seen. Lane 15, molecular
weight markers. Peak fractions
were pooled, dialysed and





Representative gel illustrating a
typical elution profde from
Mono Q resin. Lane 2, Cyp 40
following elution from Q
Sepharose, pooled and dialysed.
Lanes 3-13, typical elution
profile from Mono Q resin. The
Cyp 40 was eluted by an NaCl
gradient, "pure" fractions, lanes
8 - 13 were pooled and
concentrated and used in further
experiments.
Figure 26
Purification of recombinant Cyp 40 was achieved in 2 anion exchange steps
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4.5.2
Biochemical pull-down assay to isolate proteins specifically retained by
Cyp 40
In this experiment GST-Cyp 40 was first bound to glutathione sepharose. Unbound
material was eluted by washing with buffer, followed by incubation with whole cell
extract of the fission yeast Schizosaccharomyces pombe, kindly supplied by Terri
Gaskell (ICMB, Edinburgh). The resin was carefully washed a number of times to
remove any unbound material. The washed resin with associated proteins was then
boiled in reducing sample buffer and the protein sample subjected to SDS PAGE
analysis. Two bands at approximately 85 and 45kDa were enhanced in intensity,
suggestive of specific retention by GST-Cyp 40. These two bands were cut out of the
gel and processed to allow sequencing of the protein within the band. The proteins
within the bands were identified by sequencing as heat shock protein 90 (Hsp 90)
and Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) (Results not shown).
Thanks to Dr. Andrew Cronshaw for the protein sequencing.
Tagged and "free" Cyp 40, complementary tools to characterise Cyp 40 protein
Availability of fusion and non-fusion clones of Cyp 40 provided complementary
tools to characterise the protein and its interactions.
Fusion clone
The GST fusion clone was very useful when planning and carrying out the
interaction studies discussed above. Binding of the fusion protein to an immobilised
support allowed the exploitation of specific bioaffinity interactions between the C-
terminal TPR domain of the protein, shown to be important in the majority of
interactions between Cyp 40 and its partner proteins. However, for crystallisation
studies, use of the non-fusion version of the protein was favoured, for a number of
reasons outlined below.
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1. The best starting point for crystallisation studies is the availability of milligram
quantities of pure, homogenous protein. Recombinant proteins requiring proteolytic
cleavage i.e. GST tagged proteins are susceptible to the generation of heterogeneity
within the protein population, due to inappropriate cleavage. Such heterogeneity is
often the cause of problems in crystallisation experiments.
2. The final yield of the protein of interest may also be reduced due to failure to
completely cleave the fusion tag from the protein of interest, resulting in populations
of both cleaved and uncleaved material. Unlike some affinity tags; GST is a large
molecule and must be removed prior to crystallisation trials.
3. Thrombin cleavage of proteins, particularly when a large amount of material is
required, can be very expensive, due to the high cost of commercially available
thrombin.
Non-fusion clone
The untagged clone was chosen for further crystallisation trials for the following
reasons.
1. This clone over-expressed very well, producing large amounts of Cyp 40.
2. The protein was readily purified in two simple ion exchange steps, allowing rapid
processing from cell pellet to purified protein.
3. The purified protein was very soluble (80mg/ml in some instances), largely
homogeneous and stable at 4HC.
The above factors strongly suggested the non-fusion version of the protein was an
excellent candidate for crystallisation trials, therefore all structural studies focused on
crystals grown using non-fusion protein.
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4.5.3
Dynamic light scattering analysis
Table 7 illustrates a typical dataset obtained from a dynamic light scattering
experiment carried out using purified Cyp 40. As outlined in Chapter 2,










1 0.9 39 kDa 1.001 2.031
2 — 41 kDa 1.000 1.284
3 — 41 kDa 0.999 1.976
4 0.9 42 kDa 1.000 2.303
5 0.8 40 kDa 1.001 1.537
6 0.7 42 kDa 0.999 1.566 |
7 0.9 45 kDa 0.998 2.397
8 0.7 40 kDa 1.000 2.016
9 0.9 41 kDa 1.000 1.752
10 0.9 43 kDa 1.001 1.770
11 0.8 43 kDa 1.003 1.198
12 — 41 kDa 1.000 0.867
Mean values 0.6 42 kDa 1.000 1.725
Table 7
These results suggested the protein was essentially of a uniform composition
(monodisperse) and present in solution as a monomer. Light scattering experiments
therefore suggested the protein was an excellent candidate for crystallisation trials.
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4.5.4
Mass spectrometric analysis ofCyp 40
40500.00
The protein was further characterised by
electrospray ionisation mass spectrometry on a
Micromass Platform II spectrometer by Miss Violet
Anderson. lOpl of a solution of native Cyp 40 at
80mg/ml was diluted with water to give a stock
solution of 0.8mg/ml. 230pl of this stock solution
was mixed with 250pl acetonitrile and 20pl of a
solution of 5% formic acid. The sample was
introduced into the instrument stream via an infusion
pump at a rate of 0.48 ml/min, the m/z spectrum






Mass spectrometry gives a molecular mass of 40,500 Da. The calculated molecular
mass of the sequence is 40,620 Da and suggests that the N-terminal methionine
residue is removed post-translationally. The calculated molecular mass of the




Two crystal forms were grown from the proteins isolated using the purification
protocol outlined in section 4.2.5. The hanging drop vapour diffusion was used to
grow crystals in 24-well Linbro plates. In all trials, crystals could only be obtained at
4°C.
The first crystals obtained were grown following refinement of conditions that
produced "shaped precipitate". These preliminary crystals were typically too small to
be of any use for X-ray diffraction studies, they did however provide a point from
which to start. A number of rounds of refinement lead to the production of larger
tetragonal crystals. The crystal morphology was generally poor, producing
o
"teardrop" shaped crystals which typically diffracted to 3.5A on the home source.
Alternative crystallisation conditions
Further attempts were made to produce crystals capable of diffracting to high
resolution. Crystallisation trials were set up using non-fusion protein. These trials
took as a starting point; conditions which had previously given small tetragonal
crystals. These crystals were reproduced in the first plate set up with the non-fusion
protein. Tables 8 and 9 illustrate the stages involved in obtaining useful crystals of
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Table9 Optimisationofcrystallisationonditionsf rle vedGST-Cyp40
4.5.6
Preliminary characterisation and data collection
Figure 28 A and B
(A) Teardrop shaped crystals with dimensions up to 0.2 X 0.15 X 0.15mm grew
within a few days. These crystals typically diffracted to a resolution of 2.6A on the
home source.
(B) Monoclinic needle crystals with dimensions up to 2 X 0.01 X 0.005mm grew
within hours. Occasionally, much larger plates formed with dimensions up to 0.6 X




CYCLOPHILIN 40 3D STRUCTURE
4.6.1
X-ray structure determination and refinement of the monoclinic crystal
form ofCyp40
Two crystal forms grew with space group C2, they differed in unit cell dimensions.
In most drops, very long thin plate-like needles grow within hours with typical
dimensions 2 mm x 0.01 mm x 0.005 mm. These crystals were monoclinic with
space group C2. Unit cell dimensions were a= 125.71 b= 47.3 c= 74.6 A ,S = 93.9°.
These thin needle crystals diffract typically to a resolution of 3.6 A on a rotating
anode X-ray source (see Table 8).
Occasionally much larger plates formed with dimensions 0.6 x 0.2 x 0.15 mm. The
structure was solved using data from one of these larger plate crystals, all data
described in this thesis was derived from these larger crystals. One such crystal was
mounted in a cryo-loop and dipped in a cryo-protectant solution of mother liquor
plus 24% glycerol for 5 seconds and flash frozen in liquid nitrogen.
A complete dataset was collected on a Mar 300 image plate mounted on a rotating
o
anode generator. The crystal diffracted to a resolution of 2.1 A on the home source.
This crystal belonged to space group C2 with a= 125.83 b= 47.29 c= 85.36 A ,12 =
119.4°. There is one molecule of Cyp40 (MW = 40,500 Da) in the asymmetric unit.
The structure was initially solved using the molecular replacement programme
AMoRe (Navaza, 1994), with a single domain cyclophilin, (the structure of CYP-3
from C. elegans described in Chapter 3) as a model. This model gave a single 10
sigma peak in the rotation function, this rotated model gave a 9 sigma peak in the
translation function. The initial model had an R factor of 55% and from the first
electron density map it was possible to change residues in the cyclophilin domain to
correspond to those of the Cyp 40 sequence.
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Additionally, some residues of the TPR domain, mainly within helices, were visible
within density, over many cycles of model fitting and refinement it was possible to
manually trace almost the entire TPR domain.
o
Subsequent to the initial structure solution, a dataset to higher resolution (1.8A) was
collected at the SRS Daresbury. This dataset was used for the final refinement of the
structure. The final refined structure had an R factor of 17.83% with an Rfree of
25.63%.
The final refined structure runs from Ser2 to Tyr365, the 5 C-terminal residues were
not visible in the electron density. All other residues are well defined in the density
map, the exceptions being 2 residues in the loop region (Gly 87 and Glu 88) and Lys
172 in the C-terminal region. Data analysis indicated the structure to be of acceptable
quality.
4.6.2
X-ray structure determination and refinement of the tetragonal crystal
form ofCyp40
Tetragonal crystals grew with space group P4222. The well solution initially
consisted of 480pl MPD, 100 pi 1M imidazole at pH 6.5, 140 pi 50% v/v glycerol
solution and 280 pi water. The hanging drop consisted of 2 pi well solution plus 2 pi
of protein at 10 - 80 mg/ml in 20mM Tris pH 8 buffer containing lOOmM NaCl. The
morphology of the crystals in most drops was poorly defined, the crystals grew
teardrop-shaped with dimensions of approx. 0.05 mm. Addition of 1% glycerol with
increased MPD concentration (520pl) and 5-10 mM DTT was found to improve
crystal size and morphology (Figure 28A), large teardrop-shaped crystals with
dimensions up to 0.2 x 0.15 x 0.15 mm grew within a few days.
The unit cell dimensions were a= 94.5 A, c= 118.3 A. A complete data set out to a
resolution of 2.6 A has been collected on an Enraf Nonius rotating anode X-ray
generator with a Mar300 image plate. A subsequent dataset collected to higher
resolution (2.OA) at the SRS Daresbury was used for the final refinement of the
structure.
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Initial stages of the structure determination were similar to the monoclinic form with
clear rotation and translation solutions apparent. The final refined structure runs from
Ser2 to Asp298. The C-terminal 72 residues were not visible in the electron density.
4.6.3
Refinement statistics




Resolution range (A) 1.8- 2.0-
R-cryst 17.83% 24.32%
Rfree 25.63% 30.79%
Root mean square deviations from
ideal geometry
Bond lengths (A) 0.07 0.06
o
Angle distance (A) 0.23 0.22
Mean B-factor (A2) 14.90 37.63
Table 10
Summary of the final refinement statistics used in the structure determination of the
two crystal forms of Cyp 40.
4.6.4
The overall architecture ofbovine Cyclophilin 40
The overall architecture of Cyp 40 reveals the protein is composed of an N-terminal
cyclophilin domain and a C-terminal domain comprising three tetratricopeptide
repeats (TPRs) and an extended calmodulin-binding helix. The cyclophilin domain
belongs to the 'divergent-loop' class with an inserted octapeptide loop and two
conserved cysteine residues in close proximity to each other. A linker of 30 amino
acids joins the two domains. The TPR-domain consists of seven helices of variable
length incorporating three TPR-motifs. The structures of the cyclophilin domain
followed by the TPR domain will be described in more detail.
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4.6.4.1
The overall architecture ofthe cyclophilin domain of monoclinic and tetragonal
Cyp 40 is conserved between the two structures
The overall architecture of the cyclophilin domain of Cyp 40 is similar to that of
known X-ray and NMR cyclophilin structures (Braun et al., 1995; Taylor et al.,
1997) with an anti-parallel 8-stranded p-barrel capped at each end by two a-helices.
There is 61% identity with the sequence of human Cyp A (Figure 30B). The closest
cyclophilin relative to Cyp 40 with known 3D structure is the divergent-loop
cyclophilin from C. elegans (CYP-3) that shares a 64 % identity in amino acids.
Figure 29
Overlay of the corresponding backbone atoms of the cyclophilin domains of human
Cyp A (orange), nematode Cyp 3 (magenta), and bovine Cyp 40 monoclinic and
tetragonal (blue/cyan). This shows that the only major difference between Cyp A and
both Cyp 40 structures is caused by insertion of the 'divergent loop'. Loop regions
do show some divergence as can be seen with the loop structures of Cyp 3 and Cyp
40. The figure was prepared using Molscript (Kraulis, 1991).
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4.6.5
Key structural features of Cyclophilin 40
4.6.5.1
The active site ofCyp 40
The peptidyl-prolyl cis-trans isomerase active site of Cyp40 is similar to that of
human Cyp A. The active site of the cyclophilin family is defined by the 13 amino
acids found to be important in the binding of CsA to human Cyp A, a number of
these residues are highlighted in Figure 30A. The active site residues are identical
apart from His 141 that corresponds with Trpl20 in Cyp A. Site directed
mutagenesis of this residue in Cyp A has shown that it plays a significant role in CsA
binding, but is not so important in the PPIase enzymatic activity (Liu et ah, 1991b).
This observation is in line with the catalytic and CsA binding properties of bovine
Cyp40.
4.6.5.2
Peptidyl prolyl cis-trans isomerase activity and its inhibition by Cyclosporin A
The PPIase activity of Cyp 40 has a kcat/Km value of 1.9xl06 M"'s"' (Kieffer et al.,
1992) and 5.1xl05 for GST-Cyp 40 (Ratajczak et al., 1995) compared with the value
of 1.4xl07 M 's"1 for Cyp A (Liu et al., 1990). The inhibition by CsA is however
significantly less than Cyp A with measured IC5o values of 300nM for free Cyp40
(Kieffer et al., 1992) and 1030nM for a GST-Cyp40 protein (Ratajczak et al., 1995).
Both values suggest much weaker binding compared with the IC50 value for Cyp A
of 19nM (Liu et al., 1990). Reduced binding affinity to CsA has been observed in a
number of cyclophilins in which Tip 120 of Cyp A has been changed.
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CYP4__BOVIN MSHPSPQAKP SNPSNPRVFF DVDIGGERVG RIVLELFADI VPKTAENFRA 50
CYPH__HUMAN --MVNPTVFF DIAVDGEPLG RVSFELFADK VPKTAENFRA 38
CYP4__BOVIN LCTGEKGIGP TTGKPLHFKG CPFHRIIKKF MIQGGDFSNQ NGTGGESIYG 100
CYPH_.HUMAN LSTGEKGFG- YKG SCFHRIIPGF MCQGGDFTRH NGTGGKSIYG 80
CYP4__BOVIN EKFEDENFHY KHDKEGLLSM ANAGSNTNGS QFFITTVPTP HLDGKHWFG 150
CYPH_.HUMAN EKFEDENFIL KHTGPGILSM ANAGPNTNGS QFFICTAKTE WLDGKHWFG 130
CYP4_.BOVIN QVIKGMGVAK ILENVEVKGE KPAKLCVIAE CGELKEGDDW GIFPKDGSGD 200
CYPH_.HUMAN KVKEGMNIVE AMERFGSRNG KTSKKITIAD CGQLE 165
Figure 30 A and B
(A) Comparison of the cyclophilin domain of bovine Cyp40 (green) with human Cyp
A (yellow). C, N, and Ca atoms are shown. The backbone atoms of Cyclosporin A,
present in the human Cyp A crystal structure, are shown in blue. Side chains of the
Cyp 40 active site residues are shown: Arg75, Phe80, Phel33, Hisl41 and His 146.
The corresponding side chains for human Cyp A are shown in red. Side chains for
Cyp 40 are drawn from Cys52 to His68 that incorporates "divergent loop" residues
(60PTTGKPLH67). Glu96 and the two cysteines Cys52 and Cysl81 are drawn as
balls and sticks with atom-type colouring (oxygen coloured red, nitrogen coloured
blue and sulphur coloured yellow). (B) Sequence alignment of the Cyp domain of
both proteins, conserved binding site residues are highlighted in blue.
144
4.6.5.3
The cyclophilin domain of Cyp 40 belongs to the 'divergent-loop' family.
The 'divergent-loop cyclophilins' are determined by three features shared by the
cyclophilin domain of Cyp 40. Firstly, there is an additional loop incorporating
residues 60 through 67 (60PTTGKPLH67), secondly there are often two cysteine
residues (Cys52 and Cysl81) which are in close proximity but remain in the un-
oxidised form, and thirdly there is a highly conserved glutamate residue (Glu96) that
helps fix the conformation of the additional loop.
The 'divergent-loop' of bovine Cyp40 consists of an insert of eight residues
60PTTGKPLH67. The presence of inserts of between 6 and 8 residues has been
described previously in a number of plant (Chou and Gasser, 1997) and nematode
(Page et al., 1996) cyclophilins. A consensus sequence for this additional loop based
on multiple sequence alignments is (**GK*LH) (Dornan et al., 1999a). The
additional residues form a protruding loop located above the active site (Figure 29),
as also observed in the other two available 'divergent-loop' cyclophilin X-ray
structures of Bm-CYP-1 (Taylor et al., 1998; Mikol et al., 1998) from Brugia malayi,
and CYP-3 (Dornan et al., 1999a) from C. elegans. The loop conformations adopted
by all three structures are significantly different from each other. Cyp 3 forms a
conventional four-residue (3-turn involving 47GKSG50 while both Cyp 40 (and
bmCYP-1) form unusual five-residue loops 59GPTTG63 (and 50GKISG54) which
are defined by the G590—G63N = 2.74 A (and G50O—G54N = 2.66 A) hydrogen
bonds. Many cyclophilin homologues belonging to the 'divergent-loop' family
(Dornan et al., 1999a) also have a conserved glutamate (Glu96) in a homologous
position (Figure 14). The glutamate side chain ties down the loop using an interesting
hydrogen bonding motif in which the two carboxyl oxygen atoms form hydrogen
bonds with backbone nitrogen atoms from adjacent residues: E960E1—T61N =
2.99A and E960E2—T62N = 3.10A. It has already been suggested that the loop





Like other structurally characterised 'divergent loop' cyclophilins, Cyp 40 has two
cysteines in close proximity in the reduced form. The side chains of Cys52 and
Cysl81 are well defined in the electron density and show a sulphur—sulphur
distance of 5.4 A. The conformation adopted by these conserved cysteine side chains
is very similar to that of the other 'divergent-loop' cyclophilin structures (Taylor et
al., 1998; Dornan et ah, 1999a). As with these structures, molecular modelling shows
that a simple rotation about the Ca-Cp cysteine side chain bonds enables a
disulphide bond to form without any significant steric hindrance. The formation of a
disulphide bond in an oxidising environment may induce conformational change and
provide a signalling mechanism in response to oxidative stress.
4.6.5.5
The TPR domain is attached to the cyclophilin domain by a linker of 30 amino
acids.
The acidic linker region contains 11 aspartate and glutamate residues and forms a
well defined hydrogen bonded structure with two p-turns and a larger loop
comprising 194PKDGSGD200. The first P-turn (K185-E186-G187-D188) defines
the start of the linker and a second P-turn (F205-P206-E207-D208) occurs at the
centre of the deep cleft between the Cyp and TPR domains (Figure 32). The side-
chain of E-207 points into the cleft and is incorporated into an intricate hydrogen-
bonded network that also involves an ordered glycerol molecule. There is no direct
contact between the helices of the TPR domain and the cyclophilin domain. Elelices
P and Q form an intimate interface to the linker. The positively charged surface of
helix Q [K244, K245, K248, R251] forms salt bridges with linker residues D204 and
D200 (D204/OD... K248/N =2.99A, D200/OD2.. ,K245/N= 2.13k,
D200/OD1...K248/N= 3.16 A, Figure 32). The conformation of the cyclophilin
domain is almost unaffected by the presence of the linker region despite the




THE TETRATRICOPEPTIDE REPEAT (TPR) MOTIF IN CYP 40
AND LARGER IMMUNOPHILINS
The Hsp 90 binding immunophilins Cyp 40, FKBP 52 and 51 were identified in
1993, 1994 and 1995 respectively as TPR containing proteins (Ratajczak et al., 1993;
Radanyi et al., 1994; Baughman et al., 1995). The structure of Cyp 40 (whole
molecule), focussing on the TPR domain of Cyp 40, will now be discussed in greater
detail
4.7.1
The C-terminal domain of Cyp 40 consists ofa tetratricopeptide repeat
domain
The overall architecture of Cyp 40 was described in Chapter 4, section 4.6.4. The
structure revealed a clear separation between the cyclophilin and TPR domains,
linked by an acidic region of 30 amino acids.
4.7.1.1
The structure ofthe TPR domain.
The structure of the TPR domain consists largely of seven helices. The helices
delineated using the program DSSP (Kabsch and Sander, 1983) form an extended
helix-turn-helix pattern (Figure 32) and are labelled P,Q,R,S,T,U and V, (see Table
11). Each 34 amino acid TPR repeat consists of a helix-turn helix motif in which the
helical sub-domains are referred to generically as (Aj,,Bi) and amino acids are
numbered from 1 to 34 (Figure 31). The first three helices in the domain (P,Q,R) are
longer than expected for TPR sequences. Helix R incorporates a proline residue
(P270) that also distorts the helical conformation of the four preceding residues. (A
similar distortion occurs in all HEAT repeat helices that contain a proline in almost
all known B-helices (Groves et al., 1999).
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4.7.1.2
Sequence comparisons between TPR containing proteins
Figure 31 provides a comparison between the amino acid sequences of the C-
terminal TPR-containing domains of these immunophilins from mammals (Cyp 40,
FKBP51, FKBP52), S. cerevisiae (Cpr6, Cpr7) and S. pombe, (Wis2) with other Hsp
90 binding proteins, mammalian PP5 and CNS1 from S. cerevisiae. Over this entire
C-terminal region Cyp40 shares a 37% identity with Cpr7, but has an increased
resemblance to Wis2 (46%), FKBP52 (46%) and Cpr6 (50%). FKBP52 is most
similar to FKBP51 (61%) with a lower level of homology with Cpr7 (36%), Cpr6
(40%) and Wis2 (41%).
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TPR 2 motifs of selected Hsp90 binding proteins.
10 20 30 34
CYP4__BOVIN 273-306 LSCVLNIGAC KLKMSDWQGA VDSCLEALEI DPSN
CYP4__HUMAN 273-306 LSCVLNIGAC KLKMSNWQGA IDSCLEALEL DPSN
FKBP5._HUMAN 317-350 LAAFLNLAMC YLKLREYTKA VECCDKALGL DSAN
FKBP4__HUMAN 319-352 LASHLNLAMC HLKLQAFSAA IESCNKALEL DSNN
PPP5__HUMAN LD(T\1CN AIYYGNRSLA YLRTECYGYA LGDATRAIEL DKKY
CYP6__YEAST 270-303 VSIPLNIAIC ALKLKDYKQV LVASSEVLYA EAAD
CYP7__YEAST 292-325 MKIYLNL5LV LFNLERYDDA IMYATYLLEM DNVP
CNS1._YEAST 121-154 ESLYANRAAC ELELKNYRRC IEDCSKALTI NPKN
IEFS__HUMAN 300-333 MTYITNQAAV YFEKGDYNKC RELCEKAIEV GREN
11 t
R Helix S Helix >










































































Alignment ofTPR sequences for selected Hsp90 binding proteins.
Proteins that contain three copies only of the TPR motif and that have been shown to
interact with Hsp90 were identified from the literature and are presented above manually
aligned. Additionally the TPR2 domain of Hop (IEFS HUMAN) was included. The
horizontal cylinders below each alignment designate the extent of the seven helices of
Cyp 40, assigned using structural data. A broken cylinder indicates the helix begins or
terminates earlier or later in the protein sequence, therefore failing to conform to the
classical idealised helix (13aa) turn (3aa) helix (14aa) model for TPR motifs. Arrows
projecting from the cylinders point to the positions in the sequence where the helices
start and finish.
Closed and shaded cylinders indicate a complete helix within the TPR motif. Only TPR
3 conforms to the idealised structure. Residues identified as being important in binding
Hsp90 are red and underlined. Structurally conserved residues are italicised and blue.
The three linker residues between helix Ai and B| are underlined.
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Figure 32
Stereo picture of the monoclinic form of bovine cyclophilin 40.
The cyclophilin domain (residues 1-183) is coloured green. Side chains of selected
active site residues (Arg75, Phe80, Phel33, Hisl41, His 146) are coloured black.
Glu96, which forms hydrogen bonds to the divergent loop, is also shown. The
backbone of the linker (residues 184-213) joining the cyclophilin and TPR domains
is shown black. Selected salt bridges between the positively charged residues of helix
Q (K244, K245, K248, R251) with linker residues D204 and D200 are shown as
dashed green lines. Side chains of all charged residues on the TPR domain are
shown. Arg and Lys are blue, Glu and Asp red.
The seven helices in the TPR domain are designated P,Q,R,S,T,U,V, (see Table 11
below). The slight distortion in helix R is caused by the presence of Pro270. The
portions of the helices corresponding to the repeating TPR motifs shown in Figure 31
are coloured dark blue (TPR1, helices P and Q, residues 223-256; TPR2, helices R
and S, residues 273-306; TPR3, helices T and U, residues 307-340). The protruding
C-terminal portion of helix V is the putative calmodulin binding domain and is
coloured magenta. The figure was prepared using Molscript (Kraulis, 1991).
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P (20 residues) V216 - K235
Q (21 residues) W239 - A259
R (24 residues) D262 - K285
S (12 residues) W289 - L300
T (13 residues) T307-G319
U (14 residues) Y323 -1336
V (22 residues) K341 -K362
Table 11
Residues in the sequence of Cyp 40 forming the seven helices seen in the fully folded
structure of the TPR domain
4.7.2
A partially folded TPRdomain is trapped in the tetragonal crystal
form.
The structure of the tetragonal form retains only the first TPR motif (helices P and
Q); the second TPR motif (helices R and S) has sprung out to form an elongated
helix of approximately 42A, (Figure 33). Residues comprising helices T, U and V in
the monoclinic form are not visible in the electron density. This structure can
therefore be regarded as a trapped intermediate in the folding pathway of the helix
domain. It also suggests that such helical domains are flexible and such helix




Stereo picture of the tetragonal folding intermediate form of bovine cyclophilin 40.
Colouring is the same as in figure 32. Helices T, U and V are not visible in the
electron density. Helices are coloured according to the fully folded monoclinic form
in Figure 32, numbering of helices as highlighted in Table 11. The portions of the
helices corresponding to the repeating TPR motifs shown in Figure 31 are coloured
dark blue (TPR1, residues 223-256; TPR2, residues 273-298). Alternative
conformations of residues Ala260 and Ser287 are primarily responsible for helices R
and S adopting an extended rod like helical conformation. The figure was prepared
using Molscript (Kraulis, 1991).
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4.7.3
High fidelity recognition between two Cyp 40 structures
4.7.3.1
Tetragonal Cyp 40 - A3D domain swapped dimer?
The conservation of interactions between the two structures raises the possibility of
3D domain swapping in the TPR domain of Cyp 40.
3D domain swapping involves one domain of a multi-domain protein breaking non-
covalent bonds with the other domain(s), its place being taken by the same domain of
an identical protein chain, resulting in an intertwined dimer/higher oligomer. The
swapped domain can be anything from an entire domain to a particular element of
secondary structure. In this example an a helix is involved in inducing dimerisation.
The helices (P and Q) in the partially folded dimer, the "swapped domain", (Figure
34 A and B) make identical interactions/non-covalent bonds with the neighbouring
domain (helix R) in the other half of the dimer and also with those of the monomer.
This results in stabilisation of the dimer by the same interactions responsible for
holding the monomeric helical domain together.
3D domain swapping has been suggested as a mechanism of protein polymerisation
leading, in some cases, to the production of fibrils typically found to accumulate in
amyloid plaques (Liu et al., 2001; Janowski et al., 2001).
A role for 3D domain swapping in accumulation of folding intermediates was also
suggested, with folded but otherwise unassociated domains "domain swapping",
trapping the folding intermediate in an oligomeric state. The tetragonal crystal form
may be an example of such a phenomenon (Bennett et al., 1995).
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Figure 34 A and B
Stereo picture of the main intermolecular interactions in the tetragonal form of Cyp
40 and an overlay of the folding intermediate dimer and the fully folded confomer.
(A) The partially unfolded TPR domain forms a symmetrical dimer. One molecule is
coloured as in Figure 32, the partner molecule is coloured red. The first TPR
comprising helices P and Q (shown in the boxed region), make an intermolecular
contact with helix R' of the dimer-related molecule.
(B) The boxed region of (A), with the same colour scheme, showing helices P and Q
and R' for the tetragonal form, is overlaid with the helices P, Q and R (yellow) of the
folded TPR domain of the monoclinic form. The intra- and intermolecular
interactions of helix R with helices P and Q can be seen to be nearly identical.
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4.7.4
Amino acids in the TPRmotif that control helix packing
The average Ai-Bi inter-helix distance for each Cyp 40 TPR is between 7.5 and 8 A.
The closeness of the helices and the narrow omega angle are a consequence of the
short 3-amino acid inter helix linker and the presence of the two most strongly
conserved residues Ala/Gly8 and Ala20. The key to this tight helix-turn-helix
geometry is the stabilising and close-packed interactions between C-beta of Ala-20
and carbonyl oxygen atoms of residues 8, 16 and 17 and the C-(3 atoms of the
(normally) large amino acids 11 and 12 (Figure 31). This sharp turn also brings the
side chain of residue 8 close to the backbone of helix B and explains the requirement
of the small Gly or Ala side chain at this position. Rather than the classic 'knobs into




Geometry and intra-TPR motif interactions between helix Aj and Bj
The geometry of the turn between the Aj and Bj helices is conserved in the three TPR
motifs of Cyp 40. A portion of TPR1 from Cyp40 is shown with residues numbered
according to the relative TPR-numbers (1 to 34) defined in Figure 31. The tight turn
between the helices is governed by the (conserved) conformation of the 3-amino acid
inter helix linker (coloured yellow) and the presence of the two most strongly
conserved residues Ala/Gly8 (Ca shown as a solid sphere) and Ala20 (C(3 shown as
a solid sphere). The tight helix-tum-helix geometry is stabilised by close-packed
interactions, shown as dashed green lines, between C-(3 of Ala-20 and carbonyl
oxygen atoms of residues 8, 16 and 17 (with distances between 3.4 and 3.6 A) and
the C-(3 atoms of the (normally) large amino acids 11 and 12. The close contacts
between Gly8 Ca and the side chain atoms ofBj are also shown.
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4.7.4.1
TPR repeat geometryproduces a super-helical structure
The inter helix Q-angles (Bowie, 1997) between adjacent helices are all positive. The
interaxial angles between the pairs of helices comprising the three TPR (A^B, )
motifs average to 13°, while the angles between helices of adjacent TPR motifs (Bj,
Aj+i) average at 24°. Figure 36 shows a superposition of the structures ofCyp 40 and
PP5 (Das et al., 1998) illustrating a very similar arrangement of helices.
Figure 36
View of the r.m.s.-fit of the X-ray structure of the N-terminal TPR-domain of PP5
and the C-terminal helical domain ofCyp40.
The main chain trace of the X-ray structure of residues 18 to 181 of human Ser/Thr
phosphatase PP5 is shown in yellow. Cyp 40 is shown in cyan. A sequence
alignment of the TPR motifs for the two structures is given in Figure 31. Those
corresponding Ca atoms give an rms-fit of 1.2 A.
Modelling studies have shown that multiple TPR repeats with alternating Q. angles
near 13° and 24° leads to a right-handed super-helical structure (Das et ah, 1998).
The two anti-parallel helices of each TPR motif are connected by a 3-residue linker.
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In two cases, the 4-residue linkers joining adjacent TPR- motifs adopt type-1 (3-turns
with proline (Pro 32) at the i+1 position (Wilmot and Thornton, 1988). Differences in
inter-helical linker-length helps engineer the different inter-helical angles with the
shorter linker constraining a narrower Q angle between helices A; and Bi
When sequences of TPR1, TPR2 and TPR3 are compared among different proteins
stronger homologies emerge and suggest structural and functional roles for certain
amino acids. The nature of the helix packing in tandem repeat structures may require
subtly different structural roles for amino acids in the central and flanking TPR
motifs. For example there are no inter-helix hydrogen bonds in TPR2, however there
are conserved A-B inter-helix hydrogen bonds in TPR1
(Asn231(15)/NDl...Tyr246(24)/OH= 2.64 A) and there is a conserved salt bridge
(Arg313(7)...Asp329(23)) in TPR3. There are a total of 9 inter-helical hydrogen
bonds in the TPR domain mostly involving charged residues. A majority of the van
der Waals contacts are between the A/B anti-parallel helices of each TPR motif (P/Q
make 15 contacts , R/S make 7 and T/U make 17). The close-packed arrangement of
helices P, Q and R use the side chains of Y246 and V249 of helix B to fill and pack
the centre of the core. Y246 (24) is conserved in all Hsp90 binding proteins from
yeast through mammals.
The surface of the Cyp 40 TPR domain shows a pronounced charge distribution
(Figure 37 A and B) in which the inner groove of the TPR domain forms a positively
charged surface while the outer groove forms a negatively charged surface.
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Figure 37 A and B
Representation of the surface electrostatic potential ofCyp 40.
The pronounced charge distribution can clearly be seen, with the inner groove of the
TPR domain (A) being positively charged (blue) and the outer groove (B) forming a
largely negatively charged surface (red). The figures were prepared using the DelPhi
module from the INSIGHT II package.
4.7.5
Helix 'V maybe involved in calmodulin binding
Specific binding between large immunophilins and calmodulin has been shown in
bovine Cyp 40 (Ratajczak et al., 1995), maize FKBP 66, (Hueros et al., 1998) and
rabbit FKBP52 (Massol et al., 1992). Structural features responsible for calmodulin
binding have been determined as: an amphiphilic a-helix that carries a net positive
charge (Ghirlanda et al., 1998). The calmodulin binding site to FKBP52 has been
proposed to lie between residues 398-415 and corresponds to residues 353-370 of
Cyp 40. The X-ray structure of Cyp 40 presented here shows that this putative
interaction domain corresponds to the C-terminal portion of the V-helix (Figure 32)
which is seen to extend beyond the shorter TPR helices. The protruding and




STRUCTURE/FUNCTION INSIGHTS FROM CYP 40 TPR
DOMAIN GEOMETRY
4.8.1
Structural underpinning ofthe TPR motif
The X-ray structures of TPR proteins characterised to date provide a basis for
understanding the pattern of residue conservation seen. A consensus sequence pattern
of small and large hydrophobic residues was postulated with small residues occurring
at positions 8, 20 and 27 (Das et al., 1998). The influence of two of these conserved
residues (at positions 8 and 20 in the TPR motif sequence) on helix packing was
discussed in section 4.7.4, explaining the requirement for these small residues in
engineering the geometry of the tight turn between the Aj and Bj helices.
A more elaborate sequence of loosely conserved residues was originally suggested
(Sikorski et al., 1990). These authors proposed that when comparisons of size and
nature were made between amino acids, a largely conserved pattern of similarities
could be determined from degenerate sequences. In particular they suggested eight of
the 34 amino acids were more highly conserved, generating a consensus sequence for
positions 4 (W,L,F), 7 (L„I,M), 8 (G,A,S), 11 (Y,L,F), 20 (A,S,E), 24 (F,Y,L), 27
(A,S,L) and 32 (P,K,E).
Possible functional specialisation within the TPR motif was suggested in this paper,








Analysis of TPR domain structures (presented in Table 12) and sequence alignments
(illustrated in Figure 38), reveal Cyp 40 diverges most in overall structure from the
classical helix (13aa) turn (3aa) helix (14aa) TPR motif.
The first 3 helices of the Cyp 40 TPR domain are significantly elongated when
compared with those from other structurally characterised TPR containing proteins.
Cyp 40 shares with PP5 and TOM 20 an elongated A helix in TPR 1, the B helix of
TPR 1 is also elongated by one turn with respect to the remaining proteins. The A
helix of TPR 2 in Cyp 40 is also significantly elongated, no other structurally
characterised protein has that feature.
The remaining units of the motif comply fairly well with the classical definition of






































Al(16),Bl(9)2 134 A3(13),B4 4( 3)





4-37,39-7173-105 225-258,60 92 300-33,6 -393, 395-427,428 61
Al(15),B 42(17 A3(17),B (14) Al(14),B2((14) A3(13),B ( 2)
PEX5 PEX5 (extended) PEX5_HUMAM
(Gattoeal., 2000) (Kumaretal., 2001)
1FCH 1HXI
Receptorforthe peroxisomal targetingsi nal PTS-1
7(6) 7(3)
299-331,332 65 366-399,415 448 451-484,8 -518 519-552










Analysis of structurally characterised TPR domains.
Table 12 summarises data available on all structurally characterised TPR containing
proteins. A search of the Research Collaboratory for Structural Bioinformatics
(RSSB) PDB database for "tetratricopeptide" containing proteins identified six of the
above structures. A further search for "TPR" identified 24 structures, including the
above, however closer examination of the database entries additionally identified
Hop only as containing a recognisable TPR domain. Vesicular transport protein Sec
17 was also listed, due to local structural similarity to TPR repeat proteins. The Sec
17 structure however has a different overall twist (Rice and Brunger, 1999). Lengths
of helices were determined using data from the PDBSum database. This database
provides a summary of all the secondary structure elements contained within a
protein and hence is a useful tool in the analysis of a number of structures.
CYP4 _BOVIN (216-259)223-256 VDKILLI SEDLKNIGNT FFKSQNWEMA IKKYTKVLRY VEGSRAA
PPP5._HUMAN 28- 61 AKD NPSN
IEFS..HUMAN 225-258 ALKEKELGND AYKKKDFDTA LKHYDKAKEL DPTN
NCF2._HUMAN 3 36 LVEAISLWNE GVLAADKKDW KGALDAFSAV QDPH
NCF2..HUMAN 37- 70 SRICFNIGCM YTILKNMTEA EKAFTRSINR DKHL
PEX5._HUMAN 299-331 HPQPFEEGLR RLQEGDLPNA VLLFEAAVQQ DPKH
OM20._RAT 70-103 EAVQKF FLEEIQLGEE LLAQGDYEKG VDHLTNAIAV CGQP
TPR :2 OF SELECTED PROTEINS
CYP4._BOVIN (262-285)273-306 DADGAKLQPVA LSCVLNIGAC KLKMSDWQGA VDSCLEALEI DPSN
PPP5._HUMAN 62- 95 TEC DKKY
IEFS._HUMAN 300-333 MTYITNQAAV YFEKGDYNKC RELCEKAIEV GREN
NCF2._HUMAN 71-104 AVAYFQRGML YYQTEKYDLA IKDLKEALIQ LRGN
PEX5._HUMAN 332-365 MEAWQYLGTT QAENEQELLA ISALRRCLEL KPDN
TPR :3 OF SELECTED PROTEINS
CYP4.JBOVIN 307-340 TKALYRRAQG WQGLKEYDQA LADLKKAQEI APED
PPP5._HUMAN 96-129 LGK KPHD
IEFS._HUMAN 259-292 AKAYARIGNS YFKEEKYKDA IHFYNKSLAE HRTP
NCF2._HUMAN 121-154 ACEVLYNIAFM YAKKEEWKKA EEQLALATSM KSEP
PEX5._HUMAN 366-399 QTALMALAVS FTNESLQRQA CETLRDWLRY TPAY
TPRS 4-7 OF SELECTED PROTEINS
IEFS._HUMAN 225-258 ALKEKELGND AYKKKDFDTA LKHYDKAKEL DPTN
PEX5._HUMAN 415-448 LGPSKRILGS LLSDSLFLEV KELFLAAVRL DPTS
IEFS._HUMAN 260-292 TYITNQAAVY FEKGDYNKCR ELCEKAIEVG REN
PEX5._HUMAN 451-484 PVDQCGLGVL FNLSGEYDKA VDCFTAALSV RPND
IEFS._HUMAN 300-333 AKAYARIGNS YFKEEKYKDA IHFYNKSLAE HRTP
PEX5._HUMAN 485-518 YLLWNKLGAT LANGNQSEEA VAAYRRALEL QPGY
IEFS..HUMAN 360-393 ALEELNKGNE CFQKGDYPQA MKHYTEAIKR NPKD
PF.X5__HT.TMAN 519-552 IRSRYNLCIC CINLGAIIREA VEIIFLEALNM QRKS
IEFS..HUMAN 395-427 AKLYSNRAAC YTKLLEFQLA LKDCEECIQL EPTF
IEFS..HUMAN 428-461 IKGYTRKAAA LEAMKDYTKA MDVYQKALDL DSSC
Figure 38
Sequence alignment of TPR domains from structurally characterised proteins,
illustrating the differences seen between proteins in helix length. Proteins were
extracted from the SWISS-PROT database and manually aligned over the TPR
domain. The proteins illustrated are bovine Cyp 40 (CYP4 BOVIN), PP5
(PPP5HUMAN), Hop (IEFSHUMAN), P67phox (NCF2HUMAN), PEX5
(PEX5 HUMAN) and TOM20 (OM20 RAT).
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4.8.3
Analysis of X-ray and sequence data allows dissection of structurally
andfunctionally significant TPRmotif residues
The availability of six high resolution X-ray structures of TPR containing proteins,
combined with sequence data on the Hsp 90 binding TPR's; allowed some dissection
of the contribution of individual "conserved" residues to maintenance of structural
integrity of the molecule whilst also possibly providing insights into the nature of the
interaction with Hsp90.
4.8.3.1
Conservation ofspecific residues within a "functional of TPR proteins
Position TPR 1 TPR 2 TPR 3
2. K (9/9) K (3/5)
3. A (3/5)
5. K (9/9) Y (7/9) Y (3/5)
6. N (9/9) R (9/9) R (3/5)
7. R (7/9)
8. G (8/9) A (4/5)
10. S (3/5)
11. Y (3/5)
12. F (7/9) L (7/9)
13. K (9/9)




27. A (7/9) L (4/5)
28. L (7/9) L (3/5)
29. E (4/5)
32. P (7/9) P (3/5)
34. N (4/5)
Table 13
Conservation of specific residues within Hsp90 binding proteins (see Figure 31).
Residues completely conserved between proteins in Figure 31 are bold, italicised and
underlined, largely conserved residues are illustrated in bold. Residues conserved
between structurally characterised proteins are also illustrated on the right hand side
of each column. Numbering refers to the how many representatives of each of the
residues are conserved for a given position number (ie at position 5 in TPR 1 from all
the protein sequences illustrated in Figure 31, K is completely conserved hence K
(9/9).
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Analysis of the sequences including alignment into individual TPR repeats (see
Table 13) reveals a higher degree of conservation of residues within a functionally
specific family i.e. the Hsp90 binders compared to those structurally characterised.
Figure 39
Residues conserved between members of the Hsp90 binding sub-family (see Table
13 ) were highlighted in the Cyp 40 sequence and displayed with space filling CPK.
Conserved residues cluster in the binding groove, providing further evidence in
support of this region being important in interactions between these two proteins.
The majority of the residues are located within the positively charged inner groove, 2
residues being within the outer negatively charged groove and 1 (Pro 338) between
last 2 helices. The figure was prepared using WitnotP (Widmer, 1997).
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Figure 40
Cyp 40 TPR displayed with backbone atoms only. Conserved residues from Table 13
and Figure 38 above displayed with side chains on. Completely conserved residues
are coloured green, largely conserved residues are coloured yellow. The majority of
the residues point into the binding groove and consequently would be available for
interactions with partner proteins. A number of residues, particularly Ala and Gly
appear to be more intimately associated with conservation of structural integrity of
the TPR domain, as discussed earlier.
Amongst the structurally characterised proteins, TPR 3 is most similar, this being
largely weighted by the effect of the Hsp 90 binding proteins predominating in the
alignments These results are suggestive of functional requirement for these particular
amino acids in the interaction with the whole Hsp90 molecule. Mutagenesis studies
might help to identify if the residues highlighted above are indeed critical for the




The two very different structures of Cyp 40 provide unique and potentially extremely
interesting insights into the folding pathway of TPR containing proteins and/or an
active functional conformation of Cyp 40. One hypothesis is that of the tetragonal
form being a folding intermediate, trapped on the way to the fully folded
conformation. An interesting possibility, for which there is as yet no evidence, could
involve the extended conformation also being an active conformation. Large scale
movement of the TPR domain, as seen between the two structures, may possibly be
triggered by substrate binding and release. A recent paper reporting the crystal
structure of a highly helical, flexible, chaperone protein Prefoldin (Siegert et al.,
2000) raises the intriguing possibility of the extended conformation being an " active
chaperoning" structure. However, as Cyp 40 seems to be largely monomeric in
solution, it seems unlikely that extended Cyp 40 would function alone. Partner
proteins from a hypothetical active chaperone complex remain to be characterised.
Further experiments involving formation of a complex with substrate proteins may
shed further light onto this possibility.
The high resolution X-ray structures of two crystal forms of bovine Cyp 40 provide
further insights into the versatile nature of the TPR repeat motif. Whilst the overall
super-helical structure is maintained by these proteins, diversity can be seen between
structures. Results from comparisons between Cyp 40 and other TPR containing
proteins are indicative of this motif having greater structural flexibility than
originally envisaged. The TPR motif in Cyp 40 contains the longest helices yet
determined. The functional significance of these elongated helices remains to be
established. One possible explanation might include "fine tuning" of a binding
groove by engineering the interaction surface of the TPR domain by slight alterations
in the spatial arrangements of each TPR motif. An example of such specificity of
interaction can be seen in the hierarchy of binding affinities seen with Hsp 90 and
members of the large immunophilin family (Carrello et al., 1999).
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Another recent paper reported an "unexpected extended" conformation for the third
TPR motif of the Peroxin PEX5 from Trypanosoma brucei, in which the last two
helices are folded into one single 44A long continuous helix (Kumar et al., 2001).
This structure differed from the first structure of Pex5, suggestive of different "open"
and "closed" conformations of the protein. Possible roles for these "open" and
"closed" conformations of the TPR motif were suggested, with a role for the
extended conformation in interactions with other peroxins or whilst undergoing
membrane translocation.
An overlay of the three structures (Cyp 40 monoclinic, tetragonal and PEX5
extended) showed the PEX5 to have a very similar conformation to that of
monoclinic Cyp 40. The length of the C-terminal helices of monoclinic Cyp 40 and
PEX5 were very similar at 42A and 44A respectively, although the Cyp 40 C-
terminal helix adopts a more angular structure.
Characterisation of bovine Cyp 40 chaperone activity
Preliminary results from a project investigating chaperone activity in cyclophilins
distinct from PPIase activity, (carried out as part of a Carnegie summer studentship
held by Simon Wilkinson) provided evidence in support of Cyp 40 acting as a
molecular chaperone. To analyse the contribution from the PPIase domain alone, this
study utilised Cyp 3 (as discussed in Chapter 3) as a representative of a single
domain cyclophilin, compared and contrasted with Cyp 40. Incubation with Cyp 40
but not Cyp 3 was shown to slow the rate of aggregation of thermally denatured
citrate synthase. Complete suppression of aggregation was seen when GroEL was
used.
The chaperone activity of Cyp 40 was first characterised in 1996, maintaining an
unfolded substrate in a folding competent intermediate, lacking the ability to
completely refold substrate (Freeman et al., 1996). Data from the above experiments
do not produce evidence for any additional roles for Cyp 40 in chaperone
interactions.
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Subsets of the Cyp 40 protein family
Specialisation of functions of Cyp 40 type proteins has been suggested from studies
comparing activities of Cpr6 and Cpr7, two Cyp 40 homologues present in
Saccharomyces cerevisiae. Following heat shock, expression patterns were different
for these two proteins. Their relative PPIase activities have also been studied (Warth
et ah, 1997; Dolinski et ah, 1997; Duina et ah, 1998b). An analysis of the functional
properties of these two proteins found Cpr6 and Cpr7 differed in their stability to
thermal denaturation, their ability to isomerase Xaa-Pro peptide bonds and in their
molecular chaperone activities (Mayr et ah, 2000). The PPIase activity of Cpr7 was
about 6-fold lower than that of Cpr6, however Cpr7 was a more potent chaperone,
suggestive of significant functional specialisation between the two proteins.
Bovine Cyp 40 more closely resembles Cpr6 than Cpr7, sharing 44% identity over
the whole protein (58% identity over the cyclophilin domain and 31% identity over
the TPR domain). The limited degree of chaperone activity seen with Cyp 40 may be









Heat shock protein 90 is a ubiquitous, highly conserved, key regulatory molecule
involved in many important processes including signal transduction events, control
of elements of the cell cycle and regulation of transcription.
5.1.1
The Hsp 90 binding immunophilins
Isolation of Hsp90 from a preparation of S.pombe cell extract through a bioaffinity
interaction with Cyp 40 was described in Section 4.5.2, Chapter 4. The interaction
between large immunophilins and Hsp 90 had been previously described (Callebaut
et al., 1992; Lebeau et ah, 1992; Tai et ah, 1992; Ratajczak et ah, 1993).
This chapter will introduce the Hsp90 protein family, summarise what is known to
date of their structure and functions and conclude with sections focussing on the
isolation and characterisation of C-terminal fragments of Hsp90 p. The current lack
of structural data on the interactions of Hsp90 with partner proteins, suggested
molecular modelling of possible interactions might provide insight into the problem.
Modelled interactions between Cyp 40 (using the Cyp 40 structure described in
Chapter 4 as the basis) and Hsp90 will be considered in greater detail in Chapter 6
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5.1.2
Identification of the Hsp90 family
A number of proteins were initially identified by their marked up-regulation in
cellular concentration following heat stress. Amongst those identified were members
of what would become known as the Heat Shock Protein 90 family (Hsp90)
(Borkovich et ak, 1989). This family of proteins is highly abundant in the cell,
constituting approximately 1-2 % of soluble cellular protein under normal conditions
and is represented by numerous isoforms, (Welch and Feramisco, 1982; Gupta, 1995;
Lindquist and Craig, 1988).
Two genes encode for different, closely related mammalian isoforms of Hsp90 (a
and P), with the recently isolated mitochondrial homologue TRAP1/Hsp75 (Felts et
al., 2000) being less well conserved and also less abundant (Song et ak, 1995) and
(Chen et ak, 1996a). Homologues of Hsp90 can also be found in the endoplasmic
reticulum (Argon and Simen, 1999; Stevens and Argon, 1999) and chloroplast
(Schmitz et ak, 1996). The degree of conservation between homologues is high,
Hsp90a being 86% homologous to Hsp90p (Hickey et ak, 1989). A high degree of
conservation is also maintained over a variety of species, human Hsp90p shares 78%
homology with its homologue from D. melanogaster and is 61% homologous with
yeast Hsp90 (Rebbe et ak, 1987). The E.coli homologue HtpG is approximately 42%
homologous to Hsp90p, lacking the charged linker region.
Hsp 90 has been shown to be essential for viability in D. melanogaster (Cutforth and
Rubin, 1994; Yue et ak, 1999) and in the yeast S. cerevisiae (Aligue et ak, 1994;
Borkovich et ak, 1989). It has been suggested that for efficient protein folding in the
endoplasmic reticulum, GRP94 (the ER resident Hsp90) is essential (Gidalevitz et
ak, 2001).
A huge amount of research effort has focused on the interaction mechanisms of this
important molecule and its "client" or partner proteins.
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5.1.3
Domain structure ofHsp90 from sequence and biophysical data
Sequence alignment studies on members of the Hsp90 family revealed a high degree
of conservation between family members. Hsp90 has a modular domain structure in
which the highly conserved N and C-terminal domains, approximately 25 and 55kDa
respectively, are joined by a highly charged linker. This linker region is however,
non-essential, and is absent in both the E. coli Hsp90 homologue HtpG (Spence and
Georgopoulos, 1989) and eukaryotic mitochondrial homologues (Felts et al., 2000).
Native Hsp90 is a large molecule and continues to represent a considerable challenge
for structural biologists. Early attempts to structurally characterise Hsp90 included a
number of biophysical and biochemical studies on the whole molecule. Recently
X-ray crystallographic studies have focused on domains of Hsp90, with some degree
of success (for a review of Hsp90 structural data see (Pearl and Prodromou, 2000).
The results of some of these experiments will be briefly summarised below.
Mammalian Hsp90 was used in electron microscopic studies of the protein and
showed native Hsp90 was present as an elongated dimer. Dimerisation occurred
through the extreme carboxy terminal domain. This suggested Hsp90 was a very
flexible molecule as a number of reports had observed dimerisation between the N-
terminal domains.
Labelling the Hsp90 molecule with monoclonal antibodies raised against N and C-
terminal regions provided further insights into its structural organisation. The model
proposed from these studies was of two Hsp90 monomers aligning in an anti-parallel
orientation, with dimerisation occurring through the C-terminal domain, leaving the
N-termini of the dimer free (Maruya et al., 1999). This group also reported changes
in morphology of the Hsp90 homo-dimer into a ring like structure following addition
of ATP or exposure to heat stress, once again suggestive of great structural flexibility
within the molecule.
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The endoplasmic reticulum homologue GRP94 has also been studied, again
dimerisation was shown to be mediated via the C-terminal domain (Wearsch et al.,
1998).
ATP/GA P23 site of Steroid receptor Dimerisation TPR binding
binding domain interaction binding site domain domain
Figure 41
Cartoon representation of the five functional domains in the structure of Hsp90 (not
drawn to scale). The domains are indicated separately in the figure, however
significant functional overlap exists between domains.
5.1.4
The C-terminal domain of Hsp90 interacts with TPR containing
proteins
The C-terminal region of Hsp90 is critical for interaction with TPR motif containing
cofactors. Using the yeast two hybrid system, the TPR interaction region in Hsp90
was delineated to its C-terminal 12kDa domain, a result subsequently confirmed by
bioaffinity interaction binding assays (Chen et al., 1996b; Young et al., 1998).
Different members of the TPR protein family associate with Hsp90 in a sequential
manner, the order and specificity of the interaction being critical for proper protein
folding (Frydman and Hohfeld, 1997; Johnson and Craig, 1997). Specificity of
Hsp90 binding was investigated for three different TPR containing proteins; PP5,
FKBP52 and Hop. Mutation of conserved residues from the extreme C-terminus of
Hsp90 (Glu729, Glu730 and Asp732) inhibited binding of all three proteins,
mutation of other residues had more specific effects (Ramsey et al., 2000). This
overlapping interaction domain in Hsp90 for immunophilins, PP5 and Hop suggested
a common TPR acceptor site in Hsp90 (Russell et al., 1999).
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The binding domain in Hsp90 for Cyp 40 and Hop was also identified from a yeast
two hybrid screen. A mouse cDNA library was screened, all interacting clones
contained the intact carboxyl terminus of Hsp90, overlapping a common region
corresponding to amino acids 558-724 of murine Hsp90. Further studies delineated
the critical interaction region to lie within a 124 residue carboxy terminal segment of
Hsp 90. Deletion mutants in which the highly conserved sequence at the extreme
carboxyl terminus of Hsp90 (EEVD) was removed precluded interaction with both
Cyp 40 and Hop, underlining the importance of this motif in the interaction (Carrello
et al„ 1998).
5.2
X-RA Y STRUCTURE OF THE N-TERMINAL DOMAIN OF HSP 90
Recently structures of N-terminal fragments of both human and yeast Hsp90 have
been solved by X-ray crystallography.
5.2.1
Human Hsp90
Human Hsp90, residues 9-236, was first crystallised as a complex with the anti-
tumour antibiotic geldanamycin (GA). The interaction between Hsp90 and
geldanamycin had been characterised (Whitesell et al., 1994). Studies investigating
GA inhibition of certain cell cycle kinases showed GA binding to Hsp90 only.
Resultant indirect inhibition of kinase activity was due to failure of Hsp90 dependent
folding, (Whitesell and Cook, 1996). The precise nature of the interaction between
GA and Hsp90 was however, unknown. To further characterise this interaction; the 3
domains of Hsp90 were assayed separately for their GA binding activities, the N-
terminal domain was shown to bind GA at an approximately equimolar ratio
(Stebbins et al., 1997).
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Crystallisation trials resulted in two crystal forms. "Free" Hsp90 produced two
different crystal forms, the Hsp90/GA complex crystallised only in one of the
aforementioned forms (Stebbins et al., 1997). The site of GA binding was shown to
be in an approximately 15A deep pocket. Residues clustering in and around this
binding pocket are highly conserved over diverse species, 82% of the residues lining
the binding pocket interior are conserved from E. coli to humans. The authors went
on to speculate the structures obtained from the two different crystal forms
represented the binding pocket trapped in "open" and "closed" conformations, with
consequent implications on accessibility for ligand binding.
In the crystal structure, GA was bound in a very compact conformation, leading to
the suggestion that the conformation of bound ligand mimicked that of a potential
natural substrate, a polypeptide from a "client protein". Another important feature
identified by these authors was the conservation of residues that form a surface
groove and may be important in Hsp90 protein-protein interactions.
5.2.2
Yeast (Saccharomyces cerevisiae) Hsp90
The crystal structure of residues 1-220 of S. cerevisiae Hsp90 (Hsp82) was solved in
two crystal forms. Hsp90 was present as a dimer in both crystal forms. Dimerisation
occurred between the C-terminal P-strands of each monomer, with further
stabilisation of the dimer interface by non-covalent interactions (Prodromou et al.,
1997a). The two crystal forms grown once again captured the molecule in both
"open" and "closed" conformations, illustrative of the Hsp90 dimer having the
potential to act as a "molecular clamp", binding fragments of a polypeptide chain or
peptides. The need for great structural flexibility of the molecule was also discussed
in this paper. It was suggested that interactions occurring with other proteins in
different regions of the intact Hsp90 molecule would lead to conformational changes
in the molecule. The physiological relevance of the structure described by
Prodromou et al is yet to be proven, indeed in a follow-up paper from the same group
the validity of the potential peptide binding channel defined from the dimer structure
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was questioned, as the authors were unable to detect binding of peptides to this
channel.
The structure of the N-terminal domain of both human and yeast Hsp90 was shown
to be remarkably similar, as may have been expected from the high degree of
conservation seen between the sequences. Crystallographically, human protein is
monomeric, yeast dimeric. The overall structure of each molecule however is that of
an a /p sandwich, consisting of eight stranded anti-parallel P sheet forming a
potential binding groove, with 9 a helices on one face of the molecule, with the sides
of a deep binding pocket formed by the nine a helices.
Figure 42
Structure of the N-terminal domain (residues 9-236) of human Hsp90 in the open
conformation; with geldanamycin bound deep in the binding pocket (Stebbins et ah,
1997). The figure was prepared using PDB ID 1YET as the template and was
rendered using Molscript (Kraulis, 1991).
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5.2.3
Hsp 90 and ATP
A number of studies showed ATP was necessary for many important processes
within the Hsp90 system, including the release of Hsp 90 from substrate complexes
(Schneider et ah, 1996, Grenert et ah, 1997). ATP binding and hydrolysis was shown
to be essential for Hsp90 to function in vivo and in vitro, from both S. cerevisiae
(Hsp82), (Obermann et ah, 1998) and E. coli (HtpG) (Panaretou et ah, 1998).
The presence of ATP binding to Hsp90 was shown unambiguously by publication of
a high resolution crystal structure of a complex between ATP/ADP and the N-
terminal domain of Hsp90 (Prodromou et ah, 1997b). The ATP binding site
identified more closely resembles that seen in DNA gyrase B than a conventional
Walker site (Panaretou et ah, 1998).
This group went on to report regulation of Hsp90 ATPase activity by TPR containing
co-chaperones (Prodromou et ah, 1999) and suggested ATP hydrolysis triggered
client protein release.
A later paper suggested the ATPase cycle of Hsp90 drives a molecular clamp via
transient dimerisation of the N-terminal domains of Hsp90. This situation echoes that
seen with both MutL and DNA gyrase. In DNA gyrase the clamp mechanism
controls binding and release of a DNA duplex molecule during the topoisomerase
strand passage reaction (Kampranis et ah, 1999), whilst with MutL the exact
mechanism is as yet unclear (Ban et ah, 1999).
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FUNCTIONS OF HSP 90
The numerous roles of Hsp90 are reviewed in a number publications including a
study of plant Hsp90 functions (Pratt et al., 2001), an overview of the roles of
chaperone proteins in the maturation of steroid receptors (Kimmins and MacRae,
2000) and a review of the field of chaperones in mitogenic signal transduction and
cell cycle regulation (Helmbrecht et al., 2000). A number of other general reviews
are also available including (Caplan, 1999, Buchner, 1999; Pratt, 1998).
5.3.1
Hsp90 associated with protein kinases, cyclins and cyclin dependent
kinases
Hsp90 has been shown to be necessary for the proper maturation, intracellular
transport and regulation of activity of many protein kinases involved in signal
transduction, translation control and haem-dependent nitric oxide synthase. Amongst
those that have been shown to require Hsp90 are the Src family protein kinases, the
Weel tyrosine kinase, serine/threonine kinases Raf-1 and Mek, the cyclin dependent
serine/threonine kinase Cdk4 and the haem-dependent eIF-2a kinase (Pratt and Toft,
1997). Hsp90 is often targeted to its kinase substrate by Cdc37/p50 (Hartson et al.,
2000), in a situation which mirrors that seen with steroid hormone receptors,
Hsp90/kinase complexes act to maintain the kinase in an activation-competent state.
The best-characterised Hsp90 dependent kinases are those of the Src family. The
interactions between the Src family and Hsp90 are however very specific, as can be
seen from studies on both the viral v-Src and cellular c-Src proteins. Both proteins
require Hsp90 for the maturation of their catalytic activity, c-Src also requires Hsp90
in order to function as a substrate for the regulatory kinase Csk.
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5.3.2
Transcription factors including p53
Wild type p53 transcription factor is a nuclear tumour suppresor involved in
regulation of the cell cycle. Mutations of the p53 tumour suppressor gene are
amongst the most common molecular genetics defect found in human cancers. The
result of most p53 mutations is to produce misfolded proteins lacking their usual cell
cycle checkpoint activity. This results in tumours with high levels of aberrant
protein, due in part to the prolongation of the half-life of the misfolded p53 due to
impairment in the ubiquitin-proteasome pathway. Sequestration of mutant p53 within
the "machinery" of the molecular chaperone complex, with consequent protection
from degradation, leading to its eventual accumulation in tumours was suggested
(Whitesell et al., 1997).
A role for Hsp90 in the proper folding of mutated p53 was demonstrated, the effect
of geldanamycin was also investigated. These studies revealed the importance of
functional Hsp90 as addition of GA to reaction mixtures reduced the proportion of
mutated p53 translated in vitro. It was suggested that Hsp90 was required for the
folding and /or stabilisation of the mutated form of p53. Results from both in vitro
and in vivo experiments appeared to confirm this theory (Blagosklonny et al., 1996).
A recent paper (Whitesell et al., 1998) studied the effect of geldanamycin on
interactions between mutant p53 and components of the chaperone machinery. A
number of proteins co-precipitated in a molybdate sensitive fashion with mutant p53,
including Hsp90, Cyp 40 and p23. To establish the role(s) played by Hsp90 in
association with p53, GA was once again used to disrupt the interaction. A cell line
with a temperature sensitive mutation of p53 was used in this study. At 32°C this cell
line produced wild type protein, at 39°C it produced protein with altered
conformation, localisation and function. Wild type protein did not, under these
circumstances, stably associate with the group of molecular chaperones found in
stable association with mutant p53.
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5.3.3
Potential role in evolution as 'morphological capacitor'
An interesting series of experiments investigated the phenotypic variation seen in
populations of Drosopliila melanogaster carrying mutations in their Hsp90 genes
(.Hsp83).
Homozygous Hsp83 mutations are lethal, however a number of groups had observed
an increased prevalence of morphological abnormalities in fly stocks maintained
heterozygous for the Hsp83 mutation. Crossing these mutant flies with standard
laboratory strains also produced a significant percentage (1-2%) of the F1 offspring
with abnormalities. These effects were subsequently dissected out and shown to be a
consequence of altered Hsp90 function. This was confirmed genetically and
pharmacologically (Rutherford and Lindquist, 1998).
The genetic approach involved crossing different heterozygous Hsp83 flies, followed
by examination of the resultant offspring for phenotypic abnormalities. An increased
incidence and level of severity of abnormalities was seen.
Pharmacological confirmation of the role of Hsp83 was derived from experiments in
which flies were fed on food containing the Hsp90 inhibitor geldanamycin. A
significant proportion (7.7%) of the flies fed with the drug spiked food had
morphological abnormalities similar to those seen previously.
These authors developed an interesting hypothesis to explain the developmental
abnormalities resulting from impaired Hsp90 function. This involved Hsp90
normally functioning to mask cryptic genetic variation by suppressing the expression
of genetic variations affecting developmental pathways. Impaired Hsp90 function
would consequently allow these variations to manifest themselves at a much higher
rate in the population. It was further proposed that this could be a potential
mechanism for "evolvability", as Hsp90 has a key role in many processes and
developmental pathways. Perturbation of Hsp90 functions could therefore allow
normally silent mutations to be expressed in the population.
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5.3.4
Hsp 90 as a general molecular chaperone
The chaperone activity of Hsp90 has been investigated in vitro principally by the use
of three assay systems. One assay system relies on examining Hsp90 protein activity
alone, the others require participation of a number of Hsp90 co-chaperones. The
assay involves characterising the ability of Hsp90 to prevent aggregation of one or
more of a number of denatured proteins including citrate synthase, P-Galactosidase
and rhodanese. In vitro Hsp90 alone exhibits limited chaperone activity with a wide
variety of substrates. Chaperone activity is defined as the ability to maintain proteins
in a folding competent state and prevent further non-specific aggregation whilst
having no intrinsic refolding activity (Freeman and Morimoto, 1996; Jakob et al.,
1995; Csermely et al., 1998).
Refolding of denatured test proteins including firefly luciferase has been used as a
more stringent assay to determine the "active" chaperoning ability of Hsp90. Hsp90
facilitates refolding of proteins in co-operation with a number of co-chaperones
including Hsp70, Hsp40, Hip, Hop, the TPR containing proteins and p23. All these
proteins have some chaperoning activity in vitro apart from Hip and Hop, leading to
a very complex system from which it is very difficult to dissect out the contribution
of individual components to the resulting multi-protein chaperone machinery.
The in vivo chaperone activity of Hsp90 was investigated in an elegant series of
experiments. Nathan and co-workers investigated Hsp90 function with steroid
receptors and protein kinases (Nathan and Lindquist, 1995; Nathan et al., 1997).
Temperature sensitive mutations of S. cerevisiae Hsp90 were used to investigate its
in vivo functions. These resulted in a complete and rapid loss of Hsp90 activity
following exposure to non-permissive temperatures. These authors suggested the role
of Hsp90 in vivo was limited to acting predominantly to effect the maturation of a
group of proteins whose folding was inherently problematic and also in facilitating
the reactivation of damaged proteins. Chaperone sites in both N- and C-terminal
domains of Hsp90 have been identified, differing in their substrate specificities and
ATP dependence (Young et al., 1997; Scheibel et al., 1998). Functional association
between the two chaperone domains was also suggested (Marcu et al., 2000).
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5.3.5
Hsp90 and steroid hormone receptors
Steroid hormone receptors are soluble intracellular proteins that, dependent upon
their state of activation, can shuttle between the cytosol and the nucleus, leading to
activation of transcription. Hsp 90 acts as part of a dynamic multi-protein complex
in the assembly and maintenance in an "activatable" state, of steroid hormone
receptor complexes. The role of this family of proteins is thought to be largely to fold
the hormone-binding domain of the receptor into a high affinity steroid hormone
binding conformation. The interactions between Hsp90 and partner proteins in this
system are the best characterised to date, although there is as yet little understanding
of the mechanism involved or detail available on the interactions between individual
component proteins in this multi-protein chaperone hetero-complex.
5.3.5.1
Maturation ofSteroid Hormone Receptors (SHR's ) is a three-step process
The process of maturation of SHR's into conformational^ mature molecules can be
broken down into approximately three stages of interactions with different
components of the chaperone machinery, early, intermediate and mature.
In the early stages the SHR associates with Hsp70, Hsp40 and Hip, binding of Hsp90
and Hop to this pre-formed complex leads to the intermediate state. Studies have
shown the interaction between Hsp70, Hop and Hsp90 to be a crucial step in this
process, with Hop interacting physically with both Hsp70 and Hsp90, perhaps
modulating the activities of these proteins (Chen and Smith, 1998; Johnson et al.,
1998; Chen et al., 1998). Formation of the mature complex is brought about by the
interaction of another accessory protein, p23, with the receptor and one of a number
of TPR containing immunophilins. Hormone binding, through the high affinity
hormone binding domain of the receptor, results in disassociation of the SHR/Hsp90
multi-component complex, followed by dimerisation of the receptor with subsequent
transport into the nucleus. Movement into the nucleus is followed by the receptor
binding to specific DNA sequences, allowing initiation and regulation of
transcription. Figure 44 provides a diagrammatical representation of the component
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Illustration of the three principal stages in the maturation of a generic steroid
hormone receptor. The process can be broken down into three broad stages, early,
intermediate and late. Each of the stages is characterised by the presence of a
complex formed from a receptor specific subset of proteins with different protein
components of the chaperone machinery. The late stage is characterised by the
association of the SHR with Hsp90, p23 and PP5 or one of the large immunophilins
FKBP51, FKBP52 or Cyclophilin 40. The immunophilins interaction with Hsp90 is





The C-terminal domain of Hsp90
The interaction site of Hsp90 with large immunophilins has been shown to reside in
the C-terminal region of Hsp90. The experimental component of this chapter will
focus on experiments utilising deletion mutant constructs of the C-terminal domain
of Hsp90. The results presented will include discussions of studies carried out in an
attempt to further characterise Hsp90 C-terminal domain fragments, including
expression, purification and crystallisation trials
Selection of different lengths of Hsp90p deletion mutants for study
Earlier work by Carrello et al (Carrello et al., 1999), using a two hybrid system
screen of a mouse cDNA library, had identified the Cyp 40 binding domain in
Hsp90. All interactions between these two proteins were mediated by the carboxyl
terminus of Hsp90, and were confirmed in vitro by bio-affinity interaction studies.
The region in Hsp90 responsible for the interaction with Cyp 40 was further
characterised, revealing the key residues to lie within a 124 amino acid C-terminal
segment of Hsp90. A number of constructs were produced, covering this region.
The authors went on to describe the effect of deletion of the 5 extreme C-terminal
residues of Hsp90 (MEEVD), which resulted in complete disruption of binding to
Cyp 40.
5.4.1
Hsp 90 cloning and expression
Cloning was carried out by the Ratajczak group, Nedlands, Western Australia. The
following is provided for completeness only.
To generate N-terminal His tagged expression plasmids the following cloning
strategy was followed. Expression plasmids for Hsp 90p deletion mutants
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incorporating codons 530-724, 581-724, 600-724 and 530-719 were constructed as
follows. Each construct was PCR amplified from pET-15b-Hsp90(3 full length cDNA
template using Taq DNA polymerase with primers that introduced an Ndel site at the
5'-end and a termination codon with an Ndel site at the 3'-end. The PCR fragment
was ligated into pGEM-T and was then excised with Ndel digestion from a suitable
clone confirmed by sequence fidelity. The gel purified fragments were cloned into
the pET 28a(+) vector that had been linearised with Ndel to give the expression
plasmids pET 28a(+) 530-7240, pET 28a(+) 581-724 0, pET 28a(+) 600-724 p, pET
28a(+) 530-700 p and pET 28a(+) 530-719 p.
A similar strategy was followed to produce the expression plasmid pET-28a(+) 589-
732a, a construct for co-expression of Cyp 40 and Hsp90 600-724 was also prepared.
Hsp90 530-724 and 600-724 were chosen as initial targets for further
characterisation. These constructs were selected to provide examples of the putative
dimeric form of Hsp90, (530-724 includes the dimerisation domain of Hsp90) and
monomeric protein (600-724). Preliminary expression trials also indicated these
constructs expressed well, producing soluble protein, important for characterisation
and interaction studies.
5.4.2
pET expression of recombinant Hsp90 in E.coli.
The standard protocol developed throughout the course of this project, for large-scale
over-expression of proteins under control of the T7 promoter was used (see Chapter
2, Section 2.3) for both constructs. All work was carried out either on ice using
chilled solutions, in equipment pre-cooled to 4°C, or at 4°C in the cold room.
5.4.3
Purification of recombinant Hsp90
All constructs contained an N-terminal 6-His tag to simplify purification of
recombinant protein. The method to purify His tagged proteins under native
185
conditions, as outlined in the Qiagen Handbook was followed, and is included below
for completeness.
The cell pellets were defrosted on ice and solubilised in lysis buffer containing
50mM NaH2P04, 300mM NaCl, lOmM imidazole at pH 8.0, at a ratio of 2-5ml per
gram wet weight of cell pellet. Lysozyme (ICN/FLOW) was added to 0.1% w/v and
incubated on ice for 1 hour. An equal volume of deionised water at 4°C was added
and the cell suspension mixed. The lysate was centrifuged to remove cell debris, the
resulting clarified lysate was frozen at -20°C.
Clarified cell lysate was applied to a 10ml column of Ni-NTA Superflow in buffer A
(50mM NaH2P04, 300mM NaCl, 20mM imidazole) at pH 8.0. The column was
washed until a baseline was established, followed by elution of the tagged protein in
a series of steps of increasing concentration of buffer B (50mM NaH2P04, 300mM
NaCl, 250mM imidazole) at pH 8.0. Column fractions were tested on 15% SDS-





Dynamic light scattering analysis of the purifiedprotein
Dynamic light scattering studies of the purified protein were carried out as described
in Chapter 2, Section 2.4.1.
5.5.2
Electrospray ionisation mass spectrometry
The proteins were further characterised by electrospray ionisation mass spectrometry
on a SELDI (Surface enhanced laser desorption/ionisation) spectrometer
(Ciphergen). This instrument analyses samples applied directly to a ProteinChip.
Sample application to an appropriate ProteinChip can bring about enrichment of the
desired protein, desalting and also provides a sample for mass spectrometry analysis.
The SELDI instrument has an interface to a quadropole time-of-flight tandem mass
spectrometer. Thanks to Dr. Andrew Cronshaw for the SELDI results.
5.5.3
Crystallisation trials ofHsp90
The hanging drop vapour diffusion method as outlined in Chapter 2, Section 2.5.1.3
was used throughout this series of experiments.
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of Hsp90 530-724 on Ni-
NTA superflow. Lane 1,
clarified cell lysate. Lanes 2 -
4 wash fractions, lanes 5-7
elution with 50mM
imidazole. Lanes 7 - 13
elution with a gradient of
imidazole to 200mM. Lane
14, molecular weight markers
(B)
Pool of fractions from lanes
5-13, applied to Mono Q
column. Lanes 1 and 2, "start
material" post nickel column,
unfiltered and filtered
respectively. Lanes 4-7, wash
fractions, lanes 8-14 elution
of proteins by an NaCl
gradient to 500mM. Lanes 3
and 15, molecular weight
markers.
(C)
Pool of fractions post elution
from nickel column,
concentrated and applied to a
gel filtration column
(Sephacryl S-200). Lane 1,
"start material", lanes 2-9 and
11-13 sequential fractions
from peaks on the









trials of Hsp90 600-724 on
Ni-NTA Superflow. Lane
1, molecular weight
markers, lanes 2 and 3
clarified cell lysate
unfiltered and filtered
respectively. Lanes 4 and
5, wash fractions, lanes 6-
12 elution fractions with
50mM imidazole. Lane 13
molecular weight markers.
Protein standards providing molecular weight calibration were run on each gel,
allowing direct comparison between the proteins. SDS PAGE analysis revealed the
Hsp90 protein fragments running with a higher than expected molecular weight. The
estimate of molecular weight provided by analysis of the electrophoretic mobility of
proteins can be influenced by a number of features, including the protein construct
(discussed in greater detail later), the charge and nature of the proteins under test and
the extent to which these proteins bind the solubilisation agent SDS. Very acidic
proteins have been found to bind small amounts of SDS, the predicted pi for both
constructs investigated to date is less than 5, perhaps contributing to their greater
than expected estimated molecular weight.
Hsp90 530-724
As discussed above, the predominant protein produced by this construct is one of
approximately 26kDa. The over-expression system produces a relatively high yield
of protein that could be enriched to greater than 90% pure after one nickel agarose
resin affinity chromatography step. Subsequently, increased levels of purification
have proved harder to achieve as can be seen from the SDS PAGE gels pictured
above (Figure 45). Application of the protein to high resolution anion exchange







A representative preliminary purification run of
Hsp90 600-724
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chromatography (Mono Q resin) produced little or no improvement in protein purity,
as may have been hoped had the contaminants differed greatly in their charge from
Hsp90 530-724. Gel filtration also failed to separate the target protein from the
principal contaminants, although the separation required was approaching the limit of
resolution for the Sephacryl S-200 column. All proteins eluted very early, suggestive
of target protein and contaminants being present as a high molecular weight
aggregate. These results suggest the sample was not in an optimum state for
crystallisation trials.
Hsp90 600-724
Figure 46 above illustrates the one step purification protocol employed for Hsp90
600-724. SDS PAGE suggested the protein was greater than 95% pure after a single
nickel agarose affinity chromatography step. No further steps were taken to further
purify this construct, although trace higher molecular weight contaminants could be
seen on the gel.
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5.6.3
Dynamic light scattering analysis
Table 14 illustrates a typical dataset obtained from a dynamic light scattering
experiment carried out using both Hsp90 constructs purified as described above. As
outlined in Chapter 2, measurements were taken at room temperature using a






























1 1.7 1.5 214 110 1.002 1.006 2.263 3.734
2 1.3 1.0 216 100 1.000 1.004 2.376 3.596
3 1.7 3.0 227 151 1.002 1.012 2.181 9.884
4 2.3 1.6 254 99 1.007 1.003 4.721 3.231
5 2.8 2.7 279 151 1.035 1.041 4.974 7.662
6 1.8 1.7 317 107 1.016 0.998 6.615 4.436
7 1.9 1.6 276 98 1.008 1.003 4.219 2.736
8 1.5 1.2 234 107 1.002 1.001 2.735 4.094
9 2.2 1.0 247 105 1.002 1.002 3.094 2.899
10 2.1 0.7 246 114 1.002 0.999 2.321 3.122
11 2.1 2.3 225 179 1.002 1.028 2.128 10.69
12 1.2 1.8 244 108 1.003 1.005 2.934 4.639
Mean values 1.9 1.7 248 119 1.007 1.008 3.382 5.060
Table 14
These results suggested the proteins were not monodisperse but were in fact present
as multimers/aggregates. The results for Hsp90 530-724 are in broad agreement with








Results from electrospray ionisation mass spectrometry on a SELDI (Surface
enhanced laser desorption/ionisation) spectrometer of two Hsp90 C-terminal
fragments. Panels A and B results for the Hsp90 600-724 sample, panel C Hsp90

















21,897Da 2181Da 24,078Da 24,083Da, 24,283Da
47,964Da
Table 15
Summary of results from mass spectrometry experiments. The theoretical molecular
weight of the protein sequences were calculated by the Compute pi/Molecular
Weight tool at the ExPASy server (Wilkins M R and Gasteiger E, 1998), mass
spectrometry results were obtained as outlined earlier in this chapter in Section 5.5.2.
The results suggest strongly that Hsp90 530-724 would appear to be a better
candidate for structural studies than the shorter fragment, which appears to be present
in numerous isoforms.
The hexa-His tagged vector used in the cloning of these fragments of Hsp90 was
included to facilitate purification of the recombinant protein. The cloning/expression
region of the pET-28a-c(+) is shown below in Figure 48. This vector does, however,
add an estimated 2181 daltons to the final molecular weight of the protein products.
T7 promoter primer #69348-3
pET upstream primer #69214-3
Bgl II T7 promoter lac operator
AGATCTCGATCCCGCGAAATTAATACGACTCACTATAGGGGAATTGTGAGCGGATAACAATTCCCCTCTAGAAATAATTTTGTTTAACTTTAAGAAGGAGA









. . GGTCGGGATCCGAATTCGAGCTCCGTCGACAAGCTTGCGGCCGCACTCGAGCACCACCACCACCACCACTGAGATCCGGCTGCTAACAAAGCCC pET-28b(
. .GIyArgAspProAsnSerSerSerVaIAspLysLeuAIaAIaAIaLeuGIuHisHIsHIsHisHIsHIsEnd
. GGTCGGATCCGAATTCGAGCTCCGTCGACAAGCTTGCGGCCGCACTCGAGCACCACCACCACCACCACTGAGATCCGGCTGCTAACAAAGCCC pET*28c(
. .GlyArql leArgl IeArqAIoProSerThrSerLeuArgProHIsSerSerThrThrThrThrThrThrGIu1 IeArgLeuLeuThrLy9Pro. . .
8pu1102 I T7 terminator
GAAAGGAAGCTGAGTTGGCTGCTGCCACCGCTGAGCAATAACTAGCATAACCCCTTGGGGCCTCTAAACGGGTCTTGAGGGGTTTTTTG
T7 terminator primer #69337-3
pET-28a-c(+) cloning/expression region
Figure 48
Cloning and expression region of the pET-28a-c(+) vector. Figure taken from
Novagen technical reference literature.
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Taking into account the additional residues from the vector, results from the mass
spectrometry confirm that proteins of the expected molecular weights are being
produced. The relative proportions of desired product to contaminants appears to be
disappointing in the case of the shorter construct.
The results for the longer fragment (530-724) were more readily interpretable than
those of the shorter fragment, both sets of results will now be considered in greater
detail.
Hsp90 600-724
Hsp90 600-724 is apparently very heterogeneous, numerous peaks being identified
from the sample. This included a small proportion at approximately the expected
molecular weight of the intact protein (16,159Da). This was a somewhat unexpected
result as the sample appeared to be relatively highly purified, when analysed by SDS
PAGE and the proteins visualised by coomassie blue staining (Figure 46). Higher
molecular weight contaminants could be seen in the sample however no significant
amount of smaller contaminants were detectable on the gels. The presence of a
significant proportion of lower molecular weight contaminating proteins in the
sample suggested the protein was prone to proteolytic breakdown.
Secondary structure predictions for the C-terminal domain of Hsp90 (to be discussed
in greater detail in Chapter 6) suggest the molecule is largely helical, with short
regions of strand and the final 38 C-terminal residues lacking predicted secondary
structure. A helix running from residue 598-608 is predicted. Creation of a deletion
mutant from residue 600-724 could therefore be disrupting one of the helices of the
protein fragment. This potential disruption of secondary structure elements, together
with the unstructured C-terminal tail of the protein suggests great potential for
inducing structural instability and susceptibility to proteolytic breakdown into the
protein, as a possible consequence of incorrect folding.
Mass spectrometry analysis was carried out some time after the protein was purified,
there was therefore opportunity for the protein to have degraded over time.
Alternatively, the contaminants seen may have been as a consequence of the action
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of proteolytic enzymes, the protein having been prepared and stored without the
addition of proteolytic inhibitors.
Hsp90 530-724
This particular length of construct was chosen as it included the dimerisation domain
of Hsp90, located within the C-terminal region of the protein (residues 524-724), as
identified from studies using various lengths of deletion mutants (Nemoto et al.,
1995, Carrello et ah, 1998).
The results for Hsp90 530-724 suggest two of the three major peaks present in the
sample correspond reasonably well to the expected molecular weights of both
monomeric and dimeric forms of the protein. Structural studies of both monomeric
and dimeric Hsp90 fragments are planned. The apparent presence of two monomeric
isoforms of the protein, separated by approximately 200 daltons only, is however,
potentially problematic. Application of the purified protein to a suitable gel filtration
column should theoretically be capable of resolving the protein into its monomeric
and dimeric forms, however it would have no effect upon the two monomeric
isoforms. As discussed earlier in this chapter in Section 5.6.2, gel filtration failed to
resolve monomeric Hsp90 530-724 from contaminating proteins, should the
interaction prove to be sufficiently robust gel filtration would be the method of
choice to fractionate the protein into monomeric and dimeric forms.
5.6.5
Crystallisation trials offragments of the C-terminal domain ofHsp90
The proteins were concentrated to 20mg/ml, the following crystallisation trials were
set up for both constructs
■ Crystal screen I
■ Crystal screen II
■ Crystal Structure Screen I




To date no protein crystals have been obtained from any of these conditions. A
number of conditions looked more promising, these included ammonium sulphate
which produced "promising precipitate". Further refinement of conditions including
a broad pH screen (pH 2.2 - 9.0), suggested lower pH looked more promising.
5.7
DISCUSSION
The results presented in this Chapter include those from preliminary large-scale
expression, purification and characterisation of two constructs of the C-terminal
domain of Hsp90. The shorter construct, 600-724 was chosen to produce monomeric
Hsp90, 530-724 contains the dimerisation domain of the protein. Analysis of the
different constructs therefore would allow further dissection of the C-terminal
domain of Hsp90. Availability of four C-terminal constructs of Hsp90p covering
residues 530-724 of the protein domain implicated in interactions with the
immunophilins including Cyclophilin 40, provides an opportunity to gain some
further insight into both inter and intra molecular protein/protein interactions of this
key regulatory molecule.
The approach taken in these preliminary experiments was to attempt purification and
crystallisation of the C-terminal domain of the Hsp90 molecule alone. The results
presented earlier for both constructs suggest the protocol for the extraction,
purification and handling of these proteins required some optimisation to increase the
chances of obtaining useful crystals.
The C-terminal His tag used in this series of constructs added approximately 2181Da
to the proteins produced, and may be influencing the efficient folding of the proteins.
The tag used in these constructs is cleavable. Removal of these tags by thrombin
cleavage would provide a different protein species to be used in structural studies.
However, as discussed in Chapter 2, proteolytic cleavage of target proteins has its
own hazards, including generation of heterogeneity and inappropriate/inefficient
cleavage of target proteins. Should the tagged proteins prove resistant to
crystallisation, removal of the tag could be attempted.
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The longer construct appears to be vulnerable to aggregation, perhaps through the
formation of non-specific disulphide bonds between available cysteine residues
(there are 3 within the construct). To address this question, the protein could be
purified and stored under more strongly reducing conditions than those used
previously.
The presence of micro-heterogeneity within a protein sample can be problematic for
crystallisation. This may prove to be the case with Hsp90 530-724. Further
experiments will be necessary to determine if the protein peaks present at
approximately 24,083 and 24,283Da are genuinely present in roughly equivalent
amounts, and also whether they can be resolved prior to crystallisation experiments.
Mass spectrometry results suggest a significant proportion of the sample contains an
Hsp90 dimer, additional experiments will be required to optimise and enhance the
formation of dimeric Hsp90, producing a dimer robust enough to be maintained
throughout purification and crystallisation processes.
The shorter construct used in these experiments appears to be prone to both
aggregation and degradation. Steps to minimise deleterious effects upon the protein
might involve addition of a proteolytic inhibitor cocktail to the buffers used during
purification, hopefully minimising protein degradation. Proceeding as quickly as
possible from cell lysis to crystallisation trials may also be crucial, anecdotal
evidence suggests "fresh" protein can be very important in helping tip the balance in
favour of crystallisation for troublesome proteins. The apparent aggregation seen
from both mass spectrometry and light scattering experiments is also problematic.
This construct does not contain any cysteine residues, however as discussed earlier in
the chapter a predicted helix is disrupted by this construct, perhaps leading to
instability of this particular construct. One approach that might yield more stable






COMPARATIVE PROTEIN MODELLING STUDIES OF ELEVEN
CYCLOPHILIN 40 HOMOLOGUES
6.1
INTRODUCTION TO COMPARATIVE PROTEINMODELLING
Comparative protein modelling is based upon the observation that proteins with
highly similar sequences have similar structures (Chothia and Lesk, 1986). In the
process of comparative protein modelling, a known 3D structure of a related family
member is used as the basis for extrapolating a new structure from a protein
sequence, reviewed in (Bajorath et ah, 1993).
A search of the SWISS-PROT protein sequence database identified eleven proteins
with a high degree of homology to bovine Cyclophilin 40. Bovine Cyp 40 remains
the only family member to be structurally characterised. The aim of this part of the
project was to derive modelled structures of each of the other family members,
utilising the high resolution X-ray structure of Cyp 40 as a template. In an effort to
understand the function of a protein, knowledge of its shape and where and how it
interacts with protein substrates would be very useful information.
Analysis of modelled structures of these proteins might have provided insight into
the roles played by these proteins in their particular systems, possibly shedding light
onto the fine tuning of response made possible by minor changes in amino acid
sequence and hence structure. The aim of this part of the project was to compare and






The SWISS-MODEL server for automated comparative protein
modelling
The automated internet based SWISS-MODEL server (Guex and Peitsch, 1997;
Guex et al., 1999) was used in an attempt to produce modelled structures of the
eleven cyclophilin 40 homologues isolated from the SWISS-PROT database. The
SWISS-MODEL programme has an absolute requirement for at least one sequence
of known 3-D structure that has significant sequence similarity (ideally greater than
40%) to the target protein.
The SWISS-MODEL programme compares the target sequence with a database of
sequences derived from the Brookhaven PDB, using both FASTA and BLAST
sequence comparison programmes. Selection of suitable template structures is
additionally restricted to those proteins that share at least 35% residue identity with
40% of the target sequence, as determined by an algorithm within the programme.
This process of screening proteins for the most highly homologous allows selection
of several of the potentially most suitable templates for a given target sequence. Up
to 10 templates can be used during the modelling process. A "reference" template is
selected from those available, and is usually the protein with the highest sequence
similarity to the target. All other selected templates are superimposed upon the
reference template. 3-D matching of the structures results from superimposing the
corresponding Ca atom pairs selected automatically from the highest scoring local




First approach mode provides a very simple interface to the SWISS-MODEL
programme. The programme was accessed via an internet site
http://www.expasy.ch/SWISS-MODEL.html. The Cyp 40 protein sequences (Table
16) either as a SWISS-PROT AC code number or in FASTA format, were
individually supplied to the programme with optional template files. All results were
returned via e-mail. The modelling process took approximately 15 minutes to return
most results, however on occasions the modelling request was unsuccessful. A




Optimise mode requires use of another related programme, the Swiss-PdbViewer,
(http://www.expasy.ch/spdbv/), (Guex and Peitsch, 1997). The Swiss-PdbViewer
provides an interface that allows superposition of two or more protein sequences,
allowing generation of structural alignments between template and target molecules.
Additionally these molecules can be viewed and manipulated with the goal of
improving alignment between template and target molecule, prior to resubmission of
the modelling request to SWISS-MODEL.
6.2.3.1
Submission and modelling of target sequences
The amino acid sequence of the protein to model was loaded into the programme.
The target molecule is initially represented in the graphical interface window as a
single long helix. The PDB file of structure of bovine Cyp 40 was used throughout
this series of modelling requests as the template molecule, and was also loaded into
the graphical interface. The target sequence was then mapped onto the template,
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resulting in an automatically generated structural alignment between the two
molecules. This alignment can be manipulated either automatically or manually (in a
separate alignment window), the modelled structure being automatically updated as
changes are made in the alignment between the two proteins. For all target proteins
the sequence alignments were optimised by altering the automatic alignment
generated by Swiss-PdbViewer to conform to that generated by individual ClustalW
(Fliggins et al., 1996) alignments between each of the target molecules and bovine
Cyp 40. Following generation of an optimised alignment the modelling request was
re-submitted to SWISS-MODEL.
6.2.3.2
Visualisation and analysis ofmodelled structures
Results from the modelling process were returned via e-mail and included an
alignment of the amino acid sequences of the two proteins, together with the co¬
ordinates for the modelled structure as a PDB file. The structures were visualised
using WITNOTP (Widmer, 1997). The two structures were firstly separated into
molecule A, (Cyp 40, supplied template) and molecule B, (target molecule), each
being saved as a separate PDB file, allowing easier manipulation of individual
proteins within this program.
The following approach was routinely taken to analyse structures generated by
SWISS-MODEL. Following separation of the two structures (template and target),
each protein was coloured, magenta being reserved in each case for the template
structure (bovine). The molecules were initially displayed without side-chains, to
facilitate identification of areas of divergence from the template. This "whole
molecule" image was captured and saved, and representative residues of particular
interest were labelled. This was followed by more in depth examination of both
molecules, particularly around areas highlighted by the initial analysis. Side-chains











B. taurus 370 100% (Taylor et ah, 2001)
Cyp 40
Q08752
H. sapiens 370 94% (Kiefferet ah, 1992)
Q9CR16
M. musculus 370 92% (Kawai et ah, 2001)
Cyp 40
Q9C566
A thaliana 361 48% (Berardini et ah, 2001)
Wis2+
Q11004
S. pombe 356 43% (Weisman et ah, 1996)
Cpr6
P53691
S. cerevisiae 371 46% (Duina et ah, 1996a)
Cpr7
P47103
S. cerevisiae 393 33% (Duina et ah, 1996a)
Cyp 41
Q9P3X9
N. crassa 375 53% Sequence database
Q9N639
L. major 354 44% Sequence database
Q9XIL2
A. thaliana 404 49% Sequence database
Q9LY75
A. thaliana 570 42% Sequence database
Q9VT21
D. melanogaster 383 39% (Adams et ah, 2000)
Table 16
A search of the SWISS-PROT protein sequence database identified eleven proteins
with a high degree of homology to bovine Cyclophilin 40. These proteins are
identified in Table 16 by SWISS-PROT primary accession number and by name
where one had been used in the literature. Sequence identity for each of the proteins
is compared with that of bovine Cyp 40 (over full length Cyp 40). Various functions
have been suggested for bovine and human Cyp 40 (discussed in Chapter 4),
however the majority of these proteins are largely functionally uncharacterised.
Some data is available on Cpr6, Cpr7, Wis2 and the shortest Cyp 40 from A.
thaliana, this is discussed in the following section.
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6.3
THE CYCLOPHILIN 40 SUBFAMILY
6.3.1
The product of the Wis2+ gene ofSchizosaccharomyces pombe encodes
for a member of the Cyclopliilin 40 family.
Wis2+ was first isolated as a multi-copy suppressor of the cell cycle defect of the
triple knockout strain wee-1 50 cdc25-22 winl-1 (Warbrick and Fantes 1992,
Weisman et al., 1996). When grown on minimal media at the permissive temperature
of 35°C, the wee-1 50 cdc25-22 winl-1 triple mutant has a conditional lethal
phenotype. The triple mutant cells are highly elongated, a phenotypic characteristic
of cell cycle mutants, and also have abnormally bent and branched cells. Introduction
of a multicopy plasmid containing the open reading frame (ORF) responsible for
Wis2+ activity into the triple mutant strain suppressed its conditional lethal
phenotype.
Translation of the Wis2+ ORF predicted a polypeptide of 356 amino acids and
40.1kDa. The translated protein was identified as a member of the Cyp 40 family.
Homology between Wis2+ and bovine Cyp 40 over the 360 amino acid overlap is
43% identical, over the TPR domain the degree of identity is lower at 31%, with the
third TPR unit being most divergent. To date, Wis2+ remains the only type 40
cyclophilin to be identified by the S. pombe genome sequencing project.
The 18kDa cyclophilin (cyp 1) from S. pombe was fused to the C-terminal domain
from Wis2+. This hybrid protein suppressed the triple mutant phenotype with
comparable efficiency to that of "native" Wis2+, whilst the cyclophilin domain alone
had no such effect, showing the C-terminal domain to be critical in this interaction.
The effect of heat shock on Wis2+ transcript was also investigated. A 10 to 15 fold
increase in the level of Wis2+ mRNA was observed following a shift of exponentially
growing wild-type cells from 25 to 37°C. A further 2 fold increase was observed
when cells were shifted from 25 to 42°C. These results were highly suggestive of a
role for Wis2 in response to heat shock, however preliminary experiments showed no
203
differences in survival following heat shock between wild-type and Wis2A cells
(Weisman et al., 1996).
Subsequent studies by the same group (T Gaskell, personal communication) proved
the C-terminal TPR domain alone to isolate Hsp 90 from extracts of S. pombe. These
results suggest Wis2 is exerting its effect on mitosis by modulation of the activity of
an Hsp90 homologue.
6.3.2
Cpr6 and Cpr7from Saccharomyces cerevisiae encode for members of
the Cyclophilin 40 family
Two Cyp 40 type cyclophilins were isolated from S. cerevisiae, (Duina et ah, 1996a).
DNA sequence analysis showed the isolated clones to contain an ORF of 918
nucleotides (2 clones) and a different in frame ORF of 969 nucleotides. These ORF's
represented portions of two new members of the cyclophilin family, Cpr6 and Cpr7.
The entire Cpr6 and Cpr7 genes were cloned and characterised (Duina et ah, 1996a)
and encode for proteins with predicted molecular weights of 42 and 45kDa,
respectively, sharing 38% sequence identity over their entire length. Of the two
proteins, it was reported Cpr6 most closely resembled human Cyp 40 (44% identity
over the whole protein, 58% identity over the cyclophilin domain and 31% identity
over the TPR domain).
The effects of deletion of both genes, individually and in combination, were studied
(Duina et ah, 1996a). Cpr7A showed a slow growth phenotype, (the doubling time
for wild type cells being 1.5 hours, relative to 2.6 hours for Cpr7A cells). Cpr6A cells
had growth rates indistinguishable from those of wild type cells, whilst the Cpr6A
Cpr7A double mutant exhibited the slow growth defect attributable to that seen with
Cpr7A alone. These results showed that Cpr7 was required for normal growth in S.
cerevisiae, however both Cpr6 and Cpr7 were non-essential.
Cpr6 and Cpr7 have also been shown to form a stable association with Hsp 90,
having been identified in multiprotein complexes with Hsp90 and also from
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bioaffinity interaction studies. The C-terminal domain of each of these proteins is
sufficient for the interaction between the two proteins (Duina et al., 1998a)
The S. cerevisiae immunophilins were further studied. All 12 were knocked out
individually by gene disruption, in all cases the null mutant strains were viable. In
two cases, cpr7 and fprl, mutations conferred a slow growth phenotype when
compared with the wild-type strain, fprl is the S. cerevisiae homologue of FKBP12,
yeast strains lacking FKPB12 are resistant to both FK-506 and rapamycin and have a
slow growth phenotype (Wiederrecht et al., 1991).
To address the question of functional redundancy between members of the family
different combinatorial mutants were generated (Dolinski et al., 1997), for example
all five of the secretory pathway immunophilins were disrupted. None of these
combinations exhibited any novel phenotype or resulted in any worsening of the
single mutant phenotypes seen with cpr7 and fprl. A dodecuplet mutant strain
lacking all 12 immunophilins was found to be viable (Dolinski et al., 1997). These
results suggests that immunophilins did not play a general role in protein folding but
probably performed highly specific functions through interactions with unique sets of
restricted partner proteins as yet unidentified, possibly only under conditions of
cellular stress. A number of studies had shown that transcription of several
immunophilins was induced by heat shock or the accumulation of misfolded protein
(Sykes et al., 1993; Partaledis and Berlin, 1993).
6.3.3
Cyp 40 type proteins from Arabidopsis thaliana, Drosophila
melanogaster, Leishmania major and Neurospora crassa
Little is known of the detailed functions of the remaining bovine Cyp 40
homologues. Arabidopsis thaliana Cyp 40 has been implicated in the regulation of
specific signalling pathways, loss of function mutants in the gene encoding for the





















































































































































































E NFHYKHD REGLLSMANAG - RNTNGSQFFITTVPTPHLDGKHWFGQVIKG
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Alignment of the twelve
Cyp 40 type proteins









respectively Cpr6 and 7
from S. cerevisiae. All
other members of the
family are represented by
CYP 4 followed by an
abbreviated version of the
organism name. The three
proteins from A. thaliana
are numbered 1 to 3.
Sequences of A. thaliana
proteins 2 and 3 are
incomplete.
A number of features (as
noted in Chapter 4, section
4.6.5) are highlighted in
the alignment and include
conserved cysteine
residues (yellow) and a
highly conserved
glutamate (green). The
TPR helices of Cyp 40 are
also delineated within the
alignment (cyan).
The sequence alignment












H. sapiens Model generated N/A
M. musculus Model generated N/A
A thaliana (361aa) Model generated N/A
N. crassa Model generated N/A
D. melanogaster Model generated N/A
L. major Model generated N/A
S. pombe (Wis2+) Failed Model generated
S. cerevisiae (Cpr6) Failed Failed
S. cerevisiae (Cpr7) Failed Failed
A. thaliana (404aa) Failed Failed
A. thaliana (570aa) Failed Failed
Table 17
Results from the automated SWISS-MODEL protein-modelling server. Eleven Cyp
40 homologues were submitted to the server. The programme generated models for
six of the protein targets in "First approach" mode, one round of "Optimise" mode
resulted in a modelled structure for S. pombe Wis2. All other targets were assumed to
be insufficiently similar to the template molecule with the consequent failure of
model building, despite optimisation of sequence alignments.
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6.4.2
Human andmouse Cyp40 structures
Alignments of the three proteins shows no insertions and/or deletions, indeed 346
and 339 residues out of 370 are identical for the human and mouse sequences
respectively. The modelled structures of human and mouse Cyp 40 can therefore be
described as essentially identical to that of bovine Cyp 40 and are not therefore not
shown, having been fully covered in Chapter 4.
6.4.3
Modelled structures offive Cyp 40 homologues
Each modelled structure is presented individually overlaid with the experimentally
derived X-ray structure of bovine cyclophilin 40, discussed in Chapter 4. Figure 55
in this series is an overlay of the five modelled cyclophilins with Cyp 40. Bovine
Cyp 40 is coloured magenta throughout this series of figures. All figures were
prepared with INSIGHT, using PDB files generated by WITNOTP.
Figure 50
Overlay of the structures ofA. thaliana Cyp 40 (red) and bovine Cyp 40 (magenta).
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Figure 51
Modelled structure ofN. crassa Cyp 41 (yellow) overlaid on bovine Cyp 40
Figure 52
Modelled structure ofL. major Cyp 40 (white), overlaid on bovine Cyp 40
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Figure 53
Modelled structure of D. melanogaster Cyp 40 (green) overlaid on bovine Cyp 40.
Figure A, inner binding groove, Figure B outer binding groove. In each case the
inserted loop region from the B helix ofTPR 1 can be seen.
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Figure 54
Modelled structure of S. pombe Wis2 Cyp 40 (blue) overlaid onto bovine Cyp 40.
Figure 55
Overlay of all 5 modelled structures (A. thaliana, red, D. melanogaster, green, L.
major, white, N. crassa, yellow and S. pombe, blue) with the experimentally derived
structure of bovine Cyp 40 (magenta). Arrows point to areas of structural divergence
between modelled and derived structures.
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6.4.4
The cyclopkilin domain of the modelled proteins is largely conserved
between structures
The majority of structurally significant changes within the cyclophilin domain of the
modelled structures lie within two surface loops. Drosophila and
Leishmania diverge from bovine Cyp 40 in the surface loop joining the a-2 helix to
the (3-8 loop (region A indicated in Figure 55 above). Differences in conformation of
this loop have been noted previously, with the suggestion such charged and
accessible loops may provide recognition specificity for as yet undetermined partner
proteins (Taylor et al., 1998). S.pombe Wis2 diverges in the region of the "divergent
loop", (region B) largely due to the octapeptide insert in the sequence of Cyp 40 not
being present in Wis2. Minor changes are also seen in the linker region of the
modelled structures of L.major, N.crassa and pombe.
The TPR domain shows significant changes in surface loops and turns
Changes within the TPR domain occur mainly at the ends of helices (regions C, D
and E), maintaining the overall super-helical structure of the molecule whilst also
potentially allowing specificity of interaction with partner proteins through exposed
surface loops and turns. TPR 1 diverges in A. thaliana, melanogaster, L. major,
crassa and S. pombe, TPR 2 in N.crassa and pombe and TPR 3 in pombe. The
most striking area of divergence is seen in the B helix of TPR 1 from D.
melanogaster.
Drosophila melanogaster Cyp 40 has an inserted loop highly reminiscent of that
seen in the structure ofp67phox.
Figure 53 A and B illustrate two orientations of the modelled structure of D.
melanogaster Cyp 40. Figure 53 A illustrates the "inner" binding groove and is the
orientation used throughout this series of Figures. Orientation B is at 180° to that of
A, showing the "outer" face of the molecule. An insertion of twelve amino acids in
the sequence was modelled as a loop inserted into the B helix of TPR 1. Secondary
structure rendering of the model suggests the inserted loop forms two short regions
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of anti-parrallel p-sheets, breaking the B helix of TPR 1 into two shorter helical
regions (Figure 56). A similar loop was seen in the structure of (Lapouge et
al., 2000; Grizot et ah, 2001). This p hairpin extension in is inserted between
the third and fourth TPR repeats and suggests the modelled loop from D.
melanogaster may not have been optimally positioned by the automated sequence
alignment generated by the modelling programme.
Figure 56
Inserted residues in the sequence of D. melanogaster Cyp 40 form a loop containing
two anti-parallel P-strands linked by a tight turn. Two residues from this insertion are
in close proximity to residues within the cyclophilin domain (within 3A). The figure
was prepared using INSIGHT.
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CHAPTER 6B
MODELLED INTERACTIONS BETWEEN THE C-TERMINAL
DOMAINS OF HSP90 AND CYP 40
6.5
INTRODUCTION
Interactions between Hsp 90 andpartnerproteins
A major biological role for the large immunophilins is binding and regulation of
Hsp90 (Frydman and Hohfeld, 1997). Site directed mutagenesis of the
serine/threonine phosphatase PP5 identified Lys97, ArglOl and Lys32 to be
absolutely required for Hsp90 binding while modification of Arg74 diminished but
did not abrogate binding (Russell et al., 1999). A sequence alignment of TPR
sequences (Figure 31, Chapter 4) shows that the functionally important residues,
Lys97 and ArglOl, are conserved at position 2 and 6 of TPR3 for all the related
Hsp90-binding proteins.
A comparison of sequences for Hsp90 from different species shows the strongly
conserved C-terminal sequence of MEEVD. Deletion mutagenesis studies of the C-
terminal domain of Hsp90 have shown that the C-terminal sequence EEVD is
important for immunophilin binding (Carrello et ah, 1999; Chen et ah, 1998).
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6.6
ANALYSIS OF MONOCLINIC CYCLOPHILIN 40 CRYSTAL
GROWTH AND PACKING PROVIDES INSIGHTS INTO A
POSSIBLE INTERACTION WITH HSP 90
6.6.1
Observations from crystal growth and kinetics
An interesting observation made during crystallisation studies of the monoclinic
crystal form of Cyp 40 was the exceptionally fast growth along the needle axis
(needles grow to over 0.5mm within hours), suggestive of a particularly energetically
favourable interaction (Dornan et ah, 1999b).
Prior to solution of the structure, a secondary structure prediction of the Cyp 40
sequence gave a strongly predicted C-terminal helix of 28 amino acids in length.
This corresponded to a length of 42 A and is close to the conserved b-cell dimension
of the monoclinic needle form of Cyp 40. The b-axis also corresponds to the long
and fast-growing needle axis and it is therefore reasonable to suggest that it is this
calmodulin-binding helix which determines the length of the b-axis and also the
growth kinetics and morphology of monoclinic needle crystals.
6.6.2
Analysis ofmonoclinic Cyp 40 crystal packing
Analysis of the crystal packing (Figure 57) shows that the only intermolecular
contact in the crystal occurs upon stacking the molecules along the c-axis with the C-
terminal residues EKAAY fitting in tightly to a groove in the surface formed by the
three TPR motifs. The residues defining the groove are Lys227, Phe234, Ser274,
Asn278, Lys308 and Arg312. Significantly, the interaction involves close contacts
with the three positively charged residues identified in the site directed mutagenesis
study as being important for interaction with Hsp90 (Russell et ah, 1999).
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Figure 57
Picture of the main intermolecular interaction in the monoclinic form ofCyp40.
The yellow and blue molecules are related by a unit cell translation along b of 47.3
A. The C-terminal residues EKAAY one molecule (blue) fit into a groove of an
adjacent molecule (yellow). The groove is formed by two residues from each of the
three TPR helices (Ai^): Lys227, Phe234, Ser274, Asn278, Lys308 and Arg312
(side chains shown). Tyr 365 fits into a hydrophobic pocket in the groove and is the
last residue visible in the electron density (The C-terminal five residues are
presumably structurally disordered in the crystal).
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6.7
MODELLING THE INTERACTIONBETWEEN THE HSP 90
C-TERMINAL PENTAPEPTIDE MEEVD AND THE TPR REPEAT
DOMAIN OF CYP 40.
6.7.1
The X-ray structure of the Cyp40 TPR domain provides a model
binding surface for Hsp90.
6.7.1.1
Modelling the Cyp 40/MEEVD peptide interaction
The intermolecular interaction from crystal packing (Figure 57) was used as a guide
to model the Cyp40 interaction with the Hsp90 C-terminal MEEVD sequence.
The structure of Cyp 40 was unaltered throughout the modelling exercise. The
MEEVD pentapeptide was manually docked into the binding groove, mimicking the
interactions of EKAAY with each of the A helices of the TPR motif. Manual docking
provided a sterically reasonable fit such that each of the four carboxyl groups of the
MEEVD sequence were at distances appropriate to the formation of a salt bridge
with Lys308, Arg312 or Lys227. Furthermore; the hydrophobic pocket occupied by
Tyr365 in the crystal structure was occupied by valine. The methionine also filled an
available hydrophobic pocket.
All modelling was carried out using WITNOTP (Widmer, 1997).
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Figure 58
Picture of modelled MEEVD docked onto the Hsp 90 binding groove. An
electrostatic surface was calculated for Cyp 40 using the DelPhi module from the
INSIGHT II suite of programs. MEEVD was rendered in space filling CPK. This
representation of the two molecules clearly shows MEEVD docking into the concave
inner groove, contacting residues from each of the A helices of the TPR motif.
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Figure 59
"High resolution" picture of the conserved C-terminal Hsp90 sequence (MEEVD)
docked into the putative binding groove of Cyp 40. The MEEVD C-terminal
sequence of Hsp 90 is shown in green as balls and sticks. Those residues defining
the putative binding groove in the Cyp40 structure are coloured grey. The
conformation of the MEEVD peptide was selected to mimic the interaction shown in
Figure 57. The Cyp40 structure was not altered. Conformational angles for MEEVD
backbone and side chains all lie within acceptable values. All negatively charged
groups can form salt bridges with K227, K308 and R312. The valine and methionine
side chains sit deep in hydrophobic pockets.
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6.7.1.2
Twopossible Hsp 90 interaction modes revealed by MEEVD binding
The modelled interaction between the MEEVD motif of Hsp90 and Cyp 40 provides
an alternative to that seen in the X-ray structure of the complex between the TPR-2A
domain of Hop with the Hsp90 MEEVD motif (Scheufler et al., 2000). An overlay of
the two structures is shown in Figure 60.
Figure 60
View of an overlay of the X-ray structures of Cyp 40 and the TPR-2A domain of
Hop, solved as a complex with MEEVD. The main chain trace of Cyp 40 is shown in
magenta, residues 223 to 352 of human Hop are shown in yellow. The modelled
MEEVD is shown as capped sticks, coloured by atom type. MEEVD from the
structure in complex with the TPR-2A domain of Hop is shown in green capped
sticks.
This model requires the MEEVD peptide to run in the opposite direction to that
found in the Hop-peptide complex (Scheufler et al., 2000) suggesting the possibility




Interaction between the 95 C-terminalresidues 9G with the TPR
domain of Cyp40
6.7.2.1
Docked MEEVD provided a startingpoint formodel development
To further characterise the proposed model of C-terminal regions of Hsp 90
interacting with Cyp 40, the peptide model was expanded to include the 90 residues
preceding MEEVD in the protein sequence.
Secondary structure predictions of full length Hsp 90 suggest the C-terminal domain
is highly helical, with an unstructured tail region. The interaction domain with Cyp
40 resides within residues 600-724, as identified by deletion mutagenesis interaction
studies. Development of a model incorporating those residues, taking into account




Secondary structure predictions of full length Hsp 90p were calculated by two
independent programmes, PredictProtein (Rost et al., 1994),
(http://cubic.bioc.columbia.edu/predictprotein) and PSIpred (McGuffin et ah, 2000),
(http://insulin.brunel.ac.uk/psipred/). The resulting predictions were very similar,
with 5 helices strongly predicted in the sequence from residue numbers 540 to 724.
The modelled MEEVD binding site provided one anchor point for the C-terminal
region, incorporation of additional residues required the model to complement the
original proposed interaction.
Figure 61 shows the results obtained from the PSIpred, and PredictProtein servers.
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Residue no. 550 560 570 580 590 600
AA | ELPGDBMI HHHHB RBR|ekvtis nrlvsspcci VTSTYGWfil |
PHD sec hhhhh hhhhhhhhhh hhhhhhhhhh hhhh EEEEE EE EEE ee hhh|
Residue no. 610 620 630 640 650 660
AA RDNSTMGYMM AKKHLEINPD HIRRRRRRRRI BADKNDRRR[ HBHHHHHHRI
PHD sec 1hhhhhhhhh EEEEE hhhhhhhhh hh hhh hhhhhhhhhh|
Residue no. 670 680 690 700 710 720
AA | ■MRgfsle m HRRHlgid EDEVAAEEPN AAVPDEIPPL EGDEDASRME|
PHD sec |hhhhh hhhhhhhh hhhhhh 1
AA | EVD |
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the output from both
prediction of secondary
structure websites. Panel A
illustrates the results from
PredictProtein and shows
only predicted secondary
structure elements, all other
data was edited out prior to
incorporation into the figure.
Helices are represented by
the letter H in cyan, and
highlighted in the sequence,
in green. Panel B, results
from PSIpred. Helical
regions are delineated by
green cylinders, sheets by yellow arrows. The boxed regions in cyan illustrate the
level of confidence in the prediction for individual amino acids. The results from
both programs are very similar.
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6.8
MODELLING THE INTERACTION BETWEEN CYP 40 AND THE
FINAL THREE C-TERMINAL HELICES 90p
6.8.1
Overview ofmodelling strategy
The aim of this part of the project was to utilise insights gained from the structure of
Cyp 40 to define a binding site for the C-terminal region of Hsp 90. The working
hypothesis developed was of helical Hsp 90 docking into the groove formed by the
TPR domain of Cyp 40, with the terminal pentapeptide docked as illustrated above.
Secondary structure predictions suggested that a three or four-helix bundle would be
an appropriate template model for the C-terminal domain of Hsp90 (residues 630 -
724). This structural motif was chosen as it allowed modelling with a topologically
appropriate structure, for the following reasons:
• Basing the modelled structure on a three or four-helix bundle ensures a spatially
and topologically accurate model for the three helices of Hsp 90
• Alignment of the first helix of the bundle with the C-terminal long helix of Cyp
40 would maintain the correct topology for the molecule
• Maintenance of integrity of the bundle when aligned with Cyp 40 ensures a
sterically reasonable "fit" between the two molecules, the remaining helices dock
into the Cyp 40 binding groove
• The resultant model incorporates the required elements, a bundle of three helices,
accommodated within the Cyp 40 binding groove.
6.8.2
Selection ofan appropriate template model
The CATH protein structure classification database
The CATH protein structure classification database was searched for an appropriate
template molecule. This database uses protein structures, solved to a resolution of at
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least 3A and deposited with the Brookhaven Protein Databank. Structures are
arranged in a hierarchical manner, using the following four main features to assign
each structure:
• Class, 3 main divisions (mainly alpha, mainly beta, alpha/beta)
• Architecture, determined by overall shape of the domain structure
• Topology (fold family), determined by the overall shape and connectivity of the
secondary structure elements
• Homologous superfamily groups, protein domains thought to share a common
ancestor.
Restraints imposed upon the model
The "interaction groove" in the structure of Cyp40 defined the topological
requirements of the model, many structures from the database could be discarded by
simple visual inspection of molecular architecture. A number of potentially suitable
template molecules were chosen for closer examination, these included two
structures of ligand binding domains from the aspartate receptors of E. coli and S.
typhimurium (PDB ID 2ASR and 1LIH respectively). The PDB files for selected
structures were exported from the database and displayed using the programme
WITNOTP (Widmer, 1997). Template structures were aligned with and anchored
along the long C-terminal helix of Cyp 40, running N to C terminally. The model
structures were then examined to determine that which appeared to have the best fit,
when compared to the arrangement of secondary structural elements predicted for
Hsp90. The ligand binding domain of the aspartate receptor from E.coli (PDB ID no.
2ASR) was chosen as the best available model structure.
The first helix of the 4 helix-bundle was anchored to the long helix of Cyp 40,
subsequent helices were defined by their spatial relationship to this anchoring helix.
Key structural elements from the Hsp90 secondary structure predictions ie positions
of turns, lengths of helices and in particular the location of the helix-turn-helix-motif
(residue number Lys 649 to Gly 687 in the sequence) were mapped onto the template
structure. Positioning the helix-turn-helix motif was of particular importance as
residues within this region had been shown by site directed mutagenesis studies and
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bio-affinity interactions to be crucial in the interaction with the tetratricopeptide
repeat domain ofCyp 40 (Carrello et al., 1999).
6.8.3
Preliminary model of three Hsp90 C-terminal helices docked onto the
surface ofCyp 40
Figure 62
The full length structure of the ligand binding domain of the E. coli aspartate
receptor (PDB ID 2ASR) was used for preliminary modelling studies. The structure
was manually docked into the Cyp 40 binding groove, the N-terminal helix of 2ASR
aligned along the C-terminal putative calmodulin binding helix of Cyp 40. PDB files
of the two structures docked in WITNOTP were used to prepare the above figure in




Representation of the modelled interaction between the ligand binding domain of the
E. coli aspartate receptor (yellow) and Cyp 40 (magenta). The first helix from the
receptor can be seen aligned along the C-terminal calmodulin binding helix of Cyp
40, the remaining helices occupy the inner binding groove of Cyp 40. Manually
docked MEEVD is shown in green. The figure was prepared using WITNOTP.
To help in the visualisation of the interaction between the helices of Hsp90 and the
interaction groove of Cyp 40, regions from the helices of the aspartate receptor were
cut out from the molecule to represent lengths of helices predicted for Hsp90. These
selected residues from the sequence were mutated to correspond to those in the
appropriate predicted helical regions of the Hsp90 molecule. The mutated residues
were also renumbered as appropriate for the Hsp90 sequence.
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Figure 64
Modelled interaction of 3 predicted Hsp90 helices docking into the Cyp 40 binding
groove. The Cyp 40 molecule is displayed with a Connolly surface, the helical
regions of Hsp90 are displayed in space filling CPK. The schematic diagram
illustrates the orientation of each of the helices with respect to the Cyp 40 structure
and the MEEVD pentapeptide.
Binding studies suggests that the TPR domain alone is not sufficient for the stable
association of these immunophilins with Hsp90, but requires additional contributions
from flanking sequences upstream and downstream of the TPR region (Ratajczak and
Carrello, 1996). The proposed C-terminal Hsp90 interaction with Cyp 40 must
therefore be regarded as a model of one of a number of possible immunophilin-
Hsp90 interactions. Due to the high degree of conservation of the EEVD motif, the
interaction might possibly be driven by the initial recognition of and docking with
this particular motif to regions in partner proteins, followed by stabilising





Modelled structures of five Cyp 40 homologues. The cyclophilin domain is very
structurally conserved between the different species represented, as may have been
expected following analysis of previously published structures.
Maintenance of the overall super-helical fold of the TPR domain from these proteins
is interesting, suggestive of the necessity of maintaining this putative interaction
domain (the binding groove), whilst allowing specificity of interaction with partner
proteins through variable regions principally located in surface loops and turns
between individual TPR motifs. D. melanogaster Cyp 40 is the most divergent
structurally, containing a large insertion forming two antiparallel p sheets, located in
the model in the B helix of TPR1. Analysis of the model suggests that whilst
structurally this is a reasonable model for the region, it is probably inappropriately
located within a TPR motif and would be better placed at the end of the B helix of
TPR1.
Modelling the interaction of the C-terminal domain of Hsp90 with Cyp 40 resulted in
a hypothesis in which MEEVD docks into the binding groove of Cyp 40, which also
accommodates three strongly predicted Hsp90 helices. Mutagenesis studies suggest
other regions in these molecules are also important to stabilise and maintain this
interaction (Ratajczak and Carrello, 1996). Site point mutational analysis of both the
Cyp 40 TPR domain and the C-terminal region of Hsp90 would provide further
insight into residues crucial for the interactions between these two proteins. The
model presented above might be useful in helping to select the most structurally
appropriate residues to target for such studies.
Interactions between immunophilins and Hsp90 are without doubt complex, the









This chapter will focus on describing characterisation and structural studies carried
out on a recently described member of the FKBP family, FKBP 22 from the fungus
Neurospora crassa (Solscheid and Tropschug, 2000). Recently isolated from the
endoplasmic reticulum, the N-terminal domain of FKBP 22 was shown to be
homologous with that of the well characterised FKBP 12. Sequence analysis shows
the peptidyl-prolyl active site to be highly conserved; measured enzymatic activity is
similar to that for other members of the family. In common with the smaller FKBP
proteins, FKBP 22 has been shown to bind FK506 and rapamycin with IC50S in the
nM range.
The protein is synthesised as a precursor protein, with 20 additional amino acids at
the amino terminus, typical of an ER targeting signal. The mature protein, as
calculated from the cDNA sequence, has a molecular weight of 20,912 Da.
Electrospray mass spectrometry of the purified protein however yielded a mass of
22,043 Da, therefore the authors called the protein FKBP 22. The extreme C-
terminus of the protein contains a putative ER retention signal (-HNEL).
The N-terminal domain of NcFKBP22
The N-terminal domain of NcFKBP 22 is a typical FKBP domain, with highest
homology to the cytosolic/mitochondrial NcFKBP 13, (60%), with other % identities
averaging 50%. All residues important for PPIase activity and FK-506/rapamycin
binding are present in the FKBP domain of NcFKBP22.
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The C-terminal domain of FKBP 22
The C-terminal domain of the protein (residues 116-197) is unlike any other FKBP
that has been characterised to date. The extreme carboxy-terminus has a biased
composition of amino acids, with a clear bias against Phe, Gly, lie, Leu, Pro and Arg,
whilst Ala, Glu, Lys and Val are over-represented. This domain also has a very
acidic nature and is consistent with an amphipathic helical conformation. BLAST
searches using the C-terminal domain revealed a low sequence similarity to short
regions from late embryogenesis abundant (LEA) proteins from a number of
different species. These LEA proteins are thought to protect cells from stress
associated with dehydration.
The extreme C-terminal sequence (HNEL) is an ER retention signal; it has been
suggested that NcFKBP22 may be involved in protein folding in the ER, with the





Isolation and cloning offull-length cDNA encoding NcFKBP 22
Members of the Tropschug group, University of Freiburg, Germany, carried out all
cloning of NcFKBP22.
FKBP 22 was first isolated from a preparation of TV. crassa hyphae. The hyphal
lysate was applied to an affinity chromatography resin that comprised the FK-506
homologue ascomycin (Kay, 1996) coupled to Sepharose beads. After extensive
washes, specifically bound proteins were eluted from the resin by a shift in the pH
from 7.4 to 2.5, SDS-PAGE analysis of eluted proteins followed. In addition to
NcFKBP13 previously isolated from TV. crassa (Tropschug et al., 1990), another
protein with an apparent molecular weight of 29kDa was also routinely seen from
these preparations.
This affinity-purified material was N-terminally sequenced and shown to share 12
out of the 33 identified amino acids with NcFKBP13. A full length cDNA clone of
NcFKBP22 was prepared, allowing deduction of the full amino acid sequence of this
novel protein.
The following is provided for completeness. A Xgtll library of TV. crassa was used
for screening. One positive clone was identified that contained a short cDNA insert,
encoding for a C-terminal part of NcFKBP22. Reverse primers from this region were
used in combination with degenerate primers directed against the N-terminus to
isolate a specific NcFKBP PCR product that was finally used in plaque
hybridisations to isolate full-length cDNA. After restriction digestion, the fragment
was cloned into a suitably digested pQE-32 vector (Quiagen). Ligation and
transformation protocols of the Quiagen pQE vector manuals were followed. The




pET expression of recombinant FKBP 22 in E.coli
The standard protocol developed throughout the course of this project, for large-scale
over-expression of proteins under control of the T7 promoter was used (see Chapter
2, Section 2.3) for FKBP 22. All work was carried out either on ice using chilled
solutions, in equipment pre-cooled to 4°C or at 4°C in the cold room.
His-tagged FKBP 22 was expressed following a four hour induction with 0.4mM
IPTG (Melford Laboratories).
7.2.3
Purification of recombinant FKBP 22
The construct contained an N-terminal 6-His tag to simplify purification of
recombinant protein. The method to purify His tagged proteins under native
conditions, as outlined in the Qiagen Handbook was followed, and is included below
for completeness.
Cell pellets were defrosted on ice and solubilised in lysis buffer containing 50mM
NaH2P04, 300mM NaCl, lOmM imidazole at pH 8.0, at a ratio of 2-5ml per gram
wet weight of cell pellet. Lysozyme (ICN/FLOW) was added to 0.1% w/v and
incubated on ice for 1 hour. An equal volume of deionised water at 4°C was added
and the cell suspension mixed. The lysate was centrifuged to remove cell debris; the
resulting clarified lysate was frozen at -20°C.
Clarified cell lysate was applied to a 10ml column of Ni-NTA Superflow in buffer A
(50mM NaH2P04, 300mM NaCl, 20mM imidazole) at pH 8.0. The column was
washed until a baseline was established, followed by elution of the tagged protein by
application of a linear gradient of buffer B (50mM NaH2P04, 300mM NaCl, 250mM
imidazole) at pH 8.0. Column fractions were tested on 15% SDS-PAGE gels and
fractions containing the protein of interest were pooled.
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7.3
CHARACTERISATION OF FKBP 22
7.3.1
Dynamic light scattering experiments
Dynamic light scattering experiments on the purified FKBP 22 were carried out
using the DynaPro 801 with microsampler attatchment. A number of protein
concentrations were tested, the protein was monitored for stability and tendency to
aggregate.
7.3.2
Electrospray ionisation mass spectrometry
Purified protein was further characterised by mass spectrometry analysis providing
information on the parent ion(s) present. The sample was introduced into the
instrument stream via an infusion pump, the m/z spectrum deconvoluted using




The hanging drop vapour diffusion method as described in chapter 2, Section 2.5.1.3
was used throughout this series of experiments.
7.3.4
Data collection
Crystals were transferred from the hanging drop using an appropriately sized cryo-
loop into a cryo-protectant solution containing mother liquor plus 20% glycerol.
Crystals were removed from the cryo-protectant solution after 5 seconds and
mounted in a cryo-loop and flash frozen in liquid nitrogen. X-ray data were collected




PARTIAL STRUCTURE DETERMINATION OF FKBP 22
7.4.1
Structure solution and refinement
Members of the Structural Biology Group, ICMB, University of Edinburgh,
determined the partial structure. Professor Malcolm D. Walkinshaw obtained the
initial partial structure solution, using molecular replacement; with FKBP 12 as a
model. Dr. Joel Tyndall carried out further refinement of this structure.
o
The partial structure was solved using data to 2.6A resolution, only the FKBP





Purification ofrecombinant FKBP 22
The FKBP 22 purification illustrated was carried out by Miss Monludee





A representative gel illustrating a
typical elution profile from Ni-
NTA resin. Lane 1, molecular
weight markers, lane 2, cleared
lysate, lanes 3, 4 and 5, wash
fractions. Lanes 6-11,
elution of FKBP 22 with a linear
gradient of imidazole. Protein was
eluted at approximately 40%,
corresponding to 1 OOmM
imidazole.
Figure 65
Purification of FKBP 22 was achieved in one affinity chromatography step.
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7.5.2
Dynamic light scattering analysis
Table 18 illustrates a typical data-set obtained from a dynamic light scattering
experiment carried out using purified FKBP 22. Measurements were taken at room









1 0.0 63 kDa 1.001 4.939
2 2.0 69kDa 1.000 6.488
3 1.0 82kDa 1.000 3.529
4 1.3 77kDa 1.003 1.818
5 1.0 58kDa 0.999 4.060
6 1.3 83kDa 1.000 1.515
7 0.0 82kDa 1.001 3.711
8 2.0 88kDa 1.002 3.466
9 0.0 87kDa 1.004 1.342
10 2.5 91 kDa 1.001 3.008
11 1.7 119kDa 1.017 2.485
12 2.3 84kDa 1.000 3.488
13 0.0 70kDa 0.998 2.746
14 1.8 64kDa 0.999 2.619
Mean values 1.2 80kDa 1.002 3.230
Table 18
Purified FKBP 22 at 6mg/ml was analysed as described in Chapter 2, utilising the
room temperature micro-sampler attachment of the DynaPro 801. Bimodal analysis
of the data suggests 96% of the protein has an estimated molecular weight of 29kDa,
the remainder of the sample consisting of a large aggregate. These results also
suggest the possibility the protein may be dimeric.
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7.5.3
Mass spectrometric analysis ofFKBP 22
Figure 66
Results from mass spectrometric analysis of purified FKBP 22 from N. crassa.
Panel A, illustration of the peaks characterising the m/z ratios of the different
multiply charged ions present in solution following electrospray ionisation mass
spectrometry of FKBP 22. Panel B, automatic deconvolution of the m/z spectrum




Two crystal forms were grown from the protein isolated using the purification
protocol outlined in Section 7.2.3. The standard hanging drop vapour diffusion
method, as described in Chapter 2, Section 2.5.1.3 was followed.
Photographs illustrating changes in crystal morphology are reproduced in Figure 67.
7.5.5
Preliminary characterisation and data collection
A
Figure 67 A and B
Photographs showing changes in FKBP 22 crystal morphology during the process of
attempting refinement of crystallisation conditions
Clusters ofMicro-needles (A) and Twinned thin plate crystals (B):
Crystals of the forms pictured above grew from the same mother liquor.
The well solution consisted of 600pl Methoxypolyethylene glycol 5000, 100 jo.1 1M
2-(N-Morpholino)ethane-sulphonic acid (MES) at pFl 6.1, 30pl saturated ammonium
sulphate, 1 Ojul Dimethyl sulphoxide (DMSO) and 260 pi water. The drop consisted
of 2pl protein solution and 2pl of well solution. The protein solution consisted of
protein at either 6 or 12mg/ml in phosphate buffered saline at pH 7.0.
Crystals grew as very thin twinned/multiple sheets.
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The protein crystallised very readily, producing numerous clusters of very small
crystals. Data from a crystal such as that illustrated in Figure 67B was collected on
ID 14, EM 3 at the ESRF, Grenoble. Despite a badly twinned diffraction pattern
(Figure 68), it was possible to separate out a pattern corresponding to one single
crystal. Data was processed using DENZO and Scalepack.
Figure 68
Typical diffraction pattern obtained from FKBP 22. The diffraction pattern shows
data being produced from two crystals, an example of twinning.
Attempts at further refinement of these initial conditions, as outlined in the Materials
and Methods Chapter, Section 2.5.1.3 had little effect on crystal morphology.
Extensive refinement of crystallisation conditions has, as yet, failed to produce large
single crystals capable of diffracting to high resolution.
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7.6
FKBP 22 PARTIAL STRUCTURE
7.6.1
Structure solution and refinement
Crystals belong to space group P2i, with unit cell dimensions a= 70.83 b= 32.32 c=
77.10 A ,£ = 106.29°. The merging R factor is 10.6% and the data is 86% complete
to a resolution of 2.6A.
A partial structure was determined, using the molecular replacement programme
MOLREP (Vagin and Teplyakov, 1997), with a native FKBP 12 structure (Wilson et
al., 1995) as the search model. There are two molecules within the asymmetric unit.
The first two peaks of the rotation function produced peaks of Rf/sigma values of
6.63 and 5.93 (Figure 69). The translation function of the first molecule produced an
R factor of 0.588 and a correlation factor of 0.185. The second molecule produced an
R factor and correlation factor of 0.543 and 0.306 respectively with a sigma of 18.55.
Figure 69
Representation of output from MOFREP rotation function. The first two peaks of the
cross rotation function of the FKBP domains are shown.
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The electron density for the FKBP domain of the structure is very clear, however the
quality of data used did not allow unambiguous chain tracing extending into the C or
N terminal regions.
7.6.1.1
Summary of crystallographic statistics for FKBP 22











No. of observations 20652
No. of reflections 9372
Table 19
Summary of crystallographic statistics used in the determination of the partial
structure solution of FKBP 22
7.6.2
FKBP domain packing
The packing diagram for the FKBP domain (Figure 70) shows the FKBP domain
packing efficiently. Analysis of close contacts from the crystal packing revealed very
few bad contacts, only a few side chains were inappropriate. Such results are typical
of those obtained from a molecular replacement solution. Packing of the FKBP
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domain leaves large channels available for the remainder of the molecule, the
approximately lOkDa C-terminal domain predicted to be helical.
Figure 70
Packing diagram of the FKBP domain of FKBP 22. The unit cell is shown in green.
7.6.3
The overall architecture ofFKBP 22
Secondary structure prediction suggested that residues 116-197 form an amphipathic
a-helix (Solscheid and Tropschug, 2000). A similar prediction tool, PSIpred
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Figure 71
Output from the secondary structure prediction programme PSIpred. The C-terminal
region of the protein is predicted to be highly helical.
Attempts to locate the predicted helices of the C-terminal domain using MOLREP
(Vagin and Teplyakov, 1997) were unsuccessful. Manual chain tracing of the C-
terminal domain was also tried, however data was not of sufficiently high quality to
allow this technique to be useful.
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Analysis of crystal packing shows there is clearly space within the molecule to
accommodate the C-terminal domain, with possible helix-helix interactions between
the two crystallographically related molecules.
The partial structure of the FKBP domain generated is very well conserved with that
of all other FKBP proteins determined to date. This might have been expected due to
the high degree of sequence identity shared between proteins over this domain. A
BLAST search of the SWISS-PROT database revealed homologues of this protein to
be present in D. melanogaster and Homo sapiens. Figure 72 illustrates a sequence
alignment of these proteins with FKBP 22 from N. crassa and human FKBP 12.
FKBPl2_HUMAN GVQVET IS-PGDGRTFPKRGQTCWHY
FKBP2 3_DMELA MSKSNLVISCLLLVAISNSLVRAQ DLKVEVISTPEVCEQKSKNGDSLTMHY
FKBP2 2_HUMAN MPKTMHFLFRFIVFFYLWGLFTAQRQKKEESTEEVKIEVLHRPENCSKTSKKGDLLNAHY
FKBP2 2_NEUCR —MKSIFLSLSLLASATVGVLAAE ELGIDVTV-PVECDRKTRKGDKINVHY
.. * * *
FKBP12_HUMAN TGMLE-DGKKFDSSRDRNK—PFKFMLGKQEVIRGWEEGVAQMSVGQRAKLTISPDYAYG
FKBP2 3_DMELA TGTLQADGKKFDSSFDRDQ— PFTFQLGAGQVIKGWDQGLLNMCVGEKRKLTIPPQLGYG
FKBP2 2_HUMAN DGYLAKDGSKFYCSRTQNEGHPKWFVLGVGQVIKGLDIAMTDMCPGEKRKWIPPSFAYG
FKBP22_NEUCR RGTLQSNGQQFDASYDRGT—PFSFKLGGGQVIKGWDEGLVDMCIGEKRTLTVPPSYGYG











Alignment of the sequences of FKBP 22 from N. crassa, FKBP 23 from D.
melanogaster and human FKBP 23 and FKBP 12, (SWISS-PROT accession numbers
060046, Q9V3V2, Q9Y6BO and P20071 respectively. The alignment was carried
out using CLUSTALW.
Conservation of FKBP 22 between different species suggests an important role for
this particular member of the FKBP family, closer sequence analysis studies coupled





Results presented in this thesis include characterisation and structural studies on
three members of the immunophilin family, Cyclophilin 3 from the free living
nematode C. elegans, bovine Cyclophilin 40 and FKBP 22 from N. crassa.
This chapter will include a brief summary of results presented earlier, placing new
data into context and will include some discussion of possible future directions for
each of the projects.
CYP-3
The C. elegans genome sequencing project isolated 18 cyclophilins and 8 FKBPs, a
significant proportion of this relatively small genome encoding for members of the
immunophilin family. Such ubiquity suggests essential functions for these proteins,
as yet largely to be determined. Cyclophilin 3 is one of the most abundantly
expressed isoforms in C. elegans, and has been classified as a Cyclophilin A type
protein. C. elegans is a well characterised organism, amenable to genetic analysis.
The post-embryonic temporal expression pattern of cyp-3 indicates that this
transcript is most abundant during early larval development, peaking at the second
larval stage and dropping off in later development. A very specific tissue localisation
for this highly conserved cyclophilin was also observed, the protein expressed in the
single excretory cell of C. elegans.
Possible roles of CYP-3 in the nematode were also discussed, temporal and spatial
expression patterns for CYP-3 were characterised.
The high resolution X-ray structure of CYP-3 allowed comparisons with other
known cyclophilin structures, resulting in identification of a "divergent loop"
subclass. This subclass is defined by the following feature; an extra loop formed
from inserted residues. Also frequently present in cyclophilins containing this
"divergent loop", are two cysteines in close proximity (present in the structure in the
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reduced form). Conserved histidine and glutamate residues may also be important,
the glutamate acting to pin down the "divergent loop". A possible role in redox
signal transduction or metal co-ordination was suggested for this protein. Formation
of a disulphide bond between the two cysteines may possibly be inducing
conformation change within the protein, resulting in a redox sensitive signalling
mechanism. Results from experiments attempting to induce disulphide bond
formation by metal catalysed oxidation were inconclusive, however crystals soaked
with metals diffracted either very poorly or not at all, suggestive of metals perturbing
the crystal lattice.
CYP-3 proved to be a very robust and useful system for ligand binding studies.
Soaking crystals with the dipeptide Ala-Pro, coupled with solution studies, allowed
correlation of a crystallographic binding constant with that determined from solution,
the first report of such a study. Binding of a gold complex to the active site histidine
of the protein was also reported.
Further experiments might include repeated attempts to induce oxidation of the two
cysteine residues, to establish if the reaction does indeed induce localised
conformation changes within the molecule or otherwise act in redox sensing signal
transduction. The protein also provides an excellent target for ligand binding studies,
due to the availability of crystals amenable to soaking, freezing and short data
collection times. A number of other ligands could be investigated to further explore
the specificity of binding.
CYCLOPHILIN 40
The high resolution X-ray structure of bovine Cyclophilin 40, the first reported
structure of a two domain immunophilin; was discussed in Chapter 4. The structure
revealed Cyp 40 to have a modular domain architecture in which the two domains
were clearly separated into an N-terminal cyclophilin domain from residues 1 to 183,
a linker region of 30 amino acids from residues 184 to 213 and a C-terminal TPR
domain of 157 amino acids from residues 214 to 370. The Cyp domain can be
classified as a member of the "divergent loop" subfamily, sharing the required
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features of inserted residues forming a loop pinned down by a highly conserved
glutamate residue and two cysteines present in the unoxidised form. The TPR
domain consists largely of seven helices forming a right-handed super-helical
structure, with the final C-terminal helix (the calmodulin binding helix), protruding
beyond the shorter TPR helices.
A second crystal form produced a very different conformation that retained only the
first TPR motif; the second TPR motif having sprung out to form an elongated helix
o
of approximately 42A. This crystal form potentially represents a trapped intermediate
in the folding pathway of the fully folded monoclinic crystal form. Inter and intra
molecular interactions are conserved between helices in the two structures,
suggesting the possibility that tetragonal Cyp 40 may be an example of a domain
swapped dimer.
Two proteins were isolated by bioaffinity interaction studies with Cyp 40; GAPDH
and Hsp90. Further studies may identify additional interacting proteins.
The TPR domain in Cyp 40 was compared to other structurally characterised TPR
proteins and was revealed to be structurally the most divergent from the "classical"
helix turn helix motif first seen in the structure of PP5. Further analysis of protein
sequences and structures allowed identification of residues specifically conserved
between members of the Hsp90 binding subfamily of proteins, roles for individual
residues in either maintaining the structural integrity of the molecule or in the
interaction with FIsp90 were suggested.
Future work may include characterisation of Cyp 40 interactions with partner
proteins including calmodulin and Hsp90.
The high resolution X-ray structure of bovine Cyp 40 was used as a template in
automated model building of structures of five Cyp 40 homologues from diverse
species. Resultant structures were compared with that of the experimentally derived
bovine Cyp 40. The cyclophilin domains were very similar, mainly differing in
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surface loop regions. Despite relatively low sequence identity, a remarkable degree
of conservation of the overall TPR domain fold between Cyp 40 type proteins was
observed. Areas of structural divergence between template and modelled structure
were largely confined to N and C-terminal regions of individual TPR motifs. This
suggested variable regions provided specificity of interaction for partner proteins,
whilst conserved regions maintained the overall superhelical TPR domain structure,
providing a binding interface for partner proteins.
Insights provided by Cyp 40 crystal growth and packing led to development of a
modelled interaction for the five C-terminal residues of Hsp90 (MEEVD) within the
Cyp 40 binding groove. This preliminary model was extended to include an
additional 90 residues from the protein sequence. The model developed was of a
three helix bundle interacting through the Cyp 40 binding groove. The potential
range of interaction sites between TPR proteins and their physiological partner
proteins is yet to be fully characterised, the modelled structure described above
illustrates one of what may prove to be a number of potential sites of interaction with
partner proteins.
The modelled structure could be further tested by site point mutagenesis studies of
residues in both protein partners, followed by analysis of binding interactions
between the two proteins. Such molecular biology experiments coupled with
structural studies may prove a very powerful method by which to address defining
the interaction between immunophilins and Hsp90. Studies including structural
characterisation of a complex between Cyp 40 and the Hsp90 C-terminal domain
fragments discussed in Chapter 5 are planned.
FKBP 22
The partial X-ray structure of FKBP 22 from Neurospora crassa was reported. This
protein contains an N-terminal FKBP domain with a novel C-terminal domain. To
date, only the FKBP domain has been characterised. Experiments are underway to
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Cyclophilin 3 (CYP-3) is one of the most abundantly
expressed cyclophilin isoforms in the free living nema¬
tode Caenorhabditis elegans. The detailed post-embry¬
onic expression pattern of the cyp-3 transcript is un¬
usual, peaking during early larval development. The
spatial expression pattern was examined via reporter
gene analysis demonstrating that the cyp-3 transcript is
exclusively expressed in the single anterior excretory
cell. Recombinant cyclophilin 3 has been purified, crys¬
tallized and solved to a resolution of 1.8 A. The peptidyl-
prolyl isomerase activity of CYP-3 has been character¬
ized against the substrateV-succinyl-Ala-Ala-Pro-Phe-p-
nitroanilide, and gives a kcaJKm value of 2.4 x 10*' M_1
s"1. The immunosuppressive drug cyclosporin A binds
and inhibits CYP-3 with an IC-(I value of 16 nM, compa¬
rable with the range of values found for human cyclo¬
philin A. The x-ray structure shows that the overall fold
and active site geometry is similar to other cyclophilin
structures. There are however a number of distinctive
features, and we use this structure and amino acid se¬
quence alignment analysis to identify a subgroup of "di¬
vergent-loop cyclophilins". This subgroup has a number
of uniquely conserved features: an additional loop be¬
tween residues 48 and 54 (KSGKPLH); two cysteine res¬
idues (Cys40 and Cys168) that are in close proximity but
remain in the unoxidized form, and two other conserved
residues, His54 and Glu83. We suggest that these features
are functionally important for the role played by this
class of cyclophilins during cellular responses to stress
caused by changes in the redox environment or by up-
regulation of cellular activity. This study represents a
detailed biological, biochemical, and structural charac¬
terization of a single cyclophilin isoform in the model
organism Caenorhabditis elegans.
Cyclophilins are ubiquitous, highly conserved proteins found
in diverse prokaryotic and eukaryotic organisms (for review,
see Ref. 1). The first protein to be discovered was the abundant
cytosolic protein cyclophilin A (CypA),1 isolated by its high
affinity binding to the natural fungal cyclic undecapeptide cy¬
closporin A (2, 3). An 18-kDa protein independently isolated (4)
showed peptidyl-prolyl isomerase (PPIase) activity and was
* The costs of publication of this article were defrayed in part by the
payment of page charges. This article must therefore be hereby marked
advertisement" in accordance with 18 U.S.C. Section 1734 solely to
indicate this fact.
§ To whom correspondence should be addressed. E-mail: m.
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1 The abbreviations used are: CypA, cyclophilin A; PPIase, peptidyl-
prolyl isomerase; PCR, polymerase chain reaction; RT-PCR, reverse
transcriptase-PCR; MPEG, methoxypolyethylene glycol; CsA, cyclos¬
porin A.
subsequently shown to be identical to CypA. In vitro, cyclophi¬
lins accelerate the rate-limiting cis/trans PPIase steps in the
folding pathway of peptide and protein substrates (5, 6), espe¬
cially in proline-rich proteins (7, 8). It has also been suggested
that cyclophilins affect the dynamics of protein-protein inter¬
actions in vitro by preventing aggregation of early folding in¬
termediates of protein substrates (9). In vivo, several lines of
evidence point to a role for cyclophilins in protein folding,
transport, and assembly (1, 10).
The best characterized example of cyclophilin function in
vivo is the 26-kDa photoreceptor cyclophilin ninaA from Dro-
sophila melanogaster. The ninaA gene product has been shown
to be essential for the proper folding and intracellular trans¬
port of isoforms of the photopigment rhodopsin, RH1 and RH2,
from the rough endoplasmic reticulum through the cytoplasm
to the cell surface (11, 12). Evidence for other cyclophilin func¬
tions is growing and includes, for single domain cyclophilins,
the requirement for functional PPIase activity of CypA to pro¬
duce functional expression of homo-oligomeric a7-neuronal nic¬
otinic and type 3 serotonin receptors in Xenopus oocytes (13).
PPIase activity of the cyclophilin from Bacillus subtilis has also
been shown to be necessary to allow growth of the organism
under starvation conditions (14). In cooperation with Hsp 70
and Hsp 60, cyclophilins are a component of the mitochondrial
protein-folding machinery in Neurospora crassa (15). There is
evidence that the larger cyclophilin 40 proteins induce confor¬
mational changes in the transcriptional factor c-Myb which
allows the C-terminal negative regulatory domain of c-Myb to
interact with and inhibit its N-terminal DNA binding domain
(16). Duina et al. (17) also suggest a requirement for a Cyp
40-type cyclophilin (Cpr 7) in the negative regulation of the
heat shock response under both stress and nonstress conditions
in Saccharomyces cerevisiae.
The cloning and characterization of eleven cyclophilin genes
from C. elegans (18) provides an excellent opportunity to study
the various biological roles played by representatives of all the
cyclophilin subfamilies present within this system. The immu¬
nosuppressant drug cyclosporin A has been shown to have an
effect on parasitic helminth worms, causing structural tegu¬
mental damage. A possible mechanism for this antiparasitic
effect is the inhibition of proper cyclophilin activity (19-21)
resulting in production and accumulation ofmisfolded protein.
Detailed structural information on the nematode cyclophilins
may therefore provide useful targets for the design of new
families of antiparasitic drugs.
In this study we have fully characterized both the x-ray
structure and enzymatic activity of CYP-3 and also monitored
its expression pattern throughout the post-embryonic life cycle
of C. elegans. The expression pattern analysis of CYP-3, when
considered together with emerging structural and sequence
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data, provides an insight into the possible roles played by
cyclophilins in multicellular organisms.
MATERIALS AND METHODS
Construction of C. elegans CYP-3 Reporter Gene Fusions—The cyp-3
reporter gene recombinant plasmids were constructed using the C.
elegans lacZ promotorless reporter gene expression vector pPD95.03 (a
kind gift from Andy Fire and co-workers, Carnegie Institute). The
plasmid encodes a nuclear localization signal amino-terminal to the
lacZ gene and an N-terminal multi-intron intervening sequence. The
potential upstream regulatory region of cyp-3 was identified from an
unfinished yeast artificial chromosome clone (Y75B12, GenBank™ ac¬
cession number AL022301), identified on chromosome V by the C.
elegans genome project. The translationally "in-frame" 1026-base pair
5' untranslated region of the cyp-3 gene was amplified from genomic
DNA by polymerase chain reaction (PCR) with Taq polymerase (Ap¬
plied Biotechnologies). The PCR primers contained an artificial restric¬
tion site (underlined) to allow directional subcloning into the multiple
cloning site of the vector pPD95.03; cyp3pfxba 5'-gcgtctagagaagtccaaat-
tactgtcaac-3' (sense, Xbal)\ cyp3prbam 5'-gcgggatccctcattgttgaggcaa-
gaataggga-3' (antisense, BamHl). This construct permitted an in-frame
translational fusion to the lacZ with the first two amino acids of CYP-3.
PCR products were sequentially digested with Xbal and BaraHI, gel
purified, and ligated into similarly digested vector pPD95.03. Miniprep
DNA was prepared using a Qiagen miniprep kit, and sequencing was
performed to confirm the identity and the translational context of the
insert.
DNA Transformation, Fixation, and fi-Galactosidase Staining of C.
elegans—Transformation of adult hermaphrodite C. elegans was per¬
formed by microinjection of plasmid DNA into the syncytial gonad and
was carried out using the standard methods as described previously
(22). Transformed nematodes were fixed and stained for /3-galactosidase
activity as described previously (22).
Semi-quantitative Reverse Transcriptase (RT)-PCR—The semi-quan¬
titative RT-PCR methods including the generation of synchronous nem¬
atode cultures for staged mRNA and subsequent cDNA are described in
detail elsewhere (23). The staged cDNA samples were supplied by Iain
Johnstone (Wellcome Centre for Molecular Parasitology, The Univer¬
sity of Glasgow). The gene combinations (cyp-3 and the control gene
ama-1, which encodes the large subunit of RNA polymerase II) were
amplified from the staged cDNA samples representing pooled mRNA
samples corresponding to the different post-embryonic developmental
stages, using conditions which allowed reactants to remain in excess
(94 °C for 30 s, 58 °C for 60 s, and 72 °C for 90 s for 25 cycles in 25 p\
of final volume). Primers were designed to span introns so as to distin¬
guish between cDNA and possible genomic DNA signals, and combina¬
tions used were as follows: cyp-3, cyp3F/Nde and cyp3R/EcoRI ama-1,
amalf 5'-ttccaagcgccgctgcgcattgtctc-3' and amalr 5'-cagaatttccagcactc-
gaggagcgga-3'. The PCR reactions were electrophoresed on a 2% agar¬
ose gel and Southern blotted; blots were then probed with correspond¬
ing gene-specific (cyp-3, and the control gene ama-1) dAT-32P randomly
labeled inserts, which were generated by PCR using the above condi¬
tions and purified by gel extraction (QiaQuick gel extraction kit). After
autoradiography, the bands corresponding to the respective genes were
excised and counted by scintillation. The relative abundance of the test
genes were reproducibly determined by comparing their signal with
that of the control gene ama-1.
pET Expression of CYP-3—cyp-3 was cloned from cDNA using a
RT-PCR method as described previously (18). Briefly, poly(A)+ mRNA
was obtained using the Micro-Fast Track Kit (Invitrogen), and cDNA
was synthesized using a cDNA synthesis kit (Amersham Pharmacia
Biotech, Little Chalfont, UK). RT-PCR conditions were as follows: 10
pmol of each primer (cyp3F/Nde and cyp3R/EcoRI) 5 mM MgCl2, 6.7 mM
2-mercaptoethanol, 4.4 pM EDTA (pH 8), 1 mM of each dNTP, 113 pg/m\
nonacetylated bovine serum albumin, 2 p\ of mixed stage cDNA and 1
#xl of Taq polymerase (Advanced Biotechnologies), cycled 20X at 94 °C
for 30 s, 60 °C for 1 min, and 72 °C for 1 min in 100 pi. The primers
included engineered restriction sites (Ndel and EcoRI) that, after re¬
striction digestion, allowed directional subcloning into similarly di¬
gested pET-5a expression vector (Promega). Ligation and transforma¬
tion protocols of the Promega pET-5 technical manual were followed.
Plasmid DNA was isolated (Plasmid Kit, Qiagen), and the insert was
sequenced in both directions by thermal cycle sequencing on an Applied
Biosystems automated sequencer to validate that no mutations had
been generated by the RT-PCR procedure. The plasmid DNA was then
transformed into competent BL21(DE3 pLysS) cells (Promega) for sub¬
sequent recombinant protein expression.
Table I
Summary of the final refinement statistics used in the structure
determination of cyclophilin 3
Summary of refinement statistics Native
Resolution range (A) 10-1.8
^final (all data) <F > 4 &) 20.81% (19.69%)
Rft-ec (F > 4 &) 28.47% (26.61%)
Root mean square deviations from ideal geometry
Bond lengths (A) 0.031
Angle distance (A) 0.026
Mean B-factor (A2) 30.37
Purification ofRecombinant Cyclophilin 3—Recombinant CYP-3 was
expressed following a 4 h induction with 0.4 mM isopropyl-l-thio-/3-D-
galactopyranoside. Cell pellets were frozen at —20 °C, defrosted on ice,
and solubilized in lysis buffer (10% w/v) containing 50 mM HEPES, 5
mM benzamidine, 5 mM EDTA, 5 mM 2-mercaptoethanol, pH 7.5. Ly-
sozyme (ICN/FLOW) was added to 0.1% w/v and incubated on ice for
1 h. An equal volume of deionized water at 4 °C was added, and the cell
suspension mixed. Resulting supernatant was frozen at —20 °C, de¬
frosted slowly on ice and the pH adjusted to 6.8. Protein extract was
purified to homogeneity using two purification steps: SP-Sepharose
cation exchange chromatography with the following buffers: Buffer A,
50 mM HEPES, 5 mM EDTA, 5 mM 2-mercaptoethanol, pH 6.8, and
Buffer B, Buffer A + 0.5 m NaCl (pH 6.8). Column fractions were tested
on 15% SDS-polyacrylamide electrophoresis gels and fractions contain¬
ing the protein of interest were dialyzed overnight against Buffer A.
Protein solution was filtered through a 0.2 pm filter and applied to
Resource S resin (Amersham Pharmacia Biotech). CYP-3 was eluted
from this resin with the following buffers: Buffer A, 20 mM HEPES, pH
6.8, Buffer B, Buffer A + 0.5 M NaCl.
Fractions containing CYP-3 were pooled and concentrated to 20
mg/ml as estimated by the Bradford assay. Dynamic light scattering
showed the protein was essentially monodisperse and stable with an
estimated molecular mass of 20 kDa (results not shown).
PPIase Assay—Purified recombinant CYP-3 was assayed for PPIase
activity essentially as described by Fischer et al. (4), with the suggested
substrate solvent application as described by Kofron et al. (24). This
assay determines the rate of conversion of cis to trans of a proline-
containing peptide, working on the principle that chymotrypsin will
cleave the peptide only when it is in the trans conformation, resulting in
the release of chromogenic dye. The peptide substrate N-succinyl-Ala-
Ala-Pro-Phe-p-nitroanilide (Bachem) was dissolved in trifluroethanol
with 470 mM LiCl to give 100 mM stock solution, which was diluted to
4 mM immediately before use. The experimental setup was as follows:
CYP-3 was diluted into 50 mM HEPES, 86 mM NaCl, pH 8.0 (PPIase
Buffer), to give a 2,000 nM stock. In a 1-ml cuvette, 10 p\ of protein (20
nM final concentration) was added to 860 p\ of PPIase buffer and
incubated on ice for 1 h. Chymotrypsin (100 p\ of a 6 mg/ml solution)
was added to the cuvette followed by transfer of the cuvette to a
thermostatted Peltier cell holder by which the reaction temperature
was maintained at 5 °C. The sample was allowed to equilibrate until a
steady baseline was established. The reaction was started by the addi¬
tion of 30 pi (120 pM) ofpeptide substrate followed by rapid mixing. The
absorbance change at 400 nm due to the release of p-nitroaniline was
recorded using a Perkin-Elmer Lambda 20 spectrophotometer with
data collected every 0.1 s over a 2-min time period. A number of protein
concentrations were tested using the above method. Analysis of the
data was carried out using a double reciprocal Lineweaver-Burke plot,
which gives an intercept at 1/Vmax on the y axis, and 1/[S] = -1IKm on
the x axis. The slope of the line is Km/Vmax.
Cyclosporin A inhibition assays were carried out essentially as de¬
scribed above except that the samples were preincubated for a mini¬
mum of 60 min with varying amounts of CsA (kindly provided by
Novartis AG).
Crystallization of CYP-3—Two crystal forms were grown from the
protein isolated above using the standard hanging drop vapor diffusion
method. Crystal forms were tetragonal bipyramid and thin plates.
Tetragonal Form—4-p\ hanging drops consisted of 50 mM sodium
citrate, pH 5.6, 15.5% w/v methoxypolyethylene glycol 5000 (MPEG
5000). Protein concentration was 3.5 mg/ml. The drop was suspended
over the well containing 100 mM sodium citrate, 31% MPEG 5000 at
18 °C. Conditions for producing tetragonal crystals were refined, crys¬
tals grew in a narrow concentration range of MPEG 5000 (28-32%)
with the optimum pH for crystal growth being 5.6.
Thin Plate Form—4-p\ hanging drops consisted of 50 mM citric acid/











































MSKKURRRVFFDVTIDGNLAGRIVMELYNDIA PRTCNNFLML£ 4 3
MVNPTVFFDIAVDGEPLGRVSFELFADKVPKTAENFRALS 40
Extra loop : Gly45-His54
TGENGIGK-SGKPLHFKGSKFHJtllPNFMIQGGDFTRGNOTGGESIYGEKFPDENF K 96
TGEXGRGK-SOKPLHYKCCVFRHVIPGFM1QGGDITRCNQTGG£SIYGMNFRDESFSGKA 119
TGEKGVGO-TGKri»HFKGSKFHJtVIPNFMCOGGDFTAGNGrG3BSIYGSKFEDEKF E 9 6
TGEKGVGK-SQKPmYKGSTFHEVIPEraCOGGDFTRGNOTGGBSlYGEKFPDEKF V 9 6



















- EKPAKLCVIAE£GELKEGDDW * 190
KNRPLADWILN£GELVRRK* 180
KNRPI.ADVI ILNCGELVRRK * 180
-GKTSKKITIAIX-'GQLE 165
N-term
Fig. 1. BLAST and FASTA searches were carried out using the
sequence GIGKSGKPLHFKG as the target, producing a com¬
bined total of 50 hits. Using cyclophilin as the query and all available
data bases at the EBI produced 196 hits. Manual inspection of these
cyclophilin sequences revealed additional insert containing sequences
that also showed homology to the target sequence and were therefore
included in the analysis. Sequences (or cyclophilin domains only) were
retrieved in PIR format and aligned using CLUSTAL W. Alignments
were carried out both with and without human CypA. Manual inspec¬
tion of the two multiple alignments produced allowed identification of
residues conserved exclusively between divergent-loop containing cy-
clophilins as opposed to those conserved between all members of the
family. Representative examples covering a diverse range of species are
shown aligned against human CypA (CYPH HUMAN), included as
the cyclophilin archetype. Sequence alignment of the cyclophilin do¬
mains from C. elegans Cyp 3, accession number P52011 (CYP3 CAEEL);
Trypanosoma cruzi, accession number 076990 (CYPH TCRUZ); cyclo¬
philin 1 from Arabidopsis thaliana, accession number P34790
(CYP1 ARATH); Zea mays, P21569 (CYPH MAIZE); Synechocystis
sp., accession number P73789 (CYPH SYNEC); bovine Cyp 40, acces¬
sion number P26882 (CYP4 BOVIN); B. malayi, accession number
Q27450 (CYPH BRMAL); Cyp 1 from Onchocerca volvulus, accession
number AAD09564 (CYPH ONCHO); and human CypA, accession
number P05092 (CYPH HUMAN). The asterisk (*) inserted at the end
of an amino acid sequence indicates the sequence is incomplete, with
the cyclophilin domain only being used to produce the alignment seen.
The sequences were aligned by CLUSTAL W (50) with dashes intro¬
duced for maximum alignment. Inserted residues forming the divergent
loop seen in all the aligned sequences with the exception of human
CypA are in bold and underlined. Cysteine, histidine, and glutamate
residues conserved within this subgroup of cyclophilins are also shown
in underlined bold. Residues important in conferring CsA sensitivity
are in bold italics. Numbering refers to the amino acid sequence of
CYP-3.
sodium citrate, pH 6.0, 13% MPEG 5000. Protein concentration was 21
mg/ml. The drop was suspended over a well containing 100 mm citric
acid/sodium citrate, pH 6.0, and 26% MPEG 5000 at 4 °C. X-ray data
were also collected from the thin plate crystal. These crystals were
orthorhombic and diffracted to 1.9 A in one direction, with unit cell
dimensions of a = 58.9 A, b = 67.5 A, c = 76.4 A. No further studies
were carried out using this crystal form as they were severely
anisotropic.
Structure Determination of the Tetragonal Form of CYP-3—Crystals
were transferred from the hanging drop using an appropriately sized
cryo-loop into a cryoprotectant solution containing mother liquor plus
20% glycerol. Crystals were removed from the cryoprotectant solution
after 5 s and mounted in a cryo-loop (Hampton Research) and flash
frozen in liquid nitrogen. X-ray data were collected at 100 K (Oxford
cryosystems) using a MAR image plate and processed using DENZO
(25). The structure was solved by molecular replacement using the
program AMORE (26) with the human cyclophilin A structure as the
model. Position and B-factor refinement were performed using
SHELX97 (27), water molecules were added using SHELXWAT (27).
Fig. 2. Molscript (51) overlay of the stuctures of C. elegans
cyclophilin 3 and human cyclophilin A. The eight labeled strands
are shown in purple, the two helices are shown in green, and ceCYP3
loop structure is shown in orange. The human CypA loop (in blue)
contrasts with the shape adopted by the divergent loop, which is formed
mainly by 7 additional residues (48KSGKPLH54) in the CYP-3 sequence.
RESULTS
Cyclophilin-3 3D Structure
Crystals belong to space group P41212 with unit cell dimen¬
sions a = b = 60.60 A, c = 123.12 A. There is one molecule in
the asymmetric unit, with Vm = 3.118 A3/Da and 60.6% sol¬
vent. 145,422 observations were measured to give 22,053
unique data, 14,736 with I > 3cr (I). The merging R-factor is
8.3%, and the data is 97% complete to a resolution of 1.8 A.
Results of the final refinement are summarized in Table I. All
of the residues are well defined in the electron density map, the
exceptions being Met1 and Ser2 in the N-terminal region, Gly87
and Glu88 in the loop region and Lys172 in the C-terminal
region.
CYP-3 and CypA are 67% identical (77% similar) at the
amino acid level (18). Fig. 1 shows the alignment of the cyclo¬
philin domains from a number of cyclophilins against human
CypA. The overall architecture of CYP-3 is similar to that of
known x-ray and NMR cyclophilin structures (28, 29) with an
anti-parallel 8-stranded j3-barrel capped by two a-helices. The
CYP-3 structure is very highly conserved when compared with
the structure of human cyclophilin A, the best characterized
member of the family (30, 31) (Fig. 2). The root mean square
deviation is 0.55 A for the 620 corresponding C, N, Ca, and O
atoms from amino acid residues 2 to 44 and 55 to 171 in CYP-3
and residues 2 to 44 and 48 to 164 in CypA.
The active site of CYP-3 is also very similar to that found in
human CypA, all 13 residues important in binding to cyclos¬
porin A being conserved (32) (Fig. 3). The only significant
structural difference seen is in the conformation adopted by
Arg62, which places the corresponding side chain atoms 0.7 A
apart. This fits with the similar enzymatic activity and inhibi¬
tion by CsA as is found for human CypA. The very close struc¬
tural similarity of the active site region also suggests that the
possible natural cellular substrates are also similar between C.
elegans and mammals.
The Divergent loop—The most distinctive structural feature
distinguishing CypA and CYP-3 is the additional insert of 7
residues 48KSGKPLH54, which forms a protruding loop located
above the active site of CYP-3 (Fig. 4). This feature has also
been observed in the Bm-CYP-1 cyclophilin structure (33, 34)
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Fig. 3. Stereo diagram showing the active sites of CYP-3 and human cyclophilin A. This clearly shows the complete conservation of all
13 residues important in the binding of CsA, with the only significant structural difference between human CypA and CYP-3 being in the





Fig. 4. The divergent loop of C. elegans CYP-3. The two strong hydrogen bonds from the carboxylic group ofGlu83 to the amide main chain
nitrogen atoms of Lys48 and Ser49 are shown as violet. All cyclophilin homologues with additional divergent loops have a conserved glutamate.
from the filarial nematode Brugia malayi (Fig. 1). The loop is
held in place by a very specific network of hydrogen bonds from
the side chain ofGlu83. The carboxylic group ofGlu83 forms two
strong hydrogen bonds with amide main chain nitrogen atoms
of Lys48 and Ser49 (Fig. 4). All cyclophilin homologues with
additional loops (including human/bovine cyclophilin 40 and
some parasite and plant cyclophilins) have a conserved gluta¬
mate in a homologous position. Thus the role of Glu83 in these
divergent loop structures is to both lock and tether the loop into
a particular conformation. The loop provides a distinctive rec¬
ognition feature of this subfamily of cyclophilins, which may
prove to be important in protein-protein interactions.
Loop structures do however show some divergence as can be
seen on comparing the structures from CYP-3 and B. malayi.
The presence of inserts of 6-8 residues has been described
previously in a number of members of this protein family,
including many plant species (35) and is a particularly common
feature of the nematode cyclophilins, being found in 7 of the 11
characterized cyclophilins from C. elegans (18). A consensus
sequence for this additional loop based on multiple sequence
alignments is (**GK*LH).
It is interesting to note that this loop also contains part of a
conserved ATP/GTP-binding site motif A (A/G-.X4-G-K-S/T)
(36). The high degree of conservation of this inserted sequence
over diverse species suggests the loop structure and its locking
mechanism are an important functional part of the protein
whose role remains to be elucidated, rather than a neutral
addition.
Cys40
Fig. 5. A 2 F„-Fc electron density map around Cys4" and Cys168
is contoured at the 1.8<r level. The distance between the two sulfur
atoms is 5.38 A. The well defined electron density clearly shows that
both cysteine residues are present in the reduced form.
Conserved Cysteines—CYP-3 shares with all divergent loop
cyclophilins, including Bm-CYP-1, two highly conserved cys¬
teines (Fig. 1). The sulfur atoms of Cys40 and Cys168 are well
defined in the electron density and are separated by 5.38 A and
are present in the structure as reduced cysteine residues (Fig.
5). Torsion angles of the 2 residues are N-Ca-Cj3-S = 53° for
Cys168
a
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Fig. 6. Panel a, representative spectral progress curves showing ceCYP3 catalyzed acceleration of the rate of isomerization of the tetrapeptide
substrate. The uncatalyzed rate (no CYP3) is labeled A. The curve labeled B shows the catalytic effect of 20 nM ceCYP3. Inhibition of the
isomerization reaction by increasing concentrations of the cyclophilin binding drug cyclosporin A is illustrated by curves C through G. The spectral
curves were obtained following preincubation with 10, 20, 40, 60, and 100 nM CsA are shown. Inhibition of PPlase activity can clearly be seen to
increase with the amount of CsA added. Time is shown in seconds on x-axis. Panel b, the effect of increasing tetrapeptide substrate concentration
on the velocity of the reaction. The ceCYP3 concentration was held constant at 20 nM, and substrate concentration was varied from 50 to 1,000 /xM.
It was not possible to measure rates with substrate concentration above 700 /xM.
Cys168 and —72° for Cys40. The sulfur atom of Cys168 is 3.74A
away from nitrogen Ne2 of His54, 3.2 A from the carbonyl
oxygen of Cys40 and 3.5 A away from the backbone NH of Lys56.
Molecularmodeling has shown that a simple rotation about the
Ca-C/3 cysteine side chain bonds enables a disulfide bond to
form. (N-Ca-C/3-S = -167° for Cys168 and N-Cc*-Cj3-S = -134°
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for Cys40). These changes from the original staggered confor¬
mation to an alternatively favored staggered conformation re¬
sults in an S-S distance of 2.1 A, with no other short nonbonded
interatomic contacts. The role of these conserved residues is
unknown. The unexpected presence of the reduced form of
these cysteine residues suggests the intriguing possibility that
this feature may provide a signaling mechanism in response to
oxidative stress. The formation of an S-S bond in an oxidizing
environment may provide a dynamic signal inducing conforma¬
tional change(s). Alternatively, the sulfhydryl group of the
reduced Cys168 and Cys40 along with the imidazole side chains
of His54 may provide a metal ion coordination site. Interest¬
ingly, His54 (or equivalent) is conserved in all these divergent
loop cyclophilins (Fig. 1) and may also be an important part of
this putative redox signaling mechanism.
Peptidyl-Prolyl cis-trans Isomerase Activity and Its
Inhibition Activity by Cyclosporin A
Representative spectral progress curves showing the forma¬
tion of the Irans-isomer of the model substrate tetrapeptide can
be seen in Fig. 6a. CYP-3 clearly accelerates the rate of isomcr-
ization of the tetrapetide substrate relative to the uncatalyzed
thermal isomerization rate and the catalysis is inhibited by
additiuii of the cyclophilin binding drug cyclosporin A The
eliZVme reaction was found to follow Michaelis-Menten kinetics
with the velocity of the reaction (v) increasing with substrate
concentration IS1 as shown in Fig. Gb. Fiist uider rate kinetics
were nhserved and a double reciprocal LihOweaver-Burke plot
of 1/v against 1/|SJ gave values of &cat = 860 s"1, Km = 350 piM,
which couespunds Lu a value uf A.cat//Im of 2.1 X 1UC M 1 g 1-
These values are similar to the published values tor human
CypA, which has - TV.,Villi # \ Knl 870 p.M and kcat/Km ~
14.6 X 10° M 1 s 1 (24).
The spectral curves produced from the in vitro chymotryp-
sin-coupled peptide assay clearly shows CsA inhibition of llie
rate of CYP-3 catulyzed isoniuiizaliuii (Fig. Gu). A concentra¬
tion of 10 nM CsA was required to inhibit 50% of the CYP-3
PPIase activity (IC50). This value is comparable with the IC50
value of 19 nM obtained for the inhibition of human CypA by
CsA (37).
Tenipuiu.1 u,nd Spatial Expression Pattern of CYP 3
CYP 3 ropresonts one of the mwt abundantly expressed cy¬
clophilins in the nematode C. plpgnns This observation is based
hnth on the anatysis of relative transcript abundance and due
to the fact that it has been isolated 18 independent times
during the C. elegans expression sequence tag project (38). The
semi-quantitative RT-PCR analysis of the post-embryonic tem¬
poral expression pattern of cyp-3 indicates that this transcript
is most abundant during early larval development, peaking at
the second larval stage, and dropping off in later development
(Fig. 7). The spatial expression pattern ofCYP-3 was examined
by constructing a translational fusion of the promoter region
with a reporter gene and staining the transgenic nematodes for
/3-galactosidase activity. This analysis revealed a very specific
tissue localization for this highly conserved cyclophilin, being
expressed exclusively in larval stages in the single celled an
terior excretory system (Fig. 8, A and B). This reporter con¬
struct is tagged to a nuclear localization signal, hence the
specific signal is observed in largest mononucleate cell of C.
elegans, the excretory cell (39).
DISCUSSION
The x-ray structures of ceCYP3 together with sequence com¬
parisons of the cyclophilin domains allow us to clearly define a
subclass of divergent-loop cyclophilins, which have the follow¬
ing characteristics (highlighted in Fig. 1): an inserted loop
cyp-3/ama-lm
ll l2 L3 1A ADULT
STAGE
Fig. 7. Graphical representation of the semi-quantitative RT-
PCR result, illustrating the peak seen for the cyp-3 transcript in
the second larval stage. The temporal abundance of cyp-3 is ex¬
pressed as a ratio to the constitutively expressed gene ama-1.
Fig. 8. Micrograph showing the exclusive cyp-3 reporter gene
expression in C. elegans. Nuclear localized /3-galactosidase activity is
restricted to the single anterior mononuclear excretory cell. A and B
represent individual larval nematodes. Bar represents 10 /xM.
(48KSGKPLH54); an invariant glutamate (Glu83) and two un-
oxidized cysteines in close proximity (Cys40 and Cys168).
FASTA and BLAST searches of the available protein sequences
(40, 41) using the consensus addition loop sequence GIGKSGK-
PLHFKG identified 50 related sequences, ofwhich only 4 were
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not divergent-loop cyclophilins. In each case, those cyclophilins
that contained the loop sequence were found to contain two
cysteines corresponding to Cys40 and Cys168 of CYP-3 and also
Glu83. Conversely, cyclophilins that do not have the additional
loop have only one of the cysteine residues and also lack Glu83.
Our survey of cyclophilin sequences shows that plant cyclophi¬
lins in particular commonly contain the additional loop and
concomitant pair of cysteine residues and some of these pro¬
teins have been linked to stress responses. For example Sola¬
rium commersonii significantly increases the production of sc-
CyP under several forms of abiotic stress including cold shock,
salicylic acid, and abscisic acid (42).
There may be a general link between cyclophilins and a
cellular stress response as suggested by the association of hu¬
man CypA with the thiol-specific antioxidant protein Aopl (43).
This activity is stimulated by the interaction between Aopl
with CypA and is not inhibited by CsA. One mechanism for the
control of oxidative stress in bacteria is by the protein OxyR,
which is activated by the formation of an intramolecular disul¬
fide bond (44). A similar mechanism has been proposed for the
activation of the Hsp33 chaperone protein, which is also redox
regulated (45). Oxidation of Hsp33 by hydrogen peroxide
causes disulfide bond formation, release of bound zinc, and
activation of the chaperone activity of Hsp33.
The x-ray structures of CYP-3 described in this paper and
the structure of CYP-1 from B. malayi (33, 34), another mem¬
ber of the divergent-loop subclass of cyclophilins, both show the
invariant conserved cysteine residues in the reduced form.
Furthermore, His54, which is incorporated in the divergent
loop, is located 3.6 A from the sulfhydryl group of Cys168. The
arrangement of two cysteines and a histidine provides a suit¬
able coordination for zinc. A very similar coordination geometry
involving two cysteines and a histidine is present in the x-ray
structure of a zinc complex of alcohol dehydrogenase (46). We
suggest that the arrangement of cysteines and histidines,
uniquely and invariantly present in this newly defined diver¬
gent-loop subclass, are likely to be involved in either metal
coordination or in a redox-signaling process triggered by the
formation of a Cys40 to Cys168 disulfide bond.
The entire genome of C. elegans has now been sequenced
(38), and sequence searches show that there are a total of 14 C.
elegans proteins that contain a cyclophilin-like domain. Three
of these (CYP-3, CYP-2, and CYP-7) are single domain proteins
with high sequence similarity to human cyclophilin A. It has
been hypothesized (18) that the large number of CYP isoforms
seen in C. elegans might be reflective of regulatory flexibility,
providing interchangeable functions in different cell types, cel¬
lular compartments, or organelles. The expression pattern seen
for the cyp-3 transcript may correlate with a peak in the
amount of newly synthesized structural proteins produced by
the developing larvae. The exclusive excretory cell expression
pattern is also intriguing. The excretory system in C. elegans is
'nvolved in osmoregulation and secretion (39). The role in os-
oregulation is supported by gland cell laser ablation experi-
ents, which result in worms becoming bloated and dying in
ypotonic medium (47). The importance of excretory system in
ecretion is well established for parasitic nematodes, where it
s the source of surface coat antigens for parasites such as
'oxocara canis (48, 49). A role for CYP-3 in osmoregulation or
'•ecretion, however, remains to be established.
These expression pattern analyses coupled with the struc-
,ural observations defining the new divergent-loop subgroup
f cyclophilins, suggest that these cyclophilins may be in¬
volved in cellular responses to stress caused by changes in
the redox environment or by periods of high cellular activity.
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Experimental Section
A series of Mo/HZSM-5 catalysts were prepared as described in ref. [4b].
HZSM-5 powders were impregnated with aqueous solutions contain¬
ing a given amount of ammonia heptamolybdate (AHM), then dried
at RT and 373 K for 12 and 8 h, respectively. After calcined at 773 K
for 5 h, the catalysts were crushed and sieved to yield granules of 20-60
mesh.
A specially designed device was built for the MAS NMR study. It contains a
gas flow section, a reaction and sample preparation section, and an on-line
mass spectrometer (Figure 1). After the reaction (the temperature can be
as high as 1123 K), the reaction and sample preparation section can be
taken off and turned through 90°. Then, in the reaction atmosphere the
sample can be transferred into a NMR-rotor with the aid of a tamper (to
pack the sample into the tube) that is mounted in a bellows attatched to the
upper side of the flange. The rotor is then sealed with a cap in a rack with
the aid of tamper. A spin rate as high as 12 kHz can be reached following
this sample filling method. In the present case, the samples were treated
with a methane flow (SV = 1500 mLg"1 h~\ 1 atm) for 1 h at 573, 673, and
873 K. Subsequently, the catalysts were subjected to reactions of 10 min,
0.5 h, 1 h, 3 h, and 6 h. In all the cases, the temperature was raised at a rate
of 15°Cmin"1.
Proton MAS NMR spectra were recorded in 4 mm Zr02 rotors at
400.13 MHz on a Bruker DRX-400 spectrometer fitted with a MAS probe.
For each spectrum, a ji/10 pulse and a 4 s relaxation delay were used, and
400 scans were accumulated. Samples were spun at 8 kHz, and the DSS
(DSS = sodium 4,4-dimethyl-4-silapentane sulfonate) signal was taken as
the reference for the 'H chemical shifts. The deconvolution of the spectra
was conducted using WINNMR, supplied by the spectrometer manufac¬
turer.
Received: March 9, 2000 [Z14824]
[1] a) Y. Ono, Catal. Rev. Sci. Eng. 1992, 34, 179; b) P. Meriaudeau, C.
Naccache, Catal. Rev. Sci. Eng. 1997, 39, 5.
[2] G. Buckles, G.J. Hutchings, C. D. Williams, Catal. Lett. 1991, 11,
89.
[3] L. Wang, L. Tan, M. Xie, G. Xu, J. Huang, Y. Xu, Catal. Lett. 1993, 21,
35.
[4] a) Y. Xu, S. Liu, L. Wang, M. Xie, X. Guo, Catal. Lett. 1995,30,135; W.
Liu, Y. Xu, J. Catal. 1999, 185, 386; b) Y. Shu, Y. Xu, S.-T. Wong, L.
Wang, X. Guo,7. Catal. 1997,170,11; c) D. Wang, J. H. Lunsford, M. P.
Rosynek, J. Catal. 1997, 169, 347; d) B. M. Weckhuygsen, D. Wang,
M. P. Rosynek, J. H. Lunsford, Angew. Chem. 1997,109, 2471; Angew.
Chem. Int. Ed. Engl. 1997,36,2374; e) S. Liu, L. Wang, R. Ohnishi, M.
Ichikawa,/. Catal. 1999,181,175; f) F. Solymosi, J. Cserenyi, A. Szoke,
T. Bansagi, A.Oszko, J. Catal. 1997,165,150; g) F. Solymosi, L. Bugyi,
A. Oszko, Catal. Lett. 1999, 57, 103.
[5] H. Ernst, D. Freude, T. Mildner, I. Wolf, Stud. Surf. Sci. Catal. 1995, 94,
413; T. Mildner, D. Freude, J. Catal. 1998,178, 309.
[6] M. Hunger, T. Horvath, J. Chem. Soc. Chem. Commum. 1995, 1423;
M. Hunger, M. Seiler, T. Horvath, Catal. Lett. 1999, 57, 199; P. K.
Isbester, A. Zalusky, D. H. Lewis, M. C. Douskey, M. J. Pomije, K. R.
Mann, J. Munson, Catal. Today 1999, 49, 363.
[7] E. MacNamara, D. Raftery, J. Catal. 1998, 175, 135.
[8] J. F. Haw, B. R. Richardson, I. S. Oshiro, N. D. Lazo, J. S. Speed,/. Am.
Chem. Soc. 1989, 111, 2052; J. Munson, J. F. Haw, J. Am. Chem. Soc.
1991, 113, 6303; J. Munson, D. Murray, J. F. Haw, J. Catal. 1993, 141,
733; J. F. Haw, T. Xu, J. B. Nicholas, P. W. Goguen, Nature 1997, 389,
23; J. F. Haw, P. W. Goguen, T. Xu, T. W. Skloss, W. Song, Z. Wang,
Angew. Chem. 1998, 110,1001-1005; Angew. Chem. Int. Ed. 1998,37,
948.
[9] M. Hunger, Catal. Rev. Sci. Eng. 1997, 39, 345.
[10] M. Hunger, D. Freude, H. Pfeifer, J. Chem. Soc. Faraday Trans. 1991,
87, 657.
[11] V. R. Choudhary, A. K. Kinage, T. V. Choudhary, Science 1997, 275,
1286.
[12] In the TPSR (temperature program surface reaction) profile of this
reaction (detected by the on-line mass spectrometer) water was shown
to be produced when the temperature reached 973 K, with a
maximum at about 13 min after the reaction began. Two minutes
later (15 min after the start of the reaction) the start of benzene
formation is observed. The formation of water stopped about 1 h later
at the same temperature, but that of benzene increases slowly in the
first hour, and then appears to be constant. This indicates that the
water formation is a stoichiometric (not catalytic) reaction [see
Eq. (1)], where as benzene formation is a catalytic reaction.
[13] C. C. Liu, G. E. Maciel, Anal. Chem. 1996, 68, 1401.
First Crystal Structure of a Medicinally
Relevant Gold Protein Complex: Unexpected
Binding of [Au(PEt3)]+ to Histidine**
Juan Zou, Paul Taylor, Jacqueline Dornan,
Stephen P. Robinson, Malcolm D. Walkinshaw,* and
Peter J. Sadler*
Antiarthritic gold(i) compounds such as the injectable drugs
aurothiomalate'1' (Myochrysine) and aurothioglucose (Solga-
nol),'2' and the oral drug131 [Au'(PEt3) (2,3,4,6-tetra-O-acetyl-
/3-D-thioglucose-S)] (auranofin) are "prodrugs", which under¬
go facile ligand displacement reactions.'4-51 The critical target
sites are thought to be thiolate sulfurs (cysteine residues) in
proteins and enzymes,'51 Au1 being a very "soft" (class 'b')
metal ion.'6-71 However, there is a lack of structural data on
adducts of antiarthritic Au1 complexes with proteins.'8' We
report here investigations of reactions between the enzyme
cyclophilin and the antiarthritic complex'7-10' [Au(PEt3)Cl]
(1), and the first X-ray crystal structure of a protein adduct
with a Au' phosphane complex. Unexpectedly, in cyclophilin
crystals, Au1 binds to the nitrogen atom of an active site His
residue, despite the presence of four Cys thiol groups. The
results have implications for understanding the biological
chemistry of gold antiarthritic complexes. Additional interest
in this work arises from the need for site-specific heavy-atom
reagents for X-ray crystallography.I8'
[*] Prof. Dr. M. D. Walkinshaw, Dr. P. Taylor, J. Dornan, S. P. Robinson
Institute of Cell and Molecular Biology
Michael Swann Building
The University of Edinburgh, King's Buildings
West Mains Road, Edinburgh EH9 3JR (UK)
Fax: (+44)131-650-7055
E-mail: M.Walkinshaw@ed.ac.uk
Prof. Dr. P. J. Sadler, Dr. J. Zou
Department of Chemistry
The University of Edinburgh, King's Buildings
West Mains Road, Edinburgh EH9 3JJ (UK)
Fax: (+44)131-650-6452
E-mail: P.J.Sadler@ed.ac.uk
[**] We thank the Wellcome Trust (Fellowship for J.Z.), BBSRC, CLRC,
and EPSRC for their support for this work, Dr. Adam Gouldsworthy
and Mr. Mark Scott (Edinburgh Centre for Protein Technology) for
their assistance with LC-ESI-MS, Drs. George Kontopidis, Su-ying
Wu, and Hongzhe Sun for their valuable suggestions, discussion, and
technical assistance.
jQ Supporting information for this article is available on the WWW under
http://www.wiley-vch.de/home/angewandte/ or from the author.
2931Angew. Chem. Int. Ed. 2000, 39, No. 16 © WILEY-VCH Verlag GmbH, D-69451 Weinheim, 2000 1433-7851/00/3916-2931 $ 17.50+.50/0
COMMUNICATIONS
Cyclophilins are ubiquitous proteins involved in protein
folding, transport, and assembly, and are linked to general
cellular stress responses.'"1 They are peptidyl prolyl isomerase
(PPIase) enzymes, and cyclophilin A (an immunophilin) is the
major intracellular receptor for the immunosuppressive drug,
cyclosporin A (CsA). We chose cyclophilin-3 (Cyp-3, one of
the most abundantly expressed cyclophilin isoforms in the
free living nematode Caenorhabditis elegans) for study, since
it has a known X-ray structure'12' and possesses four free Cys
thiol groups which are potential Au1 target sites.
First the reaction between Cyp-3 and 1 was studied in
solution by mass spectrometry. For a molar ratio of Cyp-3:1 of
1:3.5, the sample after one day revealed three new peaks with
masses of 18612.0 u (calcd 18615.5 u), 18736.8 u (calcd
18733.6 u), and 18932.9 u (calcd 18930.6 u), corresponding
to {Cyp-3 + Auj, (Cyp-3 + [AuPEt3]}, and {Cyp-3 + Au +
[AuPEt-,]}, respectively (Figure 1). For a molar ratio Cyp-3:1













Figure 1. LC-ESI-MS of Cyp-3 (13.5 (im) after incubation with 1 (47.3 pM)
for 24 h at 291 K. The peaks correspond to Cyp-3 (18417.4 u, theoretical
mass: 18419.2u); {Cyp-3 + Au) (18612.0 u, theoretical mass: 18615.5 u);
(Cyp-3 + [Au(PEt,)]) (18736.8 u, theoretical mass: 18733.6 u); (Cyp-3+
Au + (Au(PEt,)]) (18932.9 u, theoretical mass: 18930.6 u).
Cyp-3 and {Cyp-3 + [AuPEt3]J had disappeared, peaks for
{Cyp-3+ Au) (18618.8 u), and {Cyp-3 + Au + [AuPEt3]}
(18930.8 u, major peak) were still detectable, and new peaks
appeared at 19242.5 u corresponding to {Cyp-3+ Au +
2[AuPEt3]) (calcd 19245.7 u) and 18812.8 u corresponding
to {Cyp-3+ 2Au| (calcd 18812.4 u). These results appeared to
be consistent with chloride displacement and [AuPEt3]+
binding to the protein, followed by PEt3 displacement (and
oxidation to OPEt3). Such a displacement might be facile in
the region of Cys 40 and Cys 168 (highly conserved in all
divergent loop cyclophilins) since their sulfur atoms are within
5.5 A and could readily provide linear S-Au-S coordination
for Au1.
Reactions of Cyp-3 with the disulfide 5,5'-dithio-bis(2-
nitrobenzoic acid (DTNB) also suggested that all four Cys
thiol groups are accessible. By UV/Vis spectroscopy, the
average thiol content of Cyp-3 was determined to be 4.2 mol
thiol permol Cyp-3. The reaction was also investigated by LC-
ESI-MS. The chromatographic peak for Cyp-3 alone corre¬
sponded to a mass of 18418.5 u (mean value, theoretical mass
18419.2 u).'13' This peak disappeared after reaction of Cyp-3
with DTNB, and the major new chromatographic peak had a
mass of 19210.6 u (Figure 2), corresponding to {Cyp-3+
2DTNB) (i.e. 4xl/2DTNB, calcd: 19211.2 u). This implies
that all four Cys thiol groups form mixed disulfides with
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Figure 2. LC-ESI-MS of Cyp-3 after reaction with excess DTNB. The
major peak (19210.6 u) corresponds to four half DTNB species bound to
Cyp-3, that is all four Cys residues blocked as mixed disulfides (theoretical
mass 19211.2 u).
To identify the gold coordination sites, we treated single
crystals of Cyp-3 with complex 1 for periods of 0.42, 2, 4, 6 h,
and two weeks. The crystals were then frozen and examined
by X-ray diffraction. All crystals soaked with 1 changed their
appearance. They became cracked and lost their sharply
defined edges. A crystal structure determined after 0.42 h
soaking did not show the presence of gold in the calculated
electron density map, and after soaking for 6 h did not diffract
at all. After samples had been soaked for two weeks, cracking
was severe. The electron density map from crystals soaked for
2 or 4 h contained a large peak corresponding to a single gold
site (Figure 3). The structure was solved by using isoinorphous
replacement since that of unliganded Cyp-3 is known.'12' In
the first difference map, Au was clearly seen together with
additional electron density in the region expected for a ligand
trans to Hisl33 Ne2. This was interpretable as PEt3 as
indicated by the shape of the electron density. The structure
was refined with SHELXL97'14' using 20154 unique data (5%
for the calculation of R(rcc) and initial constraints on the Au—N
and Au-P bond lengths of 2.05 and 2.27 A, respectively,
values similar to those in crystalline [Au(2-isopropylimidazo-
le)(Pcy3)]'15' and [Au(phthalimido)(PEt3)]'16l. The final R
factor was 18.48% and Rfrcc 24.68%.
Surprisingly, the gold ion was not bonded to a Cys sulfur
atom, but instead to the Ne2 nitrogen atom of His 133 (Au—N
2.06 A) and to PEt3 (Au—P 2.27 A). The linear geometry (N-
Au-P angle 167.7°) is characteristic of Au1. The temperature
factors for the complex (Ne2 13.86, Au 43.77, P 79.45, C(av)
74.96) suggest that the PEt3 group is undergoing rotational
motion.
Of the four His residues in Cyp-3, the imidazole rings of
only His 54 and His 133 are solvent accessible, both in a
solvent channel running between two Cyp-3 molecules related
by a twofold screw axis parallel to the b axis. Cys 168 also
appears to be readily accessible and the sulfur atom of Cys 163
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Figure 3. Top: Refined structure of the gold binding site in Cyp-3, showing His 133 bound to PEt3. The
2F0 — Fc electron density map is contoured at 1.75a. The lack of definition of the PEt3 ligand is probably
due to rotational disorder. Bottom: Stereoview of Cyp-3 after reaction with 1 showing the S atoms of the
four Cys residues (light spheres: Cys40 (top left), Cysl68 (top right), Cysl22 (bottom left), Cysl63
(bottom right)) and [AuPEt3]+ bound to the Ns2 center of His 133. Drawn using Bobscript,'26'
MolScript,!27! and Raster3D.'28l
Au1 has a moderate affinity for N
ligands in low molecular mass com¬
plexes,1'91 but a much higher affinity
for thiolate groups. Hence a Cys-S
atom is much more effective than an
imidazole-N atom in displacing the
CF ion from complex 1 in aqueous
solution.1201 Complex 1 forms ad-
ducts with His residues of serum
albumin only after the thiolate S
atom at Cys 34 has been saturated
with Au1, first as the raono-
adduct Cys34-S-(AuPEt3), and
then as a bisadduct Cys34-S-
(AuPEt3)2.12,4'21'221 Such a bisadduct
could also form with Cyp-3 in the
presence of excess 1.
This appears to be the first X-ray
structural characterization of an ad-
duct of a gold-phosphane complex
with a His residue in a protein.181
Previously it was suggested1231 that
Au'-His interactions are responsi¬
ble for the ability of complex 1 to
induce low-spin- to high-spin-state
transitions of heme proteins such as
cytochrome c, but direct structural
evidence for this was not obtainable.
The present results confirm that His
imidazole rings can indeed be target
sites for [AuPEt3]+ binding in pro¬
teins.
is visible from the protein surface, but these sites may not be
able to accommodate [AuPEt3]+ without severe structural
distortions and disruption of the crystal.
Gold binding at His 133 should inhibit Cyp-3 since this is an
active-site residue, and this was found to be the case. A
chymotrypsin-coupled assay1"1 of the isomerization of the
tetrapeptide substrate Suc-Ala-Ala-Pro-Phe-p-nitroanilide
(Bachem) showed that the concentration of 1 required to
inhibit 50% of Cyp-3 PPIase activity was 14 nM (Figure 4), a
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Figure 4. Variation of the observed rate constant for PPIase activity of
Cyp-3 with increasing concentration of 1. An IC50 value of 14 nM was
calculated from this curve.
Experimental Section
[Au(PEt3)Cl] (1) was purchased from Strem Chemicals and Alfa-Johnson
Matthey pic. Cyclophilin-3 (Cyp-3) was expressed and purified as described
previously.'12!
ESI-HPLC-MS: Cyp-3 in Tris buffer (10 mM; pH 7.3), or in HEPES buffer
(20 mM; pH 7.0), was treated with complex 1 (3.5 or 7 molar equivalents of
a 2.5 mM stock solution in ethanol or methanol, diluted to 150 mM with
buffer before use), and incubated for 1 - 5 days at 291 K. Prior to ESI-MS,
the protein was desalted, separated from free gold complex on a
Phenomenex (Jupiter) C18 reverse-phase column, and eluted with H20/
acetonitrile/TFA (0.05% v/v). Positive-ion electrospray mass spectrometry
was performed on a Platform II instrument (Micromass), with source
temperature of 413 K and data acquisition in continuum mode, scan rate
900 us-1. The data were processed with a Mass Lynx (version 2.3) Windows
NT PC data system using a maximum entropy software algorithm. Mass
accuracy was within 0.1 m/z unit.
Determination of free SH groups: Cyp-3 (14.0 pM, concentration deter¬
mined by Bradford assay) was incubated with DTNB (5 mM) in HEPES
buffer (20 mM; pH 7.0) for 30 min at 291 K, and the absorption was
measured at 412 nm.'24-
Crystallization, Au1 soaking, and data collection: Tetragonal crystals of
Cyp-3 were grown using the hanging-drop vapour diffusion method: Cyp-3
(16 mgmL"1) in sodium citrate (50 mM; pH 5.6), 16-17.5% wt/v methoxy-
polyethylene glycol 5000 (MPEG 5000) (4 pL) suspended over sodium
citrate (100 mM), 32-35% MPEG5000 at 291 K. Average crystal dimen¬
sions: 0.5 x 0.4 x 0.4 mm. For crystal soaking, an aliquot of a stock solution
of 1 in DMSO was diluted with sodium citrate (100 mM) containing 33-
35% MPEG 5000, pH 5.6, giving a final Au1 concentration of 3.5 mM with
5 % DMSO present. The stock solution of 1 in DMSO gave rise to only one
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31P{,H} NMR peak at <5 = 34.5 when monitored over a period of one month,
showing that the Au-P bond is stable under these conditions. Crystals were
transferred from hanging drops with 0.4-0.5 mm cryoloops into cryopro-
tectant solution (3 pL, mother liquor plus 20% glycerol), and 5 s after
removal from cryoprotectant were mounted in a cryoloop (Hampton
Research) and flash frozen in liquid N2. X-ray data were collected at 100 K
(Oxford Cryosystems) using MAR image plates at the Daresbury
synchrotron source, and processed using DENZO. The data set consists
of 185907 measured reflections and provides a unique data set of 20154
reflections with an Rmcrge = 0.068 and an overall completeness to 1.85 A of
0.983. Rmcigc in the 1.88-1.85 A resolution shell is 0.253.
PPIase assay: Cyp-3 was incubated with 1 at 277 K at molar ratios of 1:
Cyp-3: of 0, 0.43, 0.86, 1.0, 2.0, 3.5, 5.0, 7.0, and 10.0, for 48 h in HEPES
buffer (50 itim) containing NaCl (86 itim), pH 8.0, and 4 pL aliquots were
then assayed at 275 K following the procedure previously described.[121
ESI-MS spectra of Cyp-3 after reaction with Et3PAuCl (1) for five days , a
colour version of Figure 3, and plots of absorbance versus time for assay of
the PPIase activity of Cyp-3 are available in the Supporting Information.
The atomic coordinates (code 1E3B) have been deposited in the Protein
Data Bank, Research Collaboratory for Structural Bioinformatics, Rutgers
University, New Brunswick, NJ (http://www.rcsb.org/).
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DeNO* of Exhaust Gas from Lean-Burn
Engines through Reversible Adsorption of
N203 in Alkali Metal Cation Exchanged
Faujasite-Type Zeolites**
Asima Sultana, Raf Loenders, Orietta Monticelli,
Christine Kirschhock, Pierre A. Jacobs, and
Johan A. Martens*
Nitrogen oxide (NOJ adsorbents are key control compo¬
nents for the tailpipe emissions of transport vehicles powered
with lean-burn engines. Current adsorbents are basic oxides
which adsorb NO, as nitrates, but suffer from poisoning by
sulfur oxides. We discovered that NO and NOz can be
selectively trapped as dinitrogen trioxide in alkali metal
exchanged faujasite zeolites above 200°C. The trapped N2Oj
molecules compete with water molecules on a specific
adsorption site and can be displaced by a change in partial
pressure. Dinitrogen trioxide adsorption is not affected by the
presence of sulfur oxides.
Modern lean-burn internal combustion engines operated
with excess air show reduced fuel consumption and carbon
dioxide emission but produce excessive amounts of nitrogen
oxides (NO,). The emission of NO, at the tailpipe is the major
source of pollution from transport vehicles powered by
hydrocarbon fuels.'11 Since there is a trade-off between NO,
and particulate carbon formation in the lean-burn engine, an
efficient NO,-elimination system for the exhaust can offer a
solution to the particulate carbon emissions at the same
time.121 In the emerging technologies that focus on reducing
the NO, emission from lean-burn engines, temporary storage
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Figure 4. Molecular orbital energy level diagrams and singly occupied
molecular orbitals (SOMOs) for a) the singlet state of pair B and b) the
triplet state of pair B as obtained from the UB3LYP/6-31G* method.
OE = orbital energy.
Table 1. Becke3LYP/6-31G* energies and (S2) values for the singlet and
triplet states for pair B.
Spin state HF energy (UB + HF-LYP) [hartree] <S2)
singlet -2756.15237298 0.3394
triplet -2756.15211899 2.0013
DFT calculations.'93, d-111 The coupling constant 2/ was eval¬
uated by calculating the spin-projected energy difference
between the singlet and triplet states. The obtained 2J value of
— 45 cm-1 compares well with the experimental value of
— 77 cm-1.
In summary, we have succeeded for the first time in
determining the intermolecular exchange coupling for the
light-induced RP in a crystal of o-Cl-HABI. This study shows
that DFT methods can provide an accurate description even
for the through-space coupling in RPs. A combination study
of X-ray diffraction and DFT calculations for the light-
induced RPs in HABI derivatives will lead to a better
understanding of radical-pair chemistry and solid-state reac¬
tions.
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The First Direct Determination of a Ligand
Binding Constant in Protein Crystals
Su-ying Wu, Jacqueline Dornan, George Kontopidis,
Paul Taylor, and Malcolm D. Walkinshaw*
In the field of protein-ligand interactions there have been
many recent attempts to predict protein-ligand dissociation
constants by correlating solution binding measurements with
structural features from series of protein-ligand crystal
complexes.11"61 Indeed the whole structure-based design ap¬
proach relies on the assumption that the thermodynamics of
binding and the structures of bound ligands in the crystal will
be similar to those in the biological environment. The results
presented herein provide the first evidence that this is indeed
the case.
Cyclophilins provide a good template for the study of ligand
binding as there is relatively little change in their backbone
conformation on binding.171 To date the only structural data on
ligand complexes is for cyclosporin derivatives or proline-
containing peptides.18"101 The isoform cyclophilin 3 from
Caenorhabditis elegans (ceCyp3) was selected as the template
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for this binding study because of the availability of high
symmetry, well-diffracting crystals which were amenable to
ligand-soaking experiments. The enzymatic properties and the
X-ray structure of the free form have been described.111!
Solution binding and inhibition of ceCyp3 by the Ala-Pro
ligand was measured by its ability to inhibit peptidylprolyl
isomerase (PPIase) activity. The peptidylprolyl imide bond
can adopt cis and trans conformations and the assay depends
on the fact that chymotrypsin can only cleave the imide bond
of the chromogenic prolyl substrate when it is in the trans
conformation. The PPIase activity of cyclophilins catalyzes
the rotation about this imide bond, thus speeding up the rate
at which the cis-trans equilibrium is reached.la 131 Ala-Pro
acts as a weak inhibitor of the PPIase activity, with a measured
Kd value of 23.3 mM (Figure 1).
To measure the binding constant of the Ala-Pro ligand in
the crystal a series of native ceCyp3 crystals were equilibrated
against different concentrations of ligand (1.2-120 mM) and
the individual X-ray structures refined. X-ray refinement
statistics for the structures are given in Table 1. The refined
structure of the crystal soaked in 120 mM Ala-Pro shows a
well-defined ligand structure with seven hydrogen bonds
involved in the ligand-protein binding (Figure 2 b). The
guanidino group of Arg62 adopts a very different orientation
to that in the native structure and displaces water molecule
Wd which is present in the native structure (Figure 2 a). A
further three water molecules (Wa, Wb, and Wc) present in the
native structure are also displaced by the Ala-Pro ligand. All
other residues around the binding site, with the exception of
Arg62, adopt an identical conformation to that found in the
native structure.
The (2Fo-Fc) electron density maps around the binding site
of ceCyp3 complexed with different concentrations of Ala-
Pro provide a graphic illustration of the conversion of the
native to the ligand-bound structure (Figures 3a-g). The
crystal soaked in a 120 mM solution of the ligand (Figure 3g)
and the native crystal (Figure 3 a) provide pictures of the two
extremes. The five structures soaked with intermediate
a)




Figure 1. a) Inhibition of PPIase activity of ceCyp3 with increasing
concentrations of Ala-Pro. Absorbance values were collected every 0.1 s
over 2 min. The protein concentration was 20 nM and concentrations of
Ala-Pro ranging between 0 and 60 mM were added, b) Determination of
the Kd value for PPIase inhibition of ceCyp3 by Ala-Pro. Initial velocities
from Figure 1 a were used to determine kobsd (kohsd = v/[S]), where v is the
velocity and [S] is the substrate concentration.'151 A plot of kobsd against
inhibitor concentration gives an Ala-Pro concentration of 23.3 mM for 50%
inhibition. This IC50 value can be taken as an estimate for Kd by using Kd =
[E][L]/[EL] and at 50% inhibition [E] = [EL] = 0.5[E]T (where [Eq-] = total
protein concentration, [E] = free protein concentration, [L] = free ligand
concentration, and [EL] = protein concentration bound to ligand). With a
large excess of ligand, the assumption [L]50% = [L]«[L]r can be made. At
the point at which half maximal inhibition occurs [EL] = [E] and Kd = [L]-p
Table 1. Crystallographic statistics of the seven ceCyp3 structures.'31
Data collection statistics Native 1.2 mM Ala-Pro 6 mM Ala-Pro 18 mM Ala-Pro 36 mM Ala-Pro 60 mM Ala-Pro 120 mM Ala-Pro
space group, P41212 a = b = 60.60 A a = b = 60.87 A a = b = 60.74 A a = b = 61.03 A a = 6 = 61.42 A a = 6 = 61.05 A a = 6 =61.03 A
c = 123.1 A c = 122.99 A c = 122.72 A c = 122.7 A c = 122.47 A c = 122.67 A c = 122.66 A
a=(S = y = 90° a=f} = y = 90° a=P = y = 90° a=p = y = 90° a=ft = y = 90° a = p = y = 90° a=P=y—90°
resolution range 20-1.8 A 25-2.1 A 25-2.0 A 20-1.9 A 20-1.9 A 25-2.0 A 20-1.9 A
number of reflections 145422 165474 189319 146663 224150 270345 152448
measured
number of unique 22053 14262 16311 19030 19185 16443 19230
reflections
completeness 97.0% 98.9% 99.7% 98.6% 99.5% 95.8% 97.6%
multiplicity 6.59 11.60 11.60 7.70 11.60 16.44 7.92
Emerge ( outer shell ) 8.3% (27.8%) 9.9% (36.2%) 8.1% (31.5%) 6.7% (34.6%) 7.2% (31.3%) 7.1% (33.2%) 7.9% (33.2%)
Ho(I) (outer shell) 11.7 (2.60) 12.50 (3.36) 14.88 (3.62) 13.88 (2.34) 14.89 (2.90) 14.44 (2.09) 12.85 (2.13)
Klina! (F > 4a) 20.81% (19.69%) 17.65% (16.52%) 18.08% (17.09%) 20.93% (19.44%) 19.49% (18.32%) 22.56% (19.95%) 18.26% (17.3%)
Ffrcc (F>4CT) 28.47% (26.61%) 25.94% (24.97%) 26.57% (24.45%) 29.58% (27.20%) 26.84% (24.62%) 29.16% (26.37%) 25.05% (23.77%)
rms deviations from ideal geometry
bond lengths [A] 0.031 0.030 0.030 0.030 0.031 0.030 0.030
angle distance [A] 0.026 0.027 0.027 0.027 0.027 0.025 0.028
mean B-factor [A2] 30.37 33.70 31.93 32.73 30.95 35.84 31.36
[a] Rmcrge = 2h | / — (/) | /Zh | /1, where (/) is the mean intensity of all observations of reflection h = hkl, o{I) is the standard deviation of the measured intensity, and /?frcc
is calculated with 5% of the data omitted from refinement for cross-validation.












Figure 2. Active site of the structures with and without ligand. a) Stereoview of the active site
of native (free) ceCyp3. The four water molecules in the active site (Wa-Wd) are coloured
light gray. The side chain of Arg62 adopts a different conformation on ligand binding and is
highlighted, b) Stereview of the active site of ceCyp3 after soaking in a 120 mM solution of
Ala-Pro. The seven hydrogen bonds formed by the ligand to N/Asnl09, NH2/Arg62, We, O/





concentrations of Ala-Pro can be refined as mixtures of these
two extreme structures. For example, the electron density
maps of the crystals obtained in 18 mM and 36 mM solutions of
the ligand (Figures 3d, e) show electron density that can
clearly be interpreted as a mixture of the ligand-bound and
free structures. The partial occupancy of the ligand (<2i) is
defined as the fraction of the protein molecules in the crystal
occupied by the Ala-Pro ligand. Q„ is the fraction of protein
molecules in the crystal in the native (free) state. As each
molecule in the crystal must be in one of these states then
Qn + Qi = l- With this simple two-state model, occupancies
can be constrained in the following way. The occupancy of the
ligand (£?,) is the same as the occupancy of the Arg62(1) in its
ligand-bound conformation while the occupancy of the native
Figure 3. Difference electron density maps of crystals soaked with increasing ligand
concentration. The (2Fo-Fc) maps highlighting the ligand, Arg62, and water molecules in
the active site are contoured at 1.5 sigma using the program O.I'6' a) The native ceCyp3
structure shows the density of the water molecules, b) and c) The crystals were soaked in
1.2 mM and 6 mM Ala-Pro, respectively. The electron density contoured at 1.5 sigma looks
almost identical to the native structure, d) and e) The crystals were soaked in 18 mM and
36 mM Ala-Pro, respectively, and can be clearly interpreted as having features of both the
native (light gray) and ligand-bound (black) forms, f) and g) The crystals were soaked in 60
and 120 mM Ala-Pro, respectively. The electron density contoured at 1.5 sigma shows only
features corresponding with the fully ligand-bound form.
%-s
V
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structure (Q„) is the occupancy of Arg62(n) in the native
conformation, which must be the same as the occupancy of the
water molecules Wa, Wb, Wc, and Wd. These occupancy
constraints can be conveniently applied using the refinement
programme SHELX97,'14' and the fractional occupancies
refined. The occupancy is in fact only one parameter: (?,=
1 - Q„.
By regarding the crystal soaking experiment as a simple
equilibrium in which each protein molecule in the crystal
lattice can be bound or free, the fractional occupancy can be
related to the dissociation constant in the following way:
[PL] —► [P] + [L]
Xcd = [P][L]/[PL]




Kcd = [[P]to.al(1 - G,))[L]/[P]cotal <2, = (1- e,)[L]/Q,
<2,/Qn = [L]//Ccd
where
Kqi1 is the crystal dissociation constant, [P] is the concen¬
tration of free protein, [L] is the concentration of the ligand (it
is assumed that the concentration of ligand in the 10 pL drop
is constant throughout the soaking experiment), [PL] is the
concentration of protein with ligand, [P]totai is the total
concentration of protein, is the occupancy of ligand
(fraction of the protein sites in the crystal occupied by
ligand), Q„ is the fraction of the protein sites in the free state
(=(i-e,)).
A value of 26.8 mM was obtained for Xcd as calculated from
the slope of the plot of (QJQ„) versus [L] (Figure 4b). This
value is in close agreement with the inhibition constant of
23.3 mM measured for the Ala-Pro ligand in solution using the
PPIase assay. It is noteworthy that the quality and information
content of the X-ray data is sufficient to accurately refine the
partial occupancy of the ligand-bound structures even when
visual inspection of the electron density maps suggests the
electron density is dominated by one of the (native or ligand-
bound) forms. In general, interpreting a structure with such
low partial occupancy would be almost impossible using
conventional map-fitting methods without a well-refined
native structure being available. Indeed inspection of the
series of electron density maps shown in Figure 3 suggests
that, without prior knowledge, side-chain conformations with
occupancies less than about 20% would not be readily
apparent in electron density maps.
In protein-ligand complexes it can frequently be difficult
to distinguish water molecules or disordered water molecules
from a weakly bound ligand. A helpful feature of this system
is the movement of the Arg62 side chain on ligand binding, as
this gives an excellent double-check on the ligand occupancy.
In a separate experiment we also showed that diffusion and
binding of the ligand in this system took place on a timescale
of seconds. A crystal soaked in 120 mM ligand solution for
60 seconds was flash frozen and the refined structure shown to
be identical to that from a crystal soaked for 17 hours. The
kinetics of ligand-protein binding is likely to vary somewhat
from crystal to crystal depending on the crystal packing,






Figure 4. a) Refined occupancy for the seven different crystal structures.
Each point on the curve represents the occupancy of the Ala-Pro ligand as
determined from an X-ray refinement of a crystal soaked in a given
concentration of Ala-Pro.'17! The ligand concentrations used in the soaking
experiments were 0, 1.2, 6, 18, 36, 60, and 120 mM. The corresponding
occupancies obtained from crystallographic refinement were 0, 0.155,
0.238, 0.424, 0.613, 0.705, and 0.812. b) Plot of ligand concentration against
Q\IQn- Q\- occupancy of ligand (fraction of the protein sites in the crystal
occupied by ligand), Qn: fraction of the protein sites in the free state
(=(1 — Q\)). The ligand occupancies of the different crystals were
measured by crystallographic refinement as described in the text. The
experimental data fit the theoretical line with a high R2 value of 0.990 and a
slope 1//^ = 0.0373. This gives a value for K^ (the crystal dissociation
constant) of 26.8 mM.
for a large number of proteins, this crystallographic method of
measuring binding constants could be developed into a
relatively efficient and routine technique.
Experimental Section
Crystallization and data collection: CeCyp3 was crystallized at 16°C by the
hanging drop vapour-diffusion method using 29-31% poly(ethylene
glycol) methyl ether 5000 (MPEG 5000) as precipitant.'nl Native ceCyp3
crystals (approximately 0.2 x 0.3 x 0.3 mm) were soaked in six 10 pL drops
of well solution containing the Ala-Pro dipeptide at 1.2, 6, 18, 36, 60, and
120 mM, respectively. Crystals were soaked for between 17 and 27 hours.
The composition of the cryoprotectant was glycerol (0.2 mL), MPEG 5000
(0.7 mL), 1.0 m sodium citrate/citric acid (0.1 mL, pH 5.6). Crystals were
mounted in a 0.2-0.3-mm cryoloop (Hampton Research, Inc.), dipped in
cryoprotectant for a few seconds, and frozen by plunging into liquid
nitrogen. The frozen crystal was then transferred to a magnetic goniometer
head in a stream of nitrogen at 100 K. All diffraction data were collected on
a 300-mm MarResearch imaging plate system mounted on an ENRAF
Nonius FR571 rotating anode generator operating at 40 kV, 80 mA, and
producing CuKn radiation from a graphite crystal monochromator.
Refinement: The ceCyp3 native structure was used as a starting model.
Positional and B-factor refinement were performed using SHELX97
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(Table 1). The coordinates of Arg62(n), Arg62(i), Ala-Pro, Wa Wb, Wc, and
Wd were fixed during occupancy refinement. Arg62(n) represents the Arg62
conformation without Ala-Pro bound and Arg62(|} represents the Arg62
conformation with Ala-Pro bound to ceCyp3. The B-factors of Arg62(n),
Wa. Wb, Wc, and Wd were fixed to the same B-factor values as those of the
native structure. Individual atomic B-factors for Arg62()) and Ala-Pro were
refined together with occupancy (Figure 4). The restraints applied in the
occupancy refinement are summarized below:
C?Arg62(n) + C?Arg62(l) F 1
C?Arg62(l) ~ Q\
QArg62(n) = (2wa = (2wb = QvJc = £?Wd
where
0Arg62(n): 1S the occupancy of the Arg62 conformation with no Ala-Pro
binding, QArg62(i): is the occupancy of the Arg62 conformation with Ala-Pro
binding, and Q,: is the occupancy of Ala-Pro.
PPIase assay;!13! a-chymotrypsin selectively hydrolyzes the C-terminal p-
nitroanilide bond of the substrate in the trans X-Pro conformer only. This
hydrolysis releases the chromophore 4-nitroaniline, the accumulation of
which is recorded by measuring the absorbance at 400 nm as a function of
time. Substrate (/V-succinyl-Ala-Ala-Pro-Phe-p-nitroanilide, Bachem AG)
was dissolved in LiCl/2,2,2-trifluoroethanol (LiCL/TFE) to give a stock
solution of 100 mM. The experiment took place at 4°C. Constant temper¬
ature was maintained within the cuvette by a Peltier (PTP-1) temperature
control unit. A Perkin-Elmer UV/Vis Lambda 20 spectophotometer was
used.
Proteins: ceCyp3 solution was freshly prepared before the experiment from
frozen stock solution, at the appropriate concentration, by dilution in
buffer 50 mM 2-[4-[2hydroxyethyl)-l-piperazinyl]ethanesulfonic acid
(HEPES), 100 mM NaCl, pH 8.0 (buffer A).
a-chymotrypsin (Sigma): In a typical experiment 10 pL of 20 nM ceCyp3
was made up to 870 pL with buffer A and the appropriate volume of Ala-
Pro in a 1-mL cuvette. The cuvette was then preincubated for 30 min on ice.
Immediately before the assay, 100 pL of chymotrypsin solution
(50mgmL_1 in 10 mM HC1) was added, followed by 30 pL of a 3.7 pM
stock solution of Suc-Ala-Ala-Pro-PNA in LiCl (470 itim)/TFE. The
reaction progress was monitored by the absorbance change at 400 nm that
accompanies the hydrolysis of the amide bond and the release of
4-nitroaniline.
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A Heterogeneous cis-Dihydroxylation Catalyst
with Stable, Site-Isolated Osmium-Diolate
Reaction Centers**
An Severeyns, Dirk E. De Vos, Lucien Fiermans,
Francis Verpoort, Piet J. Grobet, and Pierre A. Jacobs*
Osmium tetroxide is by far the most versatile catalyst for
cw-dihydroxylation (DH) of double bonds.11-21 When homo¬
geneous catalysts are used, free Os04 is always present in
some step of the catalytic cycle, and the high toxicity and
volatility of Os04 have hitherto obstructed industrial appli¬
cation. Previous attempts to immobilize Os04 used polymers,
for example, with coordination of Os04 on polyvinylpyri-
dine.13-41 However, hydrolysis of the intermediate OsVI diolate
complex requires that Os is detached from the polymeric
Lewis basej51 and this implies an inherent liability to Os
leaching. Similarly, reports on immobilized alkaloids for
asymmetric DH mention that Os leaching necessitates Os
supplementation in subsequent runs.161 In another attempt,
Os04 was entrapped in polystyrene microspheres, but the
mechanism by which Os04 is retained within the polymer is
not understood.'7' Herein we report a solid with OsVI" type
reactivity, and with a persistent bond between Os and the
support. Rigorous heterogeneity tests and reactions with
12 olefins substantiate the value of the new Os catalyst.
Our approach is rooted in the mechanism of the cis-
dihydroxylation, which comprises two stages: 1) attack of the
Osv,M cils-dioxo complex on the olefin (osmylation), 2) reox-
idation of Osvl to OsVMI and hydrolytic release of the diol. Two
points are particularly relevant. First, if the hydrolytic
conditions are not too drastic, tetrasubstituted olefins are not
converted into cw-diols.'8- *' These olefins are smoothly
osmylated to an osmate(vi) ester, but the rate of subsequent
hydrolysis is zero (0% yield for a tetrasubstituted olefin vs.
83% for a trisubstituted olefin, ref. [8]). Second, an OsVI
monodiolate complex can be reoxidized to cw-dioxo OsVI"
without release of the diol; subsequent addition of a second
olefin results in an Os bisdiolate complex.'10' These two
properties make it possible to immobilize a catalytically active
Os compound by the addition of Os04 to a tetrasubstituted
olefin that is covalently linked to a silica support (la.
Scheme 1). The tetrasubstituted diolate ester (lb) which is
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The purification and crystallization of two different crystal forms of
the two-domain protein bovine cyclophilin 40 is reported. Tetragonal
crystals grown in methyl pentanediol belong to space group P4222
with unit-cell parameters a = 94.5, c = 118.3 A. Long thin needles
grown from PEG belong to space group C2 with unit-cell parameters
a = 125.71, b = 47.3, c = 74.6 A, p = 93.90°. The N-terminal 170 amino
acids have significant homology with the well characterized human
cyclophilin A. The C-terminal domain is largely made up of three
copies of the tetratricopeptide repeat motif thought to be involved in
mediating protein-protein interactions. Cyclophilins are frequently
found as domains in larger multidomain proteins. To dale, only X-ray
structures of single-domain cyclophilins have been reported, and this
work provides the first example of the purification and crystallization
of a larger protein containing a cyclophilin domain.
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1. Introduction
Cyclophilins are phylogenetically highly
conserved proteins which act as peptidyl—
prolyl cis-trans isomerases (PPIases) and are
involved in protein folding/refolding as well as
protein-protein interactions (Galat &
Metcalfe, 1995). The first member of this
expanding family to be discovered was the
18 kDa human cyclophilin A (hCyP18) which
was identified by its binding to the fungal
peptide immunosuppressant cyclosporin A
(CsA) (Handschumacher et al., 1984). The
X-ray structures of cyclophilin A and of its
complex with CsA have been determined
(Kallen etal., 1991; Pflugl era/., 1993) and show
the eight-stranded barrel structure conserved
in all cyclophilin domains.
Larger multidomain proteins such as
CyP150 from natural killer cells (Anderson et
al, 1993) and RanBP2 (Yokoyama et al., 1995)
also contain single cyclophilin domains. The
two-domain cyclophilin 40 (CyP40) protein
family has been found in mammals (Kieffer et
al., 1992 1993; Ratajczak et al., 1993) and yeast
(Weisman et al., 1996; Duina et al., 1996), and
was originally isolated and characterized in
association with the unactivated non-DNA
binding form of the oestrogen receptor
(Ratajczak et al., 1993). CyP40 is also present
as one of several components of mature
unactivated complexes of the glucocorticoid
and progesterone receptors (reviewed in Pratt
& Toft, 1997). The major chaperones, hsp90
and hsp70, are included as non-hormone-
binding components within these steroid-
receptor complexes, together with p23 and the
immunophilins FKBP51 and FKBP52 (Pratt &
Toft, 1997), which are cellular targets of the
immunosuppressant FK506 (Galat & Metcalfe,
1995). CyP40, FKBP51 and FKBP52 belong to
a distinct class of proteins which display an
N-terminal immunophilin-like domain with
overlapping regions for immunosuppressant
drug interaction and isomerase activity, toge¬
ther with a conserved C-terminal tetra¬
tricopeptide repeat (TPR) domain proposed to
mediate protein-protein interaction
(Ratajczak et al., 1993; Nair et al., 1997).
Through this conserved C-terminal region,
these immunophilins target a common inter¬
action site in hsp90, resulting in the formation
of separate immunophilin-hsp90-sleroid-
receplor complexes (Nair et al., 1997; Radanyi
et al., 1994; Hoffmann & Handschumacher,
1995; Ratajczak & Carrello, 1996; Young et al.,
1998; Carrello et al., 1999). CyP40 and its
partner immunophilins appear to have a
coordinate role with hsp90 in the functional
control of receptor activity (Pratt & Toft,
1997).
In vitro folding assays have shown that
Cyp40 and FKBP52 can function as molecular
chaperones, similar to hsp90 and hsp70, by
holding substrate proteins in a partially folded
conformation (Freeman et al., 1996; Bose et al.,
1996). The expression of these immunophilins
is ubiquitous (Ratajczak et al., 1993; Kieffer et
al., 1993; Nair et al., 1997) and there is evidence
for their association with hsp90 independently
of steroid receptors (Pratt & Toft, 1997). Cpr6
and Cpr7 are the only Saccharomyces cerevi-
siae homologues of Cyp40, and both associate
with hsp90 (Duina et al., 1996). Mutations
which decrease the level of hsp90 expression,
coupled with a deletion of Cpr7, cause a
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(Ratajczak & Carrello, 1996; Carrello et a!.,
1999).
GST-fused recombinant cyclophilin 40
(GST-bCyP40 WT; Ratajczak & Carrello,
1996) was expressed following a 4 h induc¬
tion with 0.4 mM IPTG (ICN/FLOW). Cell
pellets were frozen at 253 K, thawed slowly
on ice and solubilized in lysis buffer [20 mM
Tris buffer pH 7.8 containing 150 mM NaCl,
2 mM EDTA, 5 mM DTT, 1 %(v/v) Triton
X-100 and 5 mM benzamidine]. Lysozyme
(ICN/FLOW) was added to 0.1%(w/v) and
the cell suspension incubated on ice for 1 h.
An equal volume of distilled water at 277 K
was added and the cell suspension was
mixed and centrifuged at 48400g for 60 min.
The resulting supernatant was frozen at
253 K, thawed on ice and filtered (0.45 pm)
prior to purification. The protein extract was
purified to near homogeneity using four
purification steps, (i) Glutathione Sepharose
(Pharmacia) affinity chromatography:
protein was applied in buffer A (50 mM
Tris-HCl pH 7.5 buffer) and GST-tagged
protein was eluted with buffer A containing
reduced 25 mM glutathione (Sigma), (ii)
Anion-exchange chromatography: protein
from the glutathione Sepharose chromato¬
graphy was applied to Resource-Q resin
(Pharmacia) in buffer A. Elution with a
linear gradient from buffer A to buffer A
plus 1 M NaCl gave peak fractions which
were pooled, concentrated, quantitated for
protein concentration by the Bradford
method and dialysed overnight against
buffer A. (iii) Thrombin cleavage: GST
fusion protein was cleaved with purified
thrombin at a ratio of 1:100 for 90 min at
room temperature, (iv) Cleaved protein was
subjected to a second round of chromato¬
graphy on Resource-Q resin as already
described, followed by a final affinity chro¬
matography step on glutathione Sepharose.
Induction and harvesting of the non-
fusion version of the protein was essentially
as described above for the GST-bCyp40 WT
protein. Purification to near homogeneity
was achieved in two ion-exchange steps. The
cell extract was applied to Q Sepharose
(Amersham Pharmacia Biotech) in buffer A,
the column was washed to baseline and then
developed with a gradient of buffer A plus
1 M NaCl. Protein was eluted with 150 mM
NaCl and fractions were analysed on 12%
SDS-PAGE gels followed by staining with
Coomassie Blue. Fractions containing
bCyP40 were pooled and dialysed overnight
at 277 K against 20 mM Tris pH 8.0 buffer
(buffer B). The protein sample was applied
to Mono-Q resin (PAB) in buffer B, and
retained protein was eluted with a gradient
of buffer B plus 0.5 M NaCl. Positive frac¬
significant reduction in the rate of cell
growth (Duina et al., 1996). The involvement
of wis2, the corresponding CyP40 homolog
in Schizosaccharomyces pombe, in regu¬
lating the G2-mitosis transition (Weisman et
al, 1996) is consistent with this observation.
Hsp90 in association with Cpr7 has also been
shown to participate in the negative regula¬
tion of the heat-shock response in S. cere-
visiae (Duina et al., 1998). Taken together,
these results suggest that Cyp40 plays a
major role in hsp90-mediated signal-trans-
duction pathways.
2. Materials and methods
2.1. Expression, purification and
characterization
Expression plasmids for untagged wild-
type bovine CyP40 (bCyP40) and the
cyclophilin fused to glutathione S-trans-
ferase (GST) have been described
(b)
Figure 1
Pictures of the monoclinic
forms of Cyp40.
and tetragonal crystal
tions were pooled and concentrated.
Dynamic light-scattering analysis of the
purified protein (DynaPro-801 with Micro-
sampler attatchment, Protein Solutions,
Inc.) showed it to be essentially mono-
disperse and stable, with an estimated
molecular weight of 43 kDa.
The protein was further characterized by
electrospray ionization mass spectrometry
on a Micromass Platform II spectrometer.
The sample was introduced into the instru¬
ment stream via an infusion pump and the




method was used to grow crystals in 24-well
Linbro plates. In all trials, crystals could only
be obtained at 277 K.
Tetragonal crystals were grown by equili¬
brating a 4 pi drop of protein solution
against 1 ml of well solution. The well solu¬
tion consisted of 470-490 pi MPD, 100 pi
1 M imidazole pH 6.5, 200-360 pi 50%(v/v)
glycerol solution and 50-230 pi water. The
drop consisted of 2 pi protein solution and
2 pi well solution. The protein solution
consisted of protein at between 10 and
80 mgmf' in 20 mM Tris buffer pH 8
containing 100 mM NaCl.
The morphology of the crystals in most
drops was poorly defined and teardrop-
shaped crystals grew with dimensions of
~0.05 mm. Addition of 1% glycerol and 5-
10 mM DTT were found to improve crystal
size and morphology (Fig. la), with crystals
growing to 0.2 x 0.15 x 0.15 mm. The unit-
cell dimensions are a = 94.5, c = 118.3 A. A
complete data set to a resolution of 2.6 A
has been collected on an Enraf-Nonius
rotating-anode X-ray generator with a MAR
Research 300 image plate.
Monoclinic needles were obtained using
12%(v/v) PEG as precipitant. The 1 ml well
solution was composed of 240 pi of a 50%
solution of PEG 2000, 100 pi 1 M cacody-
late, 50 pi 1 M HC1, 200 pi 50% glycerol
solution and 410 pi water. The 4 pi hanging
drop consisted of 2 pi well solution plus 2 pi
protein at 10-80 mg ml-1 in 20 mM Tris pFI
8 buffer containing 100 mM NaCl. Very long
thin plate-like needles grew within hours
with typical dimensions 2 x 0.01 x
0.005 mm. These crystals are monoclinic
with space group CI. Unit-cell parameters
are a = 125.71, b = 47.3, c = 74.6 A, /3= 93.90°.
These thin needle crystals typically diffract
to a resolution of 3.6 A on a rotaling-anode
X-ray source, and a complete data set has
been collected.
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CYPH_HUMAN VNPTVFF DIAVDGEPLG RVSFELFADK VPKTAENFRA
CYP3_CAEEL MSRSKVFF DITIGGKASG RIVMELYDDV VPKTAGNFRA
CYP4_HUMAN MSHPSPQAKP SNPSNPRVFF DVDIGGERVG RIVLELFADI VPKTAENFRA
CYP4_B0VIN HSHPSPQAKP SNPSNPRVFF DVDIGGERVG RIVLELFADI VPKTAENFRA
















































LSTGEKGFG YKG SCFHRIIPGF MCQGGDFTRH NGTGGKSIYG
LCTGENGIGK S.GKPLHFKG SKFHRIIPNF MIQGGDFTRG NGTGGESIYG
LCTGEKGIGH TTGKPLHFKG CPFHRIIKKF MIQGGDFSNQ NGTGGESIYG
LCTGEKGIGP TTGKPLHFKG CPFHRIIKKF MIQGGDFSNQ NGTGGESIYG
l.tge.g.g kg ..fhrii..f m.qggdf... ngtgg.siyg
101 150
EKFEDENFIL KHTGPGILSM ANAGPNTNGS QFFICTAKTE WLDGKHWFG
EKFPDENFKE KHTGPGVLSM ANAGPNTNGS QFFLCTVKTE WLDGKHWFG
EKFEDENFHY KHDREGLLSM ANAGRNTNGS QFFITTVPTP HLDGKHWFG
EKFEDENFHY KHDKEGLLSM ANAGSNTNGS QFFITTVPTP HLDGKHWFG
ekf.denf.. kh...g.lsm anag.ntngs . ldgkhwf g
151 200
KVKEGMNIVE AMERFGSRNG KTSKKITIAD CGQLE
RWEGLDWK AVESNGSQSG KPVKDCMIAD CGQLKA
QVIKGIGVAR ILENVEVKGE KPAKLCVIAE CGELKEGDDG GIFPKDGSGD
QVIKGMGVAK ILENVEVKGE KPAKLCVIAE CGELKEGDDW GIFPKDGSGD
MAMAE
.v. .g e k..k...ia. cg.l
201 250
SHPDFPEDAD IDLKDVDKIL LITEDLKNIG NTFFKSQNWE MAIKKYAEVL
SHPDFPEDAD VDLKDVDKIL LISEDLKNIG NTFFKSQNWE MAIKKYTKVL
GERTECAEPP RDEPPADGAL KRAEELKTQA NDYFKAKDYE NAIKFYSQAI
d....d..l ...e.lk... n..£k....e .aik.y....
251 300
RYVDSSKAVI ETADRAKLQP IALSCVLNIG ACKLKMSNWQ GAIDSCLEAL
RYVEGSRAAA EDADGAKLQP VALSCVLNIG ACKLKMSDWQ GAVDSCLEAL
ELNP SNAIYYGNR3 LAYLRTECYG YALQDATRAI
l.p n 1 a a.
301 350
ELDPSNTKAL YRRAQGWQGL KEYDQALADL KKAQGIAPED KAIQAELLKV
EIDPSNTKAL YRRAQGWQGL KEYDQALADL KKAQEIAPED KAIQAELLKV
ELDKKYIKGY YRRAASNMAL GKFRAALRDY ETWKVKPHD KDAKMKYQEC













(a) Sequence alignment of human cyclophiiin A (CYPH_HUMAN), nematode cyclophilin 3 (CYP3_CAEEL),
human and bovine cyclophiiin 40 (CYP4_HUMAN, CYP4_BOVIN) and human protein phosphatase 5
(PPP5_HUMAN). Sequences from the Swiss-Prot database were aligned using the program MultAlign and
represent the entire sequence of the cyclophilins aligned against the N-lcrminal 150 amino acids from PP5. The
TPRs of PP5 are shown in bold. Numbering applies to the amino-acid sequence of bovine CyP40. (b) Alignment
of the three TPR motifs of bCyP40 against the N-terminal 150 TPR domain of PP5. The six helices associated
with the three TPR motifs determined in the the X-ray structure of PP5 (Das et al., 1998) are underlined. The C-
tcrminal extension of 28 amino acids is the predicted helical calmodulin-binding site. The program MullAlign
(Corpet, 1988) was used for amino-acid alignment.
3. Discussion
The amino-acid sequence for bCyP40 is
shown in Fig. 2(a) and shares 94% identity
with the human homologue. Mass spectro¬
metry gives a molecular mass of 40500 Da.
The calculated molecular mass of the
sequence shown in Fig. 2 is 40620 Da, which
suggests that the N-terminal methionine
residue is removed posl-lranslationally. The
calculated molecular mass of the sequence
omitting the N-terminal methionine is
40489 Da.
The cyclophiiin domain, consisting of the
N-terminal 187 residues, is very well
conserved between the bovine and human
proteins, with differences in only five resi¬
dues. The N-terminal domain is 61% iden¬
tical to hCyP18 and shows an even better
homology (64%) with the so-called diver¬
gent class of cyclophilins (Taylor et al., 1998),
which have an additional seven amino-acid
loop inserted at positions 60-67 (Fig. 2a).
Another feature of this divergent class of
cyclophilins is that the active-site trypto¬
phan, shown to be important in binding CsA
in hCyP18 (Pdugl et al., 1994), is replaced by
a histidine. This change may explain the
reduction of the IC50 values for CsA from
20 r\M for hCyP18 to 300 nM for hCyP40
(Kieffer et al., 1992). The CyP40/CsA/calci-
neurin was 320 nM, compared with the
CyP18/CsA/calcineurin Kt of 195 nM, and
CyP40 was found to compete with CyP18 for
binding to calcineurin in the presence of
CsA (Kieffer et al., 1993).
The C-terminal 150 amino acids (residues
188-359) of hCyP40, comprising the TPR
and putative calmodulin-binding domains, is
31% homologous with the corresponding
region of FKBP59. An X-ray structure is
available for the TPR domain of the human
protein PP5 (Das et al., 1998) which shows
that each TPR motif consists of two helices
of about 14 amino acids which are linked by
a tight turn. The predicted secondary struc¬
ture of the C-terminal CyP40 domain is
shown in Fig. 2(b), along with a sequence
alignment between human phosphatase and
bCyP40. Helical regions of the predicted
TPR motifs are also shown.
The PP5 crystal structure (Das et al., 1998)
shows that the putative calmodulin-binding
domain of CyP40 consists of an cr-helix
approximately 30 amino acids in length. The
secondary-structure prediction (Rost et al.,
1994) of the CyP40 sequence gives a strongly
predicted C-terminal helix of 28 amino acids
in length. This corresponds to a length of
42 A and is close to the conserved b cell
dimension of the monoclinic needle form of
CyP40. The ft axis also corresponds to the
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long and fast-growing needle axis, and it is
reasonable to suggest that it is this calmo-
dulin-binding helix which determines the
length of the b axis and also the kinetics and
morphology of the monoclinic needle crys¬
tals.
We thank Violet R. Anderson for the
mass spectrometry.
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Background: The "large immunophilin" family consists
of domains of cyclophilin or FK506 binding protein linked
to a tetratricopeptide (TPR) domain. They are intimately
associated with steroid receptor complexes and bind
to the C-terminal domain of Hsp90 via the TPR domain.
The competitive binding of specific large immunophilins
and other TPR-Hsp90 proteins provides a regulatory
mechanism for Hsp90 chaperone activity.
Results: We have solved the X-ray structures of mono-
clinic and tetragonal forms of Cyp40. In the monoclinic
form, the TPR domain consists of seven helices of vari¬
able length incorporating three TPR motifs, which pro¬
vide a convincing binding surface for the Hsp90 C-termi¬
nal MEEVD sequence. The C-terminal residues of Cyp40
protrude out beyond the body of the TPR domain to
form a charged helix—the putative calmodulin binding
site. However, in the tetragonal form, two of the TPR
helices have straightened out to form one extended he¬
lix, providing a dramatically different conformation of
the molecule.
Conclusions: The X-ray structures are consistent with
the role of Cyclophilin 40 as a multifunctional signaling
protein involved in a variety of protein-protein interac¬
tions. The intermolecular helix-helix interactions in the
tetragonal form mimic the intramolecular interactions
found in the fully folded monoclinic form. These con¬
served intra- and intermolecular TPR-TPR interactions
are illustrative of a high-fidelity recognition mechanism.
The two structures also open up the possibility that
partially folded forms of TPR may be important in domain
swapping and protein recognition.
'Correspondence: m.walkinshaw@ed.ac.uk
sThese authors contributed equally to this work.
Introduction
Cyclophilin 40 (Cyp40), FKBP52, and FKBP51 are the
principal members of a family of large immunophilins
found in all mammals. They comprise an N-terminal im¬
munophilin domain with homology to the well-character¬
ized single domains of cyclophilin or FK506 binding
protein (FKBP) and an extended C-terminal region incor¬
porating three units of the tetratricopeptide repeat (TPR)
motif [1-5]. In Saccharomyces cerevisiae, two Cyp40
homologs, Cpr6 and Cpr7, encode proteins which bind
the yeast transcriptional regulator and histone deacety-
lase Rpd3 [6]. Cpr7 has been observed in a trimeric
complex with hsc82 and the Stil homolog Cns1. The
Cpr7-Cns1 interaction is thought to be mediated via the
cyclophilin domain of Cpr7 [7], The detailed biological
function of large immunophilins is not well understood;
however, in all species they are associated with Hsp90
and play an important regulatory role in the maintenance
of steroid receptor activity [8]. Within mature steroid
receptor heterocomplexes, the large immunophilins
compete directly for a common TPR acceptor site in
Hsp90 [5, 9, 10].
The two structures described provide new insights
into recognition mechanisms for TPR-containing pro¬
teins possibly using domain swapping and also suggest
a folding pathway for the helical TPR domain.
Results and Discussion
The Cyclophilin Domain of Cyp40 Belongs
to the Divergent Loop Family
Both monoclinic and tetragonal forms of Cyp40 (see Table
1) have very similar cyclophilin domains which resemble
previously characterized single-domain cyclophilins [11,
12]. The "divergent loop" of bovine Cyp40 consists of
an insert of 8 residues (60PTTGKPLH67). A consensus
sequence for this additional loop, based on multiple
sequence alignments, is **GK*LH [13]. A conserved glu-
tamate (Glu96), which ties down the loop using an inter¬
esting hydrogen bonding motif, is found in a homolo¬
gous position in most divergent loop cyclophilins (Figure
1). Like other divergent loop cyclophilins [13,14], Cyp40
has two cysteines in close proximity in the reduced form.
The side chains of Cys52 and Cys181 are well defined
in the electron density and show a sulfur-sulfur distance
of 5.4 A. The formation of a disulphide bond in an oxidiz¬
ing environment may induce a conformational change
and provide a signaling mechanism in response to oxi¬
dative stress.
The peptidyl-prolyl cis-trans isomerase active site of
Cyp40 is similar to that of human cyclophylin A (hCypA)
[12]. The active site of the cyclophilin family is defined
by the 13 amino acids found to be important in the
binding of the drug cyclosporin A (CsA) to hCypA (Figure
1), and a number of these residues are highlighted in
Key words: Cyclophilin; Hsp90; immunophilin; tetratricopeptide re¬
peat; TPR; protein recognition
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Table 1. Crystal Parameters and Data Reduction Statistics






Space group C2 P4222
Unique reflections 40,561 33,904
Completeness (%) 98.3 90.5
Dmln 1.8 2.0
<I>/<ct(I)> 20.67 19.6





Bond angle dists 0.23 0.22
Ramachandran plot
N core region/N (%) 326/328 (99.4) 256/283 (97.3)
N inner core (%) 270/328 (82.3) 195/283 (74.1)
Figure 3a. The active site residues are identical, apart
from His 141, which corresponds with Trp120 in hCypA
(Figure 1). The PPIase activity of Cyp40 has a kcat/Km
value of 1.9 X 10G M^'s"1 [15] compared with the value
of 1.4 X 107 M~1s~1 for hCypA [16].
The TPR Domain of the Monoclinic Form Consists
of Seven Helices and Is Attached to the Cyclophilin
Domain by a Linker of 30 Amino Acids
The acidic linker region contains 11 aspartate and gluta-
mate residues and forms a well-defined hydrogen-
bonded structure with two (3 turns. The positively
charged surface of helix Q forms salt bridges with linker
residues D204 and D200 (D204/OD...K248/N = 2.99 A,
D200/OD2...K245/N = 2.73 A, D200/OD1 ...K248/N =
3.16 A; Figure 3a).
The seven helices labeled P, Q, R, S, T, U, and V form
an extended helix-turn-helix pattern (Figure 3a). Each
34 amino acid TPR repeat consists of a (A,, B) helix-
turn-helix motif (Figure 2). The first three helices (P, Q, R)
are longer than expected for idealized TPR sequences.
Helix R incorporates a proline residue (P270), which also
distorts the helical conformation of the 4 preceding resi¬
dues. (A similar distortion occurs in all HEAT repeat
helices which frequently contain proline [17].) The in-
terhelix fi angles [18] between adjacent helices are all
positive (H[P, Q] = 13°, n[Q, R] = 26°, fl[R, S] = 12°,
a[S,T] = 24°,n[T,U] = 14°,n[U,V] = 22°). The structure
of PP5 [19] has a similar arrangement of helices.
Figure 2 provides a comparison between the amino
acid sequences of the C-terminal TPR-containing do¬
mains of large immunophilins with other Hsp 90 binding
proteins, including PP5, Hop, and CNS1. A consensus
sequence pattern of small and large hydrophobic resi¬
dues has been postulated, with small residues occurring
at positions 8, 20, and 27 [19], The average ArB, interhe-
lix distance for each Cyp40 TPR is between 7.5 and 8 A.
This sharp turn brings the side chain of residue 8 close
to the backbone of helix B and explains the requirement
of the small Gly or Ala side chain at this position. The
N-terminal domain (residues 18-181) of human Ser/Thr
phosphatase PP5 [19] has an amino acid identity of 24%
with Cyp40 over the corresponding 133 amino acids
(Figure 2). A root mean square (rms) fit between the
corresponding 133 Ca atoms is 1.2 A
A Partially Folded TPR Domain Is Trapped
in the Tetragonal Crystal Form
The structure of the tetragonal form retains only the
first TPR motif (helices P and Q); the second TPR motif
(helices R and S) has sprung out to form an elongated
helix (Figure 3b). Residues comprising helices T, U, and
V in the monoclinic form (Ca trace shown in Figure 4)
are not visible in the electron density. This structure can
therefore be regarded as a trapped intermediate in the
folding pathway of the helix domain. It also suggests
that conformations of such helical domains are flexible
and that such helix extensions toward the end of a helical
domain may occur in protein-protein recognition pro¬
cesses. Packing in the tetragonal lattice allows compen¬
satory intermolecular helix-helix interactions (Figure 5a),
and the intermolecular interactions between helices P
and Q with helix R of an adjacent molecule are nearly
identical to the intramolecular interactions found in the
fully folded monoclinic form (Figure 5b). This provides
an excellent example of domain swapping.
Helix V in the Monoclinic Form May Be Involved
in Calmodulin Binding
Specific binding between large immunophilins and cal¬
modulin has been shown in bovine Cyp40 [20], maize
FKBP 66,[21], and rabbit FKBP52 [22], Calmodulin bind¬
ing requires an amphiphilic a helix that carries a net
positive charge [23]. The calmodulin binding site to
FKBP52 has been proposed to lie between residues
398-415 that corresponds to residues 353-370 of
Cyp40. The X-ray structure of Cyp40 presented here
shows that this putative interaction domain corresponds
to the C-terminal portion of the V helix (Figure 3a), which
is seen to extend beyond the shorter TPR helices. The
protruding and predominantly positively charged helix
V would therefore be accessible for calmodulin binding.
The X-Ray Structure of the Monoclinic Cyp40 TPR
Domain Provides a Model Binding Surface
for Hsp90
Site-directed mutagenesis of PP5 has shown that Lys97,
Arg101, Lys32, and, to a lesser extent, Arg74 are re¬
quired for Hsp90 binding [24]. A sequence alignment of
TPR sequences (Figure 2) shows that residues Lys97
and Arg101 are conserved at positions 2 and 6 of TPR3
for all the related Hsp90 binding proteins. Deletion muta¬
genesis studies of the C-terminal domain of Hsp90 have
shown that the conserved C-terminal sequence EEVD
is important for immunophilin binding [25],
The monoclinic crystal form of Cyp40 grows excep¬
tionally fast along the needle axis (needles grow to over
0.5 mm within minutes) and suggests a particularly ener¬
getically favorable interaction [26]. Analysis of the crys¬
tal packing (Figure 6) shows the C-terminal residues
EKAAY fitting tightly into a groove on the surface formed
by the three TPR motifs. The residues defining the







CYP7_YEAST MIQDPLVYLDISIDKKPIGRIVCKLFREKAPKTTENFYKLCAGDVKSPL 4 9
CYPH_HUMAN YKGSCFHRIIPGFMCQGGDFTRHN GTGGKSIYGEK FEDE 86
CYP4_BOVIN TT-GKPLHFKGCPFHRIIKKFMIQGGDFSNQN GTGGESIYGEK FEDE 106
CYP4_HUMAN TT-GKPLHFKGCPFHRI IKKFMIQGGDFSNQN GTGGESIYGEK FEDE 106
CYP4_SCHPO RCLTYKGSRFHRVIKNFMLQGGDFTRGN GTGGESIYGEK FEDE 89




















NFILKHTG PGILSMANAG-PNTNGSQFFICTAKTEWLDGKHWFGKVKEGM 13 6
NFHYKHDK EGLLSMANAG-SNTNGSQFFITTVPTPHLDGKHWFGQVIKGM 156
NFHYKHDR EGLLSMANAG-RNTNGSQFFITTVPTPHLDGKHWFGQVI KGI 156
NFELKHDK PFLLSMANAG-PNTNGSQFFITTVPTPHLDGKHWFGKVIQGK 13 9
NFTVKHDK PFLLSMANAG-PNTNGSQAFITCVPTPHLDGKHWFGEVIQGK 14 5
SFCYGNFEDENLGEFVEPFTLGMANLGSPNTNNSQFFITTYAAPHLNGKHSIFGQWHGK 168
NIVEAMER- - FGSRNGKTSKKITIADCGQLE 165
GVAKILEN--VEVKGEKPAKLCVIAECGELKEGDDWGIFPKDGSGDSHPD FPEDA 209
GVARILEN--VEVKGEKPAKLCVIAECGELKEGDDGGIFPKDGSGDSHPD FPEDA 209
STVRTI EN - - LETKNDDPWPWIEECGTCTKDQIEAPKPDVTGDSLEEFP DD 190
RIVRLIENQQCDQENNKPLRDVKIDDCGVLPDDYQVPENAEATPTDEYGDNYEDVLKQDE 205
SWRTIENCRVDSDG-VPESDVRISDCGVWEKTMGVPLYN-ASNDQIGGDVYEEYPDDDT 226



















CYP4_SCHPO KNFEESEKALAKAG NDPAISKKLAEIRQKKKDYKKRQQKAYAKMFQ 356
CYP6_YEAST NDTDMALNDLEMATTFQPNDAAILKAIHNTKLKRKQQNEKAKKSLSKMFS 371
CYP7_YEAST KRLDEALQDYIFCKEKNPDDEVIEQRIEYVNRLIEENKEKTRKNISKFFS 393
Figure 1. Alignment of Selected Cyclophilin Proteins
Sequence alignment of human cyclophilin A (CYPH_HUMAN), bovine and human cyclophilin 40 (CYP4_BOVIN and CYP4_HUMAN), WIS2 from
S. Pombe (CYP4_SCHPO), and CPR6 and CPR7 from S. cerevisiae (CPR6_YEAST and CPR7_YEAST). The sequences were aligned using
Clustal W [29]. In bold are the features discussed in the text, including conserved cysteines and glutamates and residues forming the inserted
loop. The 13 residues important in defining the active site of the cyclophilin family of proteins are shown starred above the text. The high
degree of conservation between these cyclophilin domains (residues 1-183) is clearly seen.
groove are Lys227, Phe234, Ser274, Asn278, Lys308,
and Arg312. Significantly, the interaction involves close
contacts with the three positively charged residues iden¬
tified as critical for interaction with Hsp90 [24], We have
used this intermolecular interaction as a backbone tem¬
plate to model the Cyp40 interaction with the Hsp90 C-ter-
minal MEEVD sequence (data not shown). This model re¬
quires the MEEVD peptide to run in the opposite direction
to that found in the Hop-peptide complex [27], suggesting
that the peptide binding groove of TPR domains may act
as a peptide binding site with broad specificity.
Biological Implications
The multiple but poorly understood roles of the large
immunophilin family as peptidyl-prolyl isomerases, chap-
erones, and promiscuous binding proteins can be un¬
derstood in part by the X-ray structure presented here.
The classification of the cyclophilin domain as one of
the divergent loop family implies that it plays a role in
recognizing (as yet unidentified) partner proteins after
phosphorylation or in signaling a response to oxidative
stress. The two-domain picture of the Cyp40 molecule
suggests a clear separation between the TPR binding
domain docked onto the Hsp90 and the outward-facing
enzyme active site, allowing independent functionality
of the two domains. The MEEVD peptide binding groove
in the TPR domain reveals a crucial recognition site
for Hsp90-Cyp40 interaction. This Hsp-90 immunophilin
interaction is competitive among the different large im-
munophilins (FKBP51, FKBP52, and Cyp40) that appear
to modulate the interaction of Hsp90 with client proteins,
Structure
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Alignment of TPR 1. TPR 2 and TPR 3 motifs of Hsp'X) binding proteins.
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Figure 2. Alignment of TPR Sequences for
Hsp90 Binding Proteins
Proteins that contain three copies only of the
TPR motif and that have been shown to inter¬
actwith Hsp90 were identified from the litera¬
ture and are given in the table, using
Swissprot names. Additionally, the TPR2 do¬
main of Hop has been included. Each TPR motif
from the above proteins was manually aligned.
The proteins were bovine and human cyclophi-
lin 40 (CYP4_BOVIN, CYP4_HUMAN); human
FKBP 51 and 52 (FKBP5_HUMAN and
FKBP4_HUMAN); human protein phospha¬
tase 5 (PPP5_HUMAN); Cpr 6, Cpr 7, and
Cns1 from S. cerevisiae (CYP6_YEAST,
CYP7_YEAST, and CNS1_YEAST); and hu¬
man Hop (IEFS_HUMAN). Numbering above
the sequences runs from 1 to 34 and gives
the position of a particular amino acid relative
to the start of the TPR motif. The horizontal
cylinders below each alignment designate
the extent of helices P, Q, R, S, T, and U in
the 34 amino acid sequence, using structural
data from Cyp40 to assign helices. A broken
cylinder indicates the helix begins or termi¬
nates earlier or later in the protein sequence,
therefore failing to conform to the classical,
idealized helix (13 aa) turn (3 aa) helix (14 aa)
model for TPR motifs. Arrows projecting from
the cylinders point to the positions in the se¬
quence where the helices start and finish. The
three linker residues between helix A, and he¬
lix B| are underlined. Closed and shaded cyl¬
inders illustrate a complete helix within the
TPR motif. Only TPR 3 conforms to the ideal¬
ized structure. Residues identified as being
important in binding Hsp90 are bold and
underlined. Structurally conserved residues
are italicized and bold.
X-Ray Structure of Cyclophilin 40
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Figure 3. Stereo Pictures of the Monoclinic
and the Tetragonal Folding Intermediate
Forms of Bovine Cyclophilin 40
(a) The stereo picture of the monoclinic form
of bovine cyclophilin 40 was drawn using
Molscript [30]. The cyclophilin domain (resi¬
dues 1-183) is colored green. Side chains of
selected active site residues (Arg75, Phe80,
Phe133, His141, His146) are colored black.
Glu96, which forms hydrogen bonds to the
divergent loop, is also shown. The backbone
of the linker (residues 184-213) joining the
cyclophilin and TPR domains is shown in
black. Selected salt bridges between the pos¬
itively charged residues of helix Q (K244, K245,
K248, R251) with linker residues D204 and D200
(D204/OD...K248/N = 2.99 A, D200/OD2...
K245/N = 2.73 A, D200/OD1 ...K248/N =
3.16 A) are shown as dashed green lines. Side
chains of all charged residues on the TPR
domain are shown. Arg and Lys, blue; Glu
and Asp, red. There are seven helices in the
TPR domain: P (20 residues, V216-K235), Q
(21 residues, W239-A259), R (24 residues,
D262-K285), S (12 residues, W289-L300), T
(13 residues, T307-G319), U (14 residues,
Y323-I336), and V (18 residues, K341-K362).
The slight distortion in helix R is caused by
the presence of Pro270. The portions of the
helices corresponding to the repeating TPR
motifs shown in Figure 2 are colored dark blue
(TPR1, helices P and Q, residues 223-256;
TPR2, helices R and S, residues 273-306;
TPR3, helices T and U, residues 307-340).
The protruding C-terminal portion of helix V
is the putative calmodulin domain and is col¬
ored magenta.
(b) The stereo picture of the tetragonal folding
intermediate form of bovine cyclophilin 40
was drawn using Molscript [30]. Coloring is
the same as (a). Helices T, U, and V are not
visible in the electron density. Helices are col¬
ored according to the fully folded monoclinic
form in (a): Helix P (20 residues, V216-K235),
Q (21 residues, W239-A259), R (24 residues,
D262-K285), S (12 residues, W289-D298). The
portions of the helices corresponding to the
repeating TPR motifs shown in Figure 2 are
colored dark blue (TPR1, residues 223-256;
TPR2, residues 273-298). Alternative confor¬
mations of residues Ala260 and Ser287 are pri¬
marily responsible for helices R and S adopting
an extended rod-like helical conformation.
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Figure 4. Stereo Ca Trace of the Monoclinic
Form of Bovine Cyclophilin Amino Acids Are
Labeled Every 20th Residue
including steroid receptors and kinases. The two Cyp40
structures presented here provide the basis for detailed
site-directed mutation studies to map out the complete
binding surfaces mediating the Hsp90-immunophilin
recognition. Once bound to Hsp90, it is likely that the
large immunophilins act to anchor or trigger conforma¬
tional changes in the Hsp90-bound client proteins and
may therefore play a key role in Hsp90-regulated signal
transduction pathways. Inhibition of the Hsp90-immu-
nophilin interaction by small drug molecules could pro¬
vide a new target for a wide range of therapeutic areas,
including cancer and inflammation.
Experimental Procedures
Crystallization
The hanging drop vapor diffusion method was used to grow crystals
in 24-well Linbro plates at 4°C.
Monoclinic Crystals
In most drops, very long thin monoclinic needles (2 x 0.01 x 0.005
mm) grow within hours. Occasionally, much larger plates formed
with dimensions up to 0.6 x 0.2 x 0.15 mm. The 1 ml well solution
was composed of 320 /J of a 50% solution of PEG 4000, 100 /xl of
1 M MES buffer (pH 6.1), 200 jxl of 50% v/v glycerol solution, 100
jj.l 4 M NaCI, and 280 /xl water. The 4 /xl hanging drop consisted of
2 /xl well solution plus 2 /xl of protein at 10-80 mg/ml in 20 mM Tris
(pH 8) buffer containing 100 mM NaCI.
Tetragonal Crystals
The well solution consisted of 480 /xl MPD, 100 /jlI 1 M imidazole at
pH 6.5, 140 jxl 50% v/v glycerol solution, and 280 /xl water. The
hanging drop consisted of 2 /xl well solution plus 2 /xl of protein at
10-80 mg/ml in 20 mM Tris (pH 8) buffer containing 100 mM NaCI.
Teardrop-shaped crystals with dimensions up to 0.2 x 0.15 x 0.15
mm grew within a few days.
Structure Determination
Data used in the final refinement for both structures were collected
on station 9.6 at the Daresbury synchrotron.
Monoclinic Structure
The complete model of Cyp3 from C. elegans [13] was used for a
molecular replacement search using AMORE [28]. This model gave
a single 10 a peak in the rotation function, and this rotated model
gave a 9 a peak in the translation function. The initial model gave
an R factor of 55%, and, from the first map, it was possible to
change the residues in the cyclophilin domain to match the Cyp40
sequence. Additionally, some residues of the TPR domain, mainly
within helices, were visible, and, over many cycles of model fitting
and refinement, it was possible to trace almost the entire TPR do¬
main. The final model contains 489 waters. No ions were found;
however, one glycerol molecule was located. The final refined struc¬
ture runs from Ser2 to Tyr365. The 5 C-terminal residues were not
visible in the electron density.
Tetragonal Form
Initial stages of the structure determination were similar to the mono¬
clinic form with clear rotation and translation solutions apparent.
The final model contains 224 waters and one glycerol molecule.
The refined structure runs from Ser2 to Asp298. The C-terminal 72
residues were not visible in the electron density.
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1. Introduction
Bacterial cells have evolved a wide range of
defence mechanisms against viral infection.
One such mechanism is effected through
restriction-modification (R-M) systems such as
the type I R-M enzymes (Bickle & Kruger,
1993; Murray, 2000). These enzymes allow the
bacteria to recognize their own DNA through
the strain-specific methylation of bases by
transferring methyl groups from S-adenosyl-
methionine to specific adenine or cytosine
bases in the recognition site. Where the host
DNA is hemimethylated (only one strand is
modified) after DNA replication, the enzyme
will methylate the other strand to produce fully
methylated DNA. Cleavage of unmethylated
DNA (for example, from an invading
bacteriophage) by type I R-M systems requires
two type I R-M enzymes attached at two
distant recognition sites. A complex DNA
translocation process driven by ATP hydrolysis
occurs prior to DNA cleavage (Studier &
Bandyopadhyay, 1988; Ellis et at., 1999; Berge
et at., 2000).
To counteract the bacterial R-M systems,
bacteriophages have developed anti-restriction
systems (Kruger & Schroeder, 1981; Kruger &
Bickle, 1983; Bickle & Kruger, 1993). It has
been shown that bacteriophage T7 is not
subject to restriction or modification by
Escherichia coli B and E. coli K type I R-M
systems in vivo (Eskridge et at., 1967) but is in
vitro (Eskin et at., 1973; Bandyopadhyay et at.,
1985). The ocr protein product of gene 0.3, a
26 kDa dimer (Mark & Studier, 1981), is
responsible for this protection (Studier, 1975).
Ocr is the first gene on T7 DNA and is the first
expressed after infection (Studier, 1972, 1973).
Ocr is thought to act as a polyanion mimic of
DNA and competes with DNA for the DNA-
binding site of the type I R-M enzymes (Dunn
et at., 1981; Bandyopadhyay et at., 1985). The
inhibition may be similar to the interaction of
uracil glycosylase inhibitor with the DNA
repair enzyme uracil glycosylase (Mol et at.,
1995; Sawa & Pearl, 1995; Putnam et at., 1999).
Ocr is very acidic: 34 of its amino acids are
either aspartic or glutamic acids and only six
are arginine or lysine (Dunn et at., 1981)
(Fig. 1). Structure predictions (Dryden et at.,
1995; Sturrock & Dryden, 1997) have
presented a working model of the architecture
of the binding site for ocr on a type I R-M
enzyme. A crystal structure will provide a clear
insight into how ocr mimics DNA and the
nature of the interaction of ocr with type I R-M
enzymes.
2. Results and discussion
2.1. Protein production and characterization
The wild-type ocr protein was produced by
transformation of E. coli strain BL21(DE3)-
pLysS with the plasmid pAR2993. Trans¬
formed cells were plated out on agar with
20 pg ml-1 ampicillin and 25 pg ml""1 chlor¬
amphenicol to produce single colonies. A
single colony was used to innoculate flasks
containing 500 ml LB media supplemented
with ampicillin and chloramphenicol. When
the optical density at 650 nm reached 0.6,
IPTG was added to a final concentration of
0.4 mM. After incubation for 2 h at 310 K, the
cells were harvested by centrifugation. The
cells were sonicated and cell debris removed by
centrifugation for 3 h at 30 OOOg. The super¬
natant was loaded onto a 200 x 16 mm DEAE
Sepharose fast flow ion-exchange column
equilibrated with 20 mAf Tris-HCl, 7 mM
/1-mercaptoethanol, 300 mM NH4C1 at pH 8 at
48 ml h_1. A 500 ml gradient from 0.3 to 1 M
NH4C1 was run overnight at 24 ml h"1. Frac-






Completeness (final shell) 99.3 (98.5)
Rmcv (final shell) 4.9 (9.6)
Total reflections 71916
Unique 8927
Anomalous diffraction ratio (%) 4.98
Sc (/',/") -1.0,3.0
Cs (/', /") 0.0, 3.0
t Anomalous diffraction ratio = (||F+| — |F—||)/{1/2(|F+| + |F— |)).
1.2 0.9777 0.9793
1.85 1.8 1.8
97 (85) 99.1 (96.7) 99.1 (97.1)





0.0, 5.3 0.2, 3.7 0.2, 3.7
morphology, diffracted poorly. An initial
data set for the wild type was collected to
2.5 A in space group C2, with unit-cell
parameters a = 88.18, b = 105.96, c= 73.34 A,
P = 120.319°.
The observation that caesium seemed to
help crystal growth was further investigated.
Using CsCl, a large plate-like crystal (Fig. 2)
grew within two weeks under the following
conditions: well solution 32% PEG 8000,
0.1 M Tris-HCl pH 8.2, 0.2 M CsCl, 2.8%
glycerol; drop 2 pi well solution plus 2 pi
of protein solution at 16mgmr'. This
selenomethionine form of the ocr crystals
could be flash-frozen in liquid nitrogen
without use of additional cryoprotectant.
These crystals also belong to space group
C2 and have unit-cell parameters a = 78.78,
b = 37.66, c = 35.49 A, p = 98.41°. Anom¬
alous data sets were collected for the
selenomethionine crystals on station 9.5 at
the Daresbury synchrotron and station
BM30 at the ESRF, Grenoble (Table 1).
The fluorescence spectrum was measured
to determine the absorption edge of sele¬
nium and data sets were measured at four
wavelengths; the inflection point of the edge
(0.9777 A, X2), the peak of the white-line
absorption (0.9793 A, X3) and at two remote
wavelengths (0.87 A, Ap 1.2 A, A4). The
merging R factor between Friedel pairs
within each data set does indicate a slightly
larger anomalous signal at the absorption
edge (6.9% compared with the remote R
factors of 5.7) and this is supported by the
size of the anomalous diffraction ratios for
the four data sets (Table 1). Anomalous
Patterson difference maps for each of the
four data sets were calculated (Fig. 3). Major
differences between these maps is explained
by the unexpected discovery that the crystals
incorporated significant amounts of caesium,
which has a large anomalous contribution
over this wavelength range (Fig. 4).
Figure 2
A crystal of Ihc selenium form of ocr with dimensions
0.4 x 0.4 x 0.1 mm.
Table 2
Fractional coordinates of the Se and Cs atoms used to
generate the Patterson peaks shown in Fig. 3.
X y z
Scl 0.08063 0.27275 0.24952
Sc2 0.20312 0.16840 0.51414
Sc3 0.08258 -0.00231 0.04150
Sc4 0.10748 -0.31247 0.00709
Csl 0.15214 -0.41763 0.18218
Csl 0.08887 0.12099 -0.11881
Csl 0.33431 0.20409 0.09952
tions containing ocr were put through a
HiLoad 16/60 Superdex 200 preparative
grade gel-filtration column in 20 mM
Tris-HCl, 7 mM ^i-mercaptoethanol,
300 mM NH4C1 pH 8 buffer. An additional
step was tried using a 150 x 16 mm phenyl
Sepharose affinity column equilibrated in
20 mM Tris-HCl, 7 mM /i-mercaptoethanol,
50 mM NH4C1, 2.4 M (NH4)2S04 buffer at
pH 8. Protein was applied to the column and
flushed with this buffer for 30 min at
60 ml h"1 and protein was then eluted at
48 ml h"1 with a 500 ml gradient from 2.4 to
0 M (NH4)2S04. This achieved a higher level
of purity but was not found to be necessary
for the production of good crystals. Chro¬
matography columns were from Amersham
Pharmacia. The purified ocr protein was
stored in 20 mM Tris-HCl, 7 mM p-mer-
captoethanol, 300 mM NH4C1 pH 8 buffer
containing 50% glycerol at 253 K.
A selenomethionine-substituted form of
ocr was produced by transforming the
methionine-deficient E. coli strain B834.
This strain (kindly provided by Dr W.
Hunter, Dundee University, Scotland) was






Sequence of ocr. The sccondary-slruclurc prediction for ocr is
from the program PHD (Rost & Sander, 1993).
transformed with pAR2993 as with
BL21(DE3) and grown in minimal media
supplemented with 20 pg ml-1 of all amino
acids except cysteine (to prevent reutiliza-
tion of sulfur to make normal methionine)
and with 20 pg ml"1 seleno-L-methionine
along with 20 pg ml"1 ampicillin.
Electrospray mass spectra were measured
using a Themoquest LCQ mass spectro¬
meter (Thermoquest Corporation, Paradise,
Hemel Hempstead, England). Native ocr
gave M, = 13 677 ± 1 Da, compared with a
mass of Mr = 13 959 ±1 Da for the selenium
form. The difference in mass of 47 Da x 6
indicates 100% incorporation of six Se
atoms.
2.2. Crystallization and X-ray data analysis
Crystallization was carried out using the
hanging-drop vapour-diffusion method. The
drop consisted of equal volumes (normally
2 pi) of protein solution and well solution.
Crystallization trials were performed with
Hampton Research sets I and II and crys¬
talline precipitate was observed with poly¬
ethylene glycol (PEG) 8000, Tris-HCl buffer
and sodium acetate. Refinement of these
conditions led to well formed crystals in 32%
PEG, 300 mM NH4C1, 0.1 M Tris-HCl pH
8.0 and 0.2 M sodium acetate at 291 K for
both native and selenomethionine forms of
the protein (type I). This crystal form was
metastable and after about 10 d the crystals
gradually dissolved. In some of the drops,
poorly formed plate-like crystals reappeared
after days or weeks (type II).
Caesium acetate was also used in crystal
trials and found to produce large well
formed crystals of type I. Trials
with rubidium acetate and
potassium acetate yielded
progressively poorer crystals
ranging between the caesium and
sodium acetate crystal quality. No
crystals were obtained when
ammonium acetate was used as
an additive. Crystals of type I,
irrespective of size or external








Harkcr sections calculated at y = 0. The Fourier coefficients for calculating the Patterson map for each of the four
data sets are (|F)+| — |F)—|)2. The section runs from u = 0 to 1 in 108ths and from w = 0 to 0.5 in 48ths. The stippled
circles correspond to the Harkcr peaks resulting from the Cs—Cs vectors from three independent caesium ions.
The pale filled circles correspond to the Harker peaks of the Se— Se vectors from four of the Sc atoms. Patterson
maps were calculated and plotted using the program CNS (Brungcr et al., 1998). Arrows indicate positions of the
strongest selenium and caesium peaks.
edge. The anomalous Patterson
peaks calculated with data
measured at A3 = 0.981 A and
A4 = 1.2 A are dominated by the
caesium signal. This is clearly
seen by the presence of the
strong peak u = 0.31, v = 0,
w = 0.38 (Fig. 3). The changes in
intensities of the anomalous
Patterson peaks can be
explained by inspection of Fig. 4,
which shows that the anomalous
contribution of caesium varies
between 6 electrons and 4 elec¬
trons over the four wavelengths,
while the selenium contribution
is only significant at the shorter
wavelengths. The position of the
heavy atoms (Table 2) determined by
SOLVE (Terwilliger & Berendzen, 1999)
has provided an electron-density map that is
of sufficient quality to solve the structure.
Preliminary refinement has confirmed the
assignment of the selenium and caesium
positions.
We thank the Leverhulme Trust for
providing funds for this research work
(Grant F/158/BC) and the staffs of ESRF
and Daresbury SRS for help with data
collection. DD thanks the Royal Society for
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Figure 4
Plot of the /' and f" values for Cs (dark lines) and Se (gray fines)
from 6000 eV (2 A) to 18 000 cV (0.7 A) and plotted using tools
from the web page http://www.bmsc.washinglon.edu/scalter.
A good solution to the Patterson maps has
been obtained using the program SOLVE
and most of the Ffarker peaks can be
explained by four Se atoms and three Cs
atoms. The strongest selenium peak
(u - 0.17, 0, 0.08) is in the map using
data calculated at the absorption edge
X.2 = 0-98 A (Fig. 3). This Patterson peak
is also strong in the map calculated from
data measured at Ar = 0.87 A. The selenium
signal is very much reduced at the longer
wavelengths above the selenium absorption
a University Research Fellowship and OA
was supported by a Darwin Trust student¬
ship. Plasmid pAR1993 was a kind gift from
William Studier and Alan Rosenberg
(Brookhaven National Laboratories).
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